10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)

☒	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
	For the quarterly period ended September 30, 2021
	or
☐	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ______________to _______________.

Commission File Number: 001-38608

Summit Wireless Technologies, Inc.

(Exact name of registrant as specified in its charter)

Delaware	30-1135279
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)

6840 Via Del Oro, Ste. 280

San Jose, CA 95119

(Address of principal executive offices) (Zip Code)

(408) 627-4716

(Registrant’s telephone number, including area code)

N/A

(Former name, former address and former fiscal year, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading symbol(s)	Name of each exchange on which registered
Common Stock, par value $0.0001 per share	WISA	The Nasdaq Capital Market

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes  ⌧    No  ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes  ⌧    No  ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer”, “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer  ☐	Accelerated filer  ☐
Non-accelerated filer  ⌧	Smaller reporting company  ⌧
	Emerging growth company  ⌧

If an emerging growth company, indicate by check-mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes  ☐    No  ⌧

The number of shares of the registrant’s common stock outstanding as of November 9, 2021 is 15,803,940.

SUMMIT WIRELESS TECHNOLOGIES, INC.

QUARTERLY REPORT ON FORM 10-Q

For the quarter ended September 30, 2021

	Page  Number
PART I: FINANCIAL INFORMATION
Item 1. Financial Statements (unaudited)
Condensed Consolidated Balance Sheets	3
Condensed Consolidated Statements of Operations	4
Condensed Consolidated Statements of Convertible Preferred Stock and Stockholders’ Equity (Deficit)	5
Condensed Consolidated Statements of Cash Flows	7
Notes to Condensed Consolidated Financial Statements	8
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations	30
Item 3. Quantitative and Qualitative Disclosures About Market Risk	34
Item 4. Controls and Procedures	35
PART II. OTHER INFORMATION
Item 1. Legal Proceedings	36
Item 1A. Risk Factors	36
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds	36
Item 3. Defaults Upon Senior Securities	36
Item 4. Mine Safety Disclosures	36
Item 5. Other Information	36
Item 6. Exhibits	37
SIGNATURES	38

2

PART I: FINANCIAL INFORMATION

Item 1. Financial Statements

SUMMIT WIRELESS TECHNOLOGIES, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(in thousands, except share and per share data)

	September 30, 2021		December 31, 2020
Assets	(unaudited)		(1)
Current Assets:
Cash and cash equivalents	$	16,067	$	7,415
Accounts receivable		205		85
Inventories		3,954		2,708
Prepaid expenses and other current assets		1,480		908
Total current assets		21,706		11,116
Property and equipment, net		169		142
Other assets		41		41
Total assets	$	21,916	$	11,299
Liabilities, Convertible Preferred Stock and Stockholders’ Equity
Current Liabilities:
Accounts payable	$	825	$	672
Accrued liabilities		2,040		1,433
Borrowings, current position		—		179
Total current liabilities		2,865		2,284
Other liabilities		47		39
Borrowings, net of current position		—		668
Derivative liability		—		387
Warrant liability		8		8
Total liabilities		2,920		3,386
Commitments and contingencies (Note 8)
Series A 8% Senior Convertible Preferred stock, par value $0.0001; 1,250,000 shares authorized; 0 and 250,000 shares issued and outstanding as of September 30, 2021 and December 31, 2020, (liquidation preference of $0 and $1,136,000)		—		597
Stockholders’ Equity:
Common stock, par value $0.0001; 200,000,000 shares authorized; 15,803,940 and 8,402,250 shares issued and outstanding as of September 30, 2021 and December 31, 2020, respectively		2		1
Additional paid-in capital		228,128		207,698
Accumulated deficit		(209,134)		(200,383)
Total stockholders’ equity		18,996		7,316
Total liabilities, convertible preferred stock and stockholders’ equity	$	21,916	$	11,299

(1) The condensed consolidated balance sheet as of December 31, 2020 was derived from the audited consolidated balance sheet as of that date.

Note: Share and per share amounts have been retroactively adjusted to reflect the impact of a 1-for-20 reverse stock split effected in April 2020, as discussed in Note 6.

The accompanying notes are an integral part of these condensed consolidated financial statements.

3

SUMMIT WIRELESS TECHNOLOGIES, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

For the three and nine months ended September 30, 2021 and 2020

(in thousands, except share and per share data)

(unaudited)

	Three Months Ended September 30,				Nine Months Ended September 30,
	2021		2020		2021		2020
Revenue, net	$	1,807	$	607	$	4,541	$	1,366
Cost of revenue		1,301		503		3,281		1,187
Gross profit		506		104		1,260		179
Operating Expenses:
Research and development		1,322		1,240		3,800		3,278
Sales and marketing		1,021		835		2,870		2,043
General and administrative		1,081		1,014		3,037		2,512
Total operating expenses		3,424		3,089		9,707		7,833
Loss from operations		(2,918)		(2,985)		(8,447)		(7,654)
Interest expense		(3)		(5)		(9)		(1,394)
Change in fair value of warrant liability		—		—		—		24
Gain on forgiveness of Paycheck Protection Program loan		859		—		859		—
Other expense		1		—		(6)		(41)
Warrant inducement expense		—		—		(1,146)		—
Loss before provision for income taxes		(2,061)		(2,990)		(8,749)		(9,065)
Provision for income taxes		—		—		2		3
Net loss		(2,061)		(2,990)		(8,751)		(9,068)
Convertible preferred stock dividend		—		(20)		(34)		(60)
Deemed dividend on exchange of convertible preferred stock for common stock		—		—		(1,192)		—
Deemed dividend from warrant repricing		—		—		—		(134)
Net loss attributable to common stockholders	$	(2,061)	$	(3,010)	$	(9,977)	$	(9,262)
Net loss per common share - basic and diluted	$	(0.15)	$	(0.39)	$	(0.86)	$	(2.15)
Weighted average number of common shares used in computing net loss per common share		13,917,295		7,709,692		11,600,875		4,304,721

Note: Share and per share amounts have been retroactively adjusted to reflect the impact of a 1-for-20 reverse stock split effected in April 2020, as discussed in Note 6.

The accompanying notes are an integral part of these condensed consolidated financial statements.

4

SUMMIT WIRELESS TECHNOLOGIES, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS’ EQUITY (DEFICIT)

For the three and nine months ended September 30, 2021 and 2020

(in thousands, except share and per share data)

(unaudited)

									Accumulated
									Other				Total
	Convertible Preferred Stock			Common Shares			Additional		Comprehensive		Accumulated		Stockholders’
	Shares	Amount		Shares	Amount		Paid-in Capital		Loss		Deficit		Equity
Balance as of December 31, 2020	250,000	$	597	8,402,250	$	1	$	207,698	$	—	$	(200,383)	$	7,316
Issuance of common stock upon warrant exercise	—		—	2,086,251		—		5,095		—		—		5,095
Warrants issued in connection with warrant exercise	—		—	—		—		567		—		—		567
Convertible preferred stock dividend	—		20	—		—		(20)		—		—		(20)
Stock-based compensation	—		—	643,700		—		254		—		—		254
Release of vested restricted common stock	—		—	352		—		—		—		—		—
Net loss	—		—	—		—		—		—		(3,292)		(3,292)
Balance as of March 31, 2021	250,000		617	11,132,553		1		213,594		—		(203,675)		9,920
Issuance of common stock upon warrant exercise	—		—	1,360,244		—		3,159		—		—		3,159
Warrants issued in connection with warrant exercise	—		—	—		—		579		—		—		579
Convertible preferred stock dividend	—		14	—		—		(14)		—		—		(14)
Exchange of convertible preferred stock for common stock	(250,000)		(631)	250,000		—		1,640		—		—		1,640
Warrants issued upon exchange of preferred stock for common stock	—		—	—		—		570		—		—		570
Deemed dividend on exchange of convertible preferred stock	—		—	—		—		(1,192)		—		—		(1,192)
Stock-based compensation	—		—	10,000		—		335		—		—		335
Issuance of common stock to vendor	—		—	10,000		—		34		—		—		34
Net loss	—		—	—		—		—		—		(3,398)		(3,398)
Balance as of June 30, 2021	—		—	12,762,797		1		218,705		—		(207,073)		11,633
Stock-based compensation	—		—	320,800		—		349		—		—		349
Release of vested restricted common stock	—		—	201,343		—		—		—		—		—
Issuance of common stock upon warrant exercise, net of issuance costs	—		—	19,000		—		49		—		—		49
Registered direct offering, net of issuance costs	—		—	2,500,000		1		9,025		—		—		9,026
Net loss	—		—	—		—		—		—		(2,061)		(2,061)
Balance as of September 30, 2021	—	$	—	15,803,940	$	2	$	228,128	$	—	$	(209,134)	$	18,996

Note: Share amounts have been retroactively adjusted to reflect the impact of a 1-for-20 reverse stock split effected in April 2020, as discussed in Note 6.

The accompanying notes are an integral part of these condensed consolidated financial statements.

5

SUMMIT WIRELESS TECHNOLOGIES, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS’ EQUITY (DEFICIT)

For the three and nine months ended September 30, 2021 and 2020

(in thousands, except share and per share data)

(unaudited)

									Accumulated
									Other				Total
	Convertible Preferred Stock			Common Shares			Additional		Comprehensive		Accumulated		Stockholders’
	Shares	Amount		Shares	Amount		Paid-in Capital		Loss		Deficit		Equity (Deficit)
Balance as of December 31, 2019	250,000	$	517	1,245,238	$	—	$	188,320	$	(48)	$	(187,678)	$	594
Issuance of common stock and warrants, net of offering costs	—		—	91,062		—		725		—		—		725
Issuance of common stock in connection with notes payable	—		—	500		—		4		—		—		4
Issuance of warrants in connection with convertible notes payable	—		—	—		—		630		—		—		630
Convertible preferred stock dividend	—		20	—		—		(20)		—		—		(20)
Stock-based compensation	—		—	2,000		—		75		—		—		75
Restricted stock awards cancelled	—		—	(550)		—		—		—		—		—
Release of vested restricted common stock	—		—	353		—		—		—		—		—
Net loss	—		—	—		—		—		—		(2,680)		(2,680)
Balance as of March 31, 2020	250,000		537	1,338,603		—		189,734		(48)		(190,358)		(672)
Issuance of common stock, prefunded warrants and warrants, net of public offering costs	—		—	1,525,000		—		5,515		—		—		5,515
Proceeds from the exercise of prefunded warrants and common stock warrants	—		—	485,000		—		37		—		—		37
Issuance of common stock, net of shelf offering costs	—		—	4,315,000		1		9,957		—		—		9,958
Issuance of common stock in connection with settlements	—		—	60,250		—		135		—		—		135
Deemed dividend from warrant down-round provision	—		—	—		—		(134)		—		—		(134)
Warrant repricing	—		—	—		—		134		—		—		134
Convertible preferred stock dividend	—		20	—		—		(20)		—		—		(20)
Stock-based compensation	—		—	2,000		—		72		—		—		72
Restricted stock awards cancelled	—		—	(2,500)		—		—		—		—		—
Gain on foreign currency translation from closure of subsidiary	—		—	—		—		—		48		—		48
Net loss	—		—	—		—		—		—		(3,398)		(3,398)
Balance as of June 30, 2020	250,000		557	7,723,353		1		205,430		—		(193,756)		11,675
June 2020 shelf offering - issuance costs	—		—	—		—		(42)		—		—		(42)
Convertible preferred stock dividend	—		20	—		—		(20)		—		—		(20)
Stock-based compensation	—		—	98,669		—		662		—		—		662
Release of vested restricted common stock	—		—	353		—		—		—		—		—
Net loss	—		—	—		—		—		—		(2,990)		(2,990)
Balance as of September 30, 2020	250,000	$	577	7,822,375	$	1	$	206,030	$	—	$	(196,746)	$	9,285

Note: Share amounts have been retroactively adjusted to reflect the impact of a 1-for-20 reverse stock split effected in April 2020, as discussed in Note 6.

The accompanying notes are an integral part of these condensed consolidated financial statements.

6

SUMMIT WIRELESS TECHNOLOGIES, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

For the nine months ended September 30, 2021 and 2020

(in thousands, except share and per share data)

(unaudited)

	Nine Months Ended September 30,
	2021		2020
Cash flows from operating activities:
Net loss	$	(8,751)	$	(9,068)
Adjustments to reconcile net loss to net cash used in operating activities:
Warrant inducement expense		1,146		—
Gain on forgiveness of Paycheck Protection Program loan		(859)		—
Stock-based compensation		938		809
Depreciation and amortization		59		46
Expense for issuance of common stock for services		34		—
Amortization of intangible asset		—		25
Amortization of debt discounts		—		1,389
Expense related to common stock issued in settlements		—		135
Change in fair value of warrant liability		—		(24)
Gain on foreign currency translation from closure of subsidiary		—		48
Changes in operating assets and liabilities:
Accounts receivable		(120)		(138)
Inventories		(1,246)		90
Prepaid expenses and other assets		(572)		66
Accounts payable		153		(643)
Accrued liabilities		644		(234)
Net cash used in operating activities		(8,574)		(7,499)
Cash flows from investing activities:
Purchases of property and equipment		(86)		(15)
Net cash used in investing activities		(86)		(15)
Cash flows from financing activities:
Proceeds from issuance of common stock upon warrant exercises, net of issuance costs		8,303		—
Repayment of capital lease		(17)		—
Proceeds from issuance of common stock in registered direct offering, net of issuance costs		9,026		—
Proceeds from issuance of common stock, prefunded warrants and warrants, net of issuance costs		—		6,240
Proceeds from issuance of common stock, net of shelf offering costs		—		9,951
Proceeds from the exercise of prefunded warrants and common stock warrants		—		37
Proceeds from issuance of promissory notes		—		847
Proceeds from issuance of convertible notes payable, net of issuance costs		—		1,396
Repayment of convertible notes payable		—		(2,151)
Net cash provided by financing activities		17,312		16,320
Net increase in cash and cash equivalents		8,652		8,806
Cash and cash equivalents as of beginning of period		7,415		298
Cash and cash equivalents as of end of period	$	16,067	$	9,104
Supplemental disclosure of cash flow information:
Cash paid for interest	$	3	$	352
Cash paid for income taxes	$	2	$	3
Noncash Investing and Financing Activities:
Exchange of convertible preferred stock for common stock	$	1,640	$	—
Deemed dividend on exchange of convertible preferred stock for common stock	$	(1,192)	$	—
Issuance of warrants in connection with exchange of preferred stock	$	570	$	—
Convertible preferred stock dividend	$	34	$	60
Issuance of warrants in connection with convertible notes payable	$	—	$	630
Issuance of common stock in connection with convertible notes payable	$	—	$	4
Issuance of warrants in connection with common stock offerings	$	—	$	8,354
Deemed dividend from warrant repricing	$	—	$	(134)
Issuance costs for shelf offering of common stock in accounts payable	$	—	$	35
Warrant repricing	$	—	$	134
Property and equipment purchased through capital lease	$	—	$	72

The accompanying notes are an integral part of these condensed consolidated financial statements.

7

SUMMIT WIRELESS TECHNOLOGIES, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

For the Nine Months Ended September 30, 2021 and 2020

(unaudited)

1.    Business and Summary of Significant Accounting Policies

Summit Wireless Technologies, Inc. (together with its subsidiaries also referred to herein as “we”, “us”, “our”, or the “Company”) was originally formed as a limited liability company in Delaware on July 23, 2010. The Company develops wireless audio semiconductors and modules for consumer electronics companies to enable mainstream consumers and audio enthusiasts to experience high quality audio.

Basis of Presentation

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial information and pursuant to Article 10 of Regulation S-X of the Securities Act of 1933, as amended (“Securities Act”). Accordingly, they do not include all of the information and notes required by U.S. GAAP for complete financial statements. These unaudited condensed consolidated financial statements include all normal and recurring adjustments that the Company believes are necessary to fairly state the Company’s financial position and the results of operations and cash flows. Interim period results are not necessarily indicative of results of operations or cash flows for a full year or any subsequent interim period. The condensed consolidated balance sheet as of December 31, 2020 has been derived from audited consolidated financial statements at that date, but does not include all disclosures required by U.S. GAAP for complete financial statements.

Use of Estimates

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates.

Reclassification

Certain reclassifications have been made to prior periods’ consolidated financial statements to conform to the current period presentation. These reclassifications did not result in any change in previously reported net loss, total assets or stockholders’ equity.

Concentration of Credit Risk and Other Risks and Uncertainties

Financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash and cash equivalents and accounts receivable. Cash and cash equivalents are deposited in demand and money market accounts at one financial institution. At times, such deposits may be in excess of insured limits. The Company has not experienced any losses on its deposits of cash and cash equivalents.

The Company’s accounts receivable are derived from revenue earned from customers located throughout the world. The Company performs credit evaluations of its customers’ financial condition as necessary, and sometimes requires partial payment in advance of shipping. As of September 30, 2021 and December 31, 2020, there was no allowance for doubtful accounts. As of September 30, 2021, the Company had one customer accounting for 63% of accounts receivable. As of December 31, 2020, the Company had three customers accounting for 36%, 31% and 15% of accounts receivable. The Company had three customers accounting for 63%, 12% and 12% of its net revenue for the three months ended September 30, 2021. The Company had three customers accounting for 33%, 17%, and 10% of its net revenue for the nine months ended September 30, 2021. The Company had four customers accounting for 30%, 18%, 15% and 11% of its net revenue for the three months ended September 30, 2020. The Company had three customers accounting for 54%, 28% and 11% of its net revenue for the nine months ended September 30, 2020.

The Company’s future results of operations involve a number of risks and uncertainties. Factors that could affect the Company’s future operating results and cause actual results to vary materially from expectations include, but are not limited to, rapid technological change, continued acceptance of the Company’s products, competition from substitute products and larger companies, protection of proprietary technology, strategic relationships and dependence on key individuals.

8

SUMMIT WIRELESS TECHNOLOGIES, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

For the Nine Months Ended September 30, 2021 and 2020

(unaudited)

1.    Summary of Significant Accounting Policies, continued

The Company relies on sole-source suppliers to manufacture some of the components used in its product. The Company’s manufacturers and suppliers may encounter problems during manufacturing due to a variety of reasons, any of which could delay or impede their ability to meet demand. The Company is heavily dependent on a single contractor in China for assembly and testing of its products, a single contractor in Japan for the production of its transmit semiconductor chip and a single contractor in China for the production of its receive semiconductor chip.

Convertible Financial Instruments

The Company bifurcates conversion options and warrants from their host instruments and accounts for them as freestanding derivative financial instruments if certain criteria are met. The criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re-measured at fair value under otherwise applicable generally accepted accounting principles with changes in fair value reported in earnings as they occur and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument. An exception to this rule is when the host instrument is deemed to be conventional, as that term is described under applicable U.S. GAAP.

When the Company has determined that the embedded conversion options and warrants should be bifurcated from their host instruments, discounts are recorded for the intrinsic value of conversion options embedded in the instruments based upon the differences between the fair value of the underlying common stock at the commitment date of the transaction and the effective conversion price embedded in the instrument.

Debt discounts under these arrangements are amortized to interest expense using the interest method over the earlier of the term of the related debt or their earliest date of redemption.

Warrants for Shares of Common Stock and Derivative Financial Instruments

Warrants for shares of common stock and other derivative financial instruments are classified as equity if the contracts (1) require physical settlement or net-share settlement or (2) give the Company a choice of net-cash settlement or settlement in its own shares (physical settlement or net-share settlement). Contracts which (1) require net-cash settlement (including a requirement to net cash settle the contract if an event occurs and if that event is outside the control of the Company), (2) give the counterparty a choice of net-cash settlement or settlement in shares (physical settlement or net-share settlement), or (3) that contain reset provisions that do not qualify for the scope exception are classified as liabilities. The Company assesses classification of its warrants for shares of common stock and other derivatives at each reporting date to determine whether a change in classification between equity and liabilities is required.

The issuance of the convertible notes payable generated a beneficial conversion feature (“BCF”), which arises when a debt or equity security is issued with an embedded conversion option that is beneficial to the investor or in the money at inception because the conversion option has an effective strike price that is less than the market price of the underlying stock at the commitment date. The Company recognized the BCF by allocating the intrinsic value of the conversion option, which is the number of shares of common stock available upon conversion multiplied by the difference between the effective conversion price per share and the fair value of common stock per share on the commitment date, to shares of common stock, resulting in a discount on the convertible debt.

9

SUMMIT WIRELESS TECHNOLOGIES, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

For the Nine Months Ended September 30, 2021 and 2020

(unaudited)

1.    Summary of Significant Accounting Policies, continued

Revenue Recognition

Revenue consists primarily of the sale of the wireless modules. The Company applies the following five steps: (1) identify the contract with a customer, (2) identify the performance obligations in the contract, (3) determine the transaction price, (4) allocate the transaction price to the performance obligations in the contract, and (5) recognize revenue when a performance obligation is satisfied. The Company considers customer purchase orders to be the contracts with a customer. Revenues, net of expected discounts, are recognized when the performance obligations of the contract with the customer are satisfied and when control of the promised goods are transferred to the customer, typically when products, which have been determined to be the only distinct performance obligations, are shipped to the customer. Expected costs of assurance warranties and claims are recognized as expense.

Taxes assessed by a governmental authority that are both imposed on and concurrent with a specific revenue-producing transaction, that are collected by us from a customer and deposited with the relevant government authority, are excluded from revenue. Our revenue arrangements do not contain significant financing components.

Sales to certain distributors are made under arrangements which provide the distributors with price adjustments, price protection, stock rotation and other allowances under certain circumstances. The Company does not provide its customers with a contractual right of return. However, the Company accepts limited returns on a case-by-case basis. These returns, adjustments and other allowances are accounted for as variable consideration. We estimate these amounts based on the expected amount to be provided to customers and reduce revenue recognized. We believe that there will not be significant changes to our estimates of variable consideration.

If a customer pays consideration, or the Company has a right to an amount of consideration that is unconditional before we transfer a good or service to the customer, those amounts are classified as contract liabilities which are included in other current liabilities when the payment is made or it is due, whichever is earlier.

Contract Balances

We receive payments from customers based on a billing schedule as established in our contracts to partially offset prepayments required by our vendors on long lead time materials. Amounts collected prior to the fulfillment of the performance obligation are considered contract liabilities and classified as customer advances within accrued liabilities on the condensed consolidated balance sheets. Contract assets are recorded when we have a conditional right to consideration for our completed performance under the contracts. Accounts receivables are recorded when the right to this consideration becomes unconditional. We do not have any material contract assets as of September 30, 2021 and December 31, 2020.

(in thousands)

	September 30,		December 31,
	2021		2020
Contract Liabilities	$	715	$	373

During the nine months ended September 30, 2021, the Company recognized $373,000 of revenue that was included in the contract liabilities as of December 31, 2020.

Revenue by Geographic Area

In general, revenue disaggregated by geography (See Note 10) is aligned according to the nature and economic characteristics of our business and provides meaningful disaggregation of our results of operations. Since we operate in one segment, all financial segment and product line information can be found in the condensed consolidated financial statements.

10

SUMMIT WIRELESS TECHNOLOGIES, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

For the Nine Months Ended September 30, 2021 and 2020

(unaudited)

1.    Summary of Significant Accounting Policies, continued

Advertising Costs

Advertising costs are charged to sales and marketing expenses as incurred. Advertising costs for the three and nine months ended September 30, 2021 were $152,000 and $451,000, respectively. Advertising costs for the three and nine months ended September 30, 2020 were $65,000 and $81,000, respectively.

Comprehensive Loss

Comprehensive loss represents the changes in equity of an enterprise, other than those resulting from stockholder transactions. Accordingly, comprehensive loss may include certain changes in equity that are excluded from net loss. For the three and nine months ended September 30, 2021 and 2020, the Company’s comprehensive loss is the same as its net loss.

Foreign Currency

The financial position and results of operations of the Company’s foreign operations are measured using currencies other than the U.S. dollar as their functional currencies. Accordingly, for these operations all assets and liabilities are translated into U.S. dollars at the current exchange rates as of the respective balance sheet date. Expense items are translated using the weighted average exchange rates prevailing during the period. Cumulative gains and losses from the translation of these operations’ financial statements are reported as a separate component of stockholders’ equity, while foreign currency transaction gains or losses, resulting from re-measuring local currency to the U.S. dollar are recorded in the condensed consolidated statement of operations in other income (expense), net and were not material for the three and nine months ended September 30, 2021 and 2020.

Net Loss per Common Share

Basic net loss per common share is calculated by dividing the net loss attributable to common stockholders by the weighted average number of shares of common stock outstanding during the period, without consideration for potentially dilutive securities. Diluted net loss per common share is computed by dividing the net loss attributable to common stockholders by the weighted average number of shares of common stock and potentially dilutive common share equivalents outstanding for the period determined using the treasury-stock and if-converted methods. For purposes of the diluted net loss per common share calculation, Series A Preferred Stock, warrants exercisable for common stock, restricted stock units and shares issuable upon the conversion of convertible notes payable are considered to be potentially dilutive securities.

For the three and nine months ended September 30, 2021, warrants to purchase 4,475,424 shares of common stock, 711,805 shares of restricted stock, 310,000 shares of restricted stock issued under an inducement grant and 456,931 shares underlying restricted stock units have been excluded from the calculation of net loss per common share because the inclusion would be antidilutive. For the three and nine months ended September 30, 2020, warrants to purchase 7,337,199 shares of common stock, 250,000 shares of Series A Preferred Stock and 98,669 shares of restricted stock have been excluded from the calculation of net loss per common share because the inclusion would be antidilutive.

11

SUMMIT WIRELESS TECHNOLOGIES, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

For the Nine Months Ended September 30, 2021 and 2020

(unaudited)

1.     Summary of Significant Accounting Policies, continued

Recently Issued and Not Yet Adopted Accounting Pronouncements

In February 2016, the FASB issued ASU 2016-02, “Leases”. The objective of the update is to increase transparency and comparability among organizations by recognizing lease assets and liabilities on the balance sheet for leases with a lease term of more than 12 months. In addition, the update will require additional disclosures regarding key information about leasing arrangements. Under existing guidance, operating leases are not recorded as lease assets and lease liabilities on the balance sheet. In October 2019, the FASB decided to defer the mandatory effective date of ASU 2016-02 to fiscal years beginning after December 15, 2020 for certain entities, including private companies. In June 2020, in response to adverse effect caused by Coronavirus Disease pandemic on private businesses, the FASB issued ASU 2020-05 which deferred the effective date for ASU 2016-02 for private businesses to annual reporting periods beginning after December 15, 2021. As an emerging growth company, the Company is allowed to adopt accounting pronouncements at the same time as non-public business entities. As a result, we will adopt the update for our fiscal year beginning after December 15, 2021. The Company does not expect the adoption of this standard to significantly impact the condensed consolidated financial statements.

2.     Going Concern

The condensed consolidated financial statements of the Company have been prepared on a going concern basis, which contemplates the realization of assets and the discharge of liabilities in the normal course of business. The Company has incurred net operating losses each year since inception. As of September 30, 2021, the Company had cash and cash equivalents of $16.1 million and reported net cash used in operations of $8.6 million during the nine months ended September 30, 2021. The Company expects operating losses to continue in the foreseeable future because of additional costs and expenses related to research and development activities, plans to expand its product portfolio, and increase its market share. The Company’s ability to transition to attaining profitable operations is dependent upon achieving a level of revenues adequate to support its cost structure.

Based on current operating levels, the Company will need to raise additional funds by selling additional equity or incurring debt. To date, the Company has not generated significant revenues and has funded its operations primarily through sales of its common stock in public markets, sales of common and preferred units prior to its initial public offering (“IPO”), and proceeds from the exercise of warrants to purchase common stock and the sale of convertible notes. The Company also obtained a loan of $847,000, pursuant to the Paycheck Protection Program under Division A, Title I of the Coronavirus Aid, Relief, and Economic Security Act, but the use of funds from such loan, by its terms, has been limited to making payroll payments to our employees and other permitted purposes relating to the operation of our business. (See Note 4 – Borrowings – Payroll Protection Program Note Agreement.) Additionally, future capital requirements will depend on many factors, including the rate of revenue growth, the selling price of the Company’s products, the expansion of sales and marketing activities, the timing and extent of spending on research and development efforts and the continuing market acceptance of the Company’s products. These factors raise substantial doubt about the Company’s ability to continue as a going concern.

Management of the Company intends to raise additional funds through the issuance of equity securities or debt. There can be no assurance that, in the event the Company requires additional financing, such financing will be available at terms acceptable to the Company, if at all. Failure to generate sufficient cash flows from operations, raise additional capital and reduce discretionary spending could have a material adverse effect on the Company’s ability to achieve its intended business objectives. As a result, the substantial doubt about the Company’s ability to continue as a going concern has not been alleviated. The accompanying condensed consolidated financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.

12

SUMMIT WIRELESS TECHNOLOGIES, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

For the Nine Months Ended September 30, 2021 and 2020

(unaudited)

3.    Balance Sheet Components

Inventories (in thousands):

	September 30,		December 31,
	2021		2020
Raw materials	$	1,693	$	1,872
Work in progress		539		283
Finished goods		1,722		553
Total inventories	$	3,954	$	2,708

Property and equipment, net (in thousands):

	September 30,		December 31,
	2021		2020
Machinery and equipment	$	952	$	866
Tooling		11		11
Computer software		89		89
Furniture and fixtures		15		15
Leasehold improvements		40		40
		1,107		1,021
Less: Accumulated depreciation and amortization		(938)		(879)
Property and equipment, net	$	169	$	142

Depreciation and amortization expense for the three months ended September 30, 2021 and 2020 was $20,000 and $17,000, respectively. Depreciation and amortization expense for the nine months ended September 30, 2021 and 2020 was $59,000 and $46,000, respectively.

The cost and accumulated depreciation of assets acquired under capital lease included in machinery and equipment in the above table as of September 30, 2021 were $72,000 and $26,000, respectively.

Accrued liabilities (in thousands):

	September 30,		December 31,
	2021		2020
Accrued vacation	$	344	$	328
Accrued compensation		321		84
Customer advances		715		373
Accrued professional fees		158		161
Accrued rebate		319		326
Accrued other		183		161
Total accrued liabilities	$	2,040	$	1,433

13

SUMMIT WIRELESS TECHNOLOGIES, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

For the Nine Months Ended September 30, 2021 and 2020

(unaudited)

4.    Borrowings

Funding Agreement

On January 23, 2020, we entered into a funding agreement, as amended (the “Funding Agreement”), which provided for the issuance to an unaffiliated accredited investor of a convertible promissory note in the principal amount of $111,100, reflecting a 10% original issue discount, 500 shares of our common stock and a five-year warrant exercisable for 7,936 shares of our common stock at an exercise price of $9.80 per share in consideration for $100,000, which was funded on January 24, 2020. Repayment of the convertible promissory note was due 45 days from execution of the Funding Agreement, or March 9, 2020, and the investor was granted a most favored nation right. On March 31, 2020, the outstanding debt owed to such investor pursuant to the Funding Agreement was fully repaid. During the three and nine months ended September 30, 2020, the Company recognized $0 and $20,000, respectively, of interest expense from amortization of debt discounts related to the Funding Agreement.

Convertible Promissory Note

On March 30, 2020, the Company completed a private placement (the “March 2020 Private Placement”) of a senior secured convertible instrument (the “March 2020 Note”) and a warrant (the “March 2020 Warrant”) to purchase 227,679 shares of common stock at an exercise price of $6.40 per share, pursuant to which Maxim Group LLC (“Maxim”), acted as placement agent. The March 2020 Note and March 2020 Warrant were issued pursuant to a securities purchase agreement, entered into as of March 22, 2020 (the “March 2020 Purchase Agreement”) by and between the Company and an institutional investor. The March 2020 Private Placement resulted in gross proceeds of $1,700,000, before fees and other expenses associated with the transaction, including but not limited to, an $85,000 commitment fee payable to such investor. The net proceeds received by us in connection with the March 2020 Private Placement were used primarily for working capital, debt repayment and general corporate purposes. Additionally, the Company issue a warrant to Maxim to purchase up to an aggregate of 20,400 shares of common stock, subject to adjustment, as partial consideration for serving as placement agent in connection with the March 2020 Private Placement (the “March 2020 Maxim Warrant”).

The March 2020 Note ranked senior to the Company’s existing and future indebtedness and was secured to the extent and as provided in the security agreements entered into between the investor and each of the Company and its wholly-owned subsidiary, in connection with the March 2020 Private Placement. The March 2020 Note was convertible in whole or in part at the option of the investor into shares of common stock at a conversion price equal to the lesser of (a) 90% of the average of the five lowest daily VWAPs during the previous twenty trading days prior to delivery to the Company of such investor’s applicable notice of conversion and (b) $6.40, subject to certain adjustments, at any time following the earlier of (i) 60 days from execution of the March 2020 Purchase Agreement and (ii) the date on which a registration statement covering the shares of common stock underlying each of the March 2020 Note and the related warrant is declared effective by the SEC; however, if the Company entered into an underwriting agreement within 45 days of the date on which the March 2020 Note was issued in connection with an underwritten offering that closes within 45 days of the execution of the Purchase Agreement, such investor may not convert the March 2020 Note prior to the 61st day after the date on which such underwriting agreement was executed.

The March 2020 Note contained full ratchet anti-dilution protection, subject to certain price limitations required by the rules and regulations of Nasdaq and certain exceptions, upon any subsequent transaction at a price lower than the conversion price then in effect and standard adjustments in the event of stock dividends, stock splits, combinations or similar events. Additionally, upon three days’ written notice to the holder after receipt of a notice of conversion, in lieu of delivering shares of common stock upon a conversion, the Company had the right to pay the investor, in cash, an amount equal to 103% of the portion of the outstanding principal amount stated in such notice of conversion. Further, at the investor’s option, the March 2020 Note was convertible into shares of common stock or redeemable for 103% of the portion of the outstanding principal amount to be converted in the event that any transaction causes the conversion price to be lower than as required by Nasdaq rules and regulations. Subject to certain exceptions, commencing on the Conversion Trigger Date (as such term is defined in the March 2020 Note) and for a nine-month period after such date, the investor could convert only up to an aggregate of $102,000 in outstanding principal amount during any calendar month.

14

SUMMIT WIRELESS TECHNOLOGIES, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

For the Nine Months Ended September 30, 2021 and 2020

(unaudited)

4.    Borrowings, continued

At any time after issuance of the March 2020 Note, the Company could repay all (but not less than all) of the outstanding principal amount of the March 2020 Note upon ten days’ written notice to the investor. If the Company exercised its right to prepay the March 2020 Note, the investor had the right, upon five days written notice to the Company after receipt of the notice of prepayment, to convert up to 33% of the principal amount of the March 2020 Note at the applicable conversion price. The investor also had the right to require the Company to repay 105% of the outstanding principal amount of the March 2020 Note in the event of a Change of Control (as defined in the March 2020 Purchase Agreement).

At any time after the closing date of the March 2020 Private Placement, in the event that the Company issued or sold any shares of common stock or common stock equivalents (as defined in the March 2020 Note), subject to certain exceptions, at an effective price lower than the conversion price then in effect or without consideration, then the conversion price would be reduced to the price per share paid for such shares of common stock or common stock equivalents.

In connection with the March 2020 Note, the Company issued the March 2020 Warrant to the investor and the March 2020 Maxim Warrant to Maxim, respectively (see Note 6 – Convertible Preferred Stock and Stockholders’ Equity for fair value computation). The sum of the fair value of the March 2020 Warrant and the March 2020 Maxim Warrant, and the original issue discount for interest and issuance costs for the March 2020 Note were recorded as debt discounts to be amortized to interest expense over the respective term using the effective interest method.

The March 2020 Note contained several embedded conversion features. The Company determined that there was no significant value to the embedded conversion features as the underlying events to trigger the conversion features were not likely to occur. The Company did not record any embedded conversion liability related to the March 2020 Note.

On April 29, 2020, the outstanding debt of $2,040,000, owed to the investor pursuant to the March 2020 Note, was fully repaid. During the three months ended September 30, 2021 and 2020, the Company recognized $0 and $0 of interest expense from the amortization of debt discounts. During the nine months ended September 30, 2021 and 2020, the Company recognized $0 and $1,389,000 of interest expense from the amortization of debt discounts.

Payroll Protection Program Note Agreement

On May 3, 2020, we received a loan (the “PPP Loan”) from Wells Fargo Bank, National Association in the aggregate amount of $847,000, pursuant to the Paycheck Protection Program (the “PPP”) under Division A, Title I of the Coronavirus Aid, Relief, and Economic Security Act, which was enacted on March 27, 2020. The PPP Loan was funded on May 7, 2020. The PPP Loan, which is in the form of a PPP promissory note and agreement, dated May 3, 2020 (the “PPP Note Agreement”), had a maturity date of May 3, 2022 and bore interest at a rate of 1.00% per annum. Pursuant to a change in guidance by the U.S. Small Business Administration, the initial monthly payment date of the PPP Note Agreement was deferred from November 1, 2020 to August 18, 2021. The PPP Loan may be prepaid by us at any time prior to maturity with no prepayment penalties. We have used the PPP Loan amount for payroll costs, costs used to continue group health care benefits, rent, and utilities. Under the terms of the PPP Note Agreement, certain amounts of the PPP Loan may be forgiven.

Under the terms of the CARES Act, PPP loan recipients can apply for and be granted forgiveness for all or a portion of the loan granted under the PPP. Such forgiveness will be determined, subject to limitations, based on the use of loan proceeds for qualifying expenses. During the third quarter of 2021, the Company received full loan forgiveness for obligations related to the PPP loan. The Company accounted for the PPP loan as debt, and the loan forgiveness was accounted for as a debt extinguishment. The amount of loan and interest forgiven totaling $859,000, was recognized as a gain upon debt extinguishment and was reported in the accompanying condensed consolidated statements of operations for the three months and nine months ended September 30, 2021.

15

SUMMIT WIRELESS TECHNOLOGIES, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

For the Nine Months Ended September 30, 2021 and 2020

(unaudited)

5.    Fair Value Measurements

The Company measures the fair value of financial instruments using a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value into three broad levels. Each level of input has different levels of subjectivity and difficulty involved in determining fair value.

● Level 1 – Inputs used to measure fair value are unadjusted quoted prices that are available in active markets for the identical assets or liabilities as of the reporting date. Therefore, determining fair value for Level 1 investments generally does not require significant judgment, and the estimation is not difficult.

● Level 2 – Pricing is provided by third-party sources of market information obtained through investment advisors. The Company does not adjust for or apply any additional assumptions or estimates to the pricing information received from its advisors.

● Level 3 – Inputs used to measure fair value are unobservable inputs that are supported by little or no market activity and reflect the use of significant management judgment. These values are generally determined using pricing models for which the assumptions utilize management’s estimates of market participant assumptions. The determination of fair value for Level 3 instruments involves the most management judgment and subjectivity.

The Company’s financial assets and liabilities that are measured at fair value on a recurring basis as of September 30, 2021 and December 31, 2020 by level within the fair value hierarchy, are as follows:

(in thousands)	September 30, 2021
			Significant
	Quoted prices		other		Significant
	in active		observable		unobservable
	markets		inputs		inputs
	(Level 1)		(Level 2)		(Level 3)
Liabilities:
Warrant liability	$	—	$	—	$	8

(in thousands)	December 31, 2020
			Significant
	Quoted prices		other		Significant
	in active		observable		unobservable
	markets		inputs		inputs
	(Level 1)		(Level 2)		(Level 3)
Liabilities:
Derivative liability	$	—	$	—	$	387
Warrant liability	$	—	$	—	$	8

There were no transfers between Level 1, 2 or 3 during the three and nine months ended September 30, 2021 or September 30, 2020.

16

SUMMIT WIRELESS TECHNOLOGIES, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

For the Nine Months Ended September 30, 2021 and 2020

(unaudited)

5.    Fair Value Measurements, continued

Warrant Liability

The following table includes a summary of changes in fair value of the Company’s warrant liability measured at fair value using significant unobservable inputs (Level 3) for the three and nine months ended September 30, 2021 and 2020:

	For the three months ended				For the nine months ended
(in thousands)	September 30, 2021		September 30, 2020		September 30, 2021		September 30, 2020
Beginning balance	$	8	$	—	$	8	$	24
Additions		—		—		—		—
Change in fair value		—		—		—		(24)
Ending balance	$	8	$	—	$	8	$	—

The changes in fair value of the warrant liability are recorded in change in fair value of warrant liability in the condensed consolidated statements of operations.

The warrant liability is not significant at September 30, 2021 and there are no material changes to the significant unobservable inputs from December 31, 2020.

Derivative Liability

As of September 30, 2021, the Company no longer has a derivative liability. The Series A Preferred Stock was exchanged for common stock and warrants during the three months ended June 30, 2021, thereby eliminating the conversion feature which gave rise to the derivative. Prior to the exchange the Company had measured the fair value of the derivative by estimating the fair value of the Series A Preferred Stock as if conversion occurred at the end of the reporting period. The Company calculated the value of the conversion feature using the Fixed Conversion Price of the Series A Preferred Stock, as adjusted to 95% of the volume weighted average price of the common stock for the previous ten trading days constrained by the specified floor price of $30.00. The fair value of the derivative liability as of September 30, 2021 and December 31, 2020 was $0 and $387,000, respectively.

6.    Convertible Preferred Stock and Stockholders’ Equity (Deficit)

Reverse Stock Split

On March 31, 2020, the Company held a special meeting of its stockholders, at which its stockholders approved an amendment to the Company’s certificate of incorporation, as amended, to effect a reverse stock split of all of the outstanding shares of common stock at a specific ratio within a range from one-for-four to one-for-twenty, and to grant authorization to the board of directors to determine, in its sole discretion, the specific ratio and timing of the reverse stock split. On April 9, 2020, a 1-for-20 reverse stock split was effected and the condensed consolidated financial statements have been retroactively adjusted. All common stock share numbers, warrants to purchase common stock, prices and exercise prices have been retroactively adjusted to reflect the reverse stock split. The par value of the common stock and the Series A 8% Senior Convertible Preferred Stock, par value $0.0001 per share (the “Series A Preferred Stock”) outstanding and its par value were not adjusted for the reverse stock split. The common stock began trading on a split-adjusted basis on that day under the new CUSIP number 86633R 203.

17

SUMMIT WIRELESS TECHNOLOGIES, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

For the Nine Months Ended September 30, 2021 and 2020

(unaudited)

6.    Convertible Preferred Stock and Stockholders’ Equity (Deficit), continued

Series A 8% Senior Convertible Preferred Stock

On April 18, 2019, we entered into a Securities Purchase Agreement, dated as of April 18, 2019, with Lisa Walsh (the “Preferred SPA”), pursuant to which we issued 250,000 shares of our Series A 8% Senior Convertible Preferred Stock, par value $0.0001 per share (the “Series A Preferred Stock”), which shares did have a stated value of $4.00, grant holders the same voting rights as holders of our shares of common stock, and are convertible into shares of our common stock at price of $80.00 per share, subject to a floor price of $30.00 and to adjustment under our Certificate of Designations of the Preferences, Rights and Limitations of the Series A Preferred Stock, in consideration for $1,000,000 (the “Initial Tranche”). The Series A Preferred Stock may be issued in tranches of at least $500,000 and in an aggregate of up to $5 million. In connection with the Initial Tranche, the Company also issued to Ms. Walsh a warrant to purchase 12,756 shares of our common stock.

The Series A Preferred Stock contained an embedded conversion feature that the Company determined is a derivative requiring bifurcation. The fair value of the derivative liability at the issuance of the Series A Preferred Stock was $216,000, which was recorded as a derivative liability with the offset recorded as a discount to the Series A Preferred Stock. (See Note 5 – Fair Value Measurements for the fair value computation.)

As of September 30, 2021, the Company no longer has a derivative liability or any preferred stock outstanding, as all outstanding shares of Series A Preferred Stock were exchanged for 250,000 shares of common stock and warrants to purchase up to 187,500 shares of Common Stock during the three months ending June 30, 2021. On June 4, 2021, the Company and Lisa Walsh (the “Investor”) entered into an exchange agreement pursuant to which the Company effected such exchange of securities with the Investor.

As of September 30, 2021, there are 20,000,000 shares of preferred stock authorized, but there are no shares issued or outstanding.

Common Stock

Carve-Out Plan

For the three and nine months ended September 30, 2021, 0 and 352 shares of restricted stock issued under the Carve-Out Plan (the “Plan”), respectively, were released with an intrinsic value of approximately $0 and $2,000, respectively. For the three and nine months ended September 30, 2020, 353 and 706 shares of restricted stock were released with an intrinsic value of approximately $1,000 and $3,000, respectively.

2018 Long Term Stock Incentive Plan

On January 30, 2018, the Company’s board of directors approved the establishment of the Company’s 2018 Long-Term Stock Incentive Plan (the “LTIP”) and termination of the Plan. Under the LTIP, the aggregate maximum number of shares of common stock (including shares underlying options) that may be issued under the LTIP pursuant to awards of Restricted Shares or Options will be limited to 15% of the outstanding shares of common stock , which calculation shall be made on the first trading day of each new fiscal year; provided that, in any year no more than 8% of the common stock or derivative securitization with common stock underlying 8% of the common stock may be issued in any fiscal year. Thereafter, the 15% evergreen provision governs the LTIP. For fiscal year 2021, up to 672,180 shares of common stock are available for participants under the LTIP.

For the three and nine months ended September 30, 2021, 29,064 shares of restricted stock issued under the LTIP, were released with an intrinsic value of approximately $93,000. For the three and nine months ended September 30, 2020, 0 shares of restricted stock were released.

18

SUMMIT WIRELESS TECHNOLOGIES, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

For the Nine Months Ended September 30, 2021 and 2020

(unaudited)

6.    Convertible Preferred Stock and Stockholders’ Equity (Deficit), continued

A summary of activity related to restricted stock awards (excluding the deferred shares and the inducement grant restricted stock award) for the nine months ended September 30, 2021 is presented below:

		Weighted-Average
Stock Awards	Shares	Grant Date Fair Value
Non-vested as of January 1, 2021	87,169	$	2.26
Granted	664,500	$	3.57
Vested	(29,064)	$	2.26
Forfeited	—	$	—
Non-vested as of September 30, 2021	722,605	$	3.46

As of September 30, 2021, the unamortized compensation costs related to the unvested restricted stock awards was approximately $2,028,000 which is to be amortized on a straight-line basis over a weighted-average period of approximately 2.4 years.

On September 13, 2021, the Company issued 310,000 shares of restricted common stock to Eric Almgren, the Company’s new Chief Strategist, as an inducement grant (“September 2021 Inducement Grant”). Such shares were issued outside the Company’s LTIP and 2020 Stock Plan. In accordance with the September 2021 Inducement Grant, 77,500 shares will vest monthly over a period of 36 months and the remaining 232,500 will vest in 77,500 increments, upon the achievement of certain company milestones related to the volume weighted average closing price per share of the Company’s common stock, as reported on NASDAQ, for the ten (10) consecutive days in which thresholds of the Company’s market capitalization of $75 million, $100 million and $150 million are achieved. The September 2021 Inducement Grant has been valued with an approximate value of $772,000 and will be amortized over 36 months. The Company recorded $10,000 of stock-based compensation for the three and nine months ended September 30, 2021.

2020 Stock Incentive Plan

On July 27, 2020, the board of directors adopted the Company’s 2020 Stock Incentive Plan (the “2020 Stock Plan”) and the reservation of an aggregate of 650,000 shares of the Company’s common stock authorized for issuance under the 2020 Stock Plan, subject to stockholder approval. The 2020 Stock Plan authorizes the grant of equity-based compensation to the Company’s senior managers, employees, directors, consultants, professionals and service providers in the form of stock options, restricted stock and restricted stock units. On July 27, 2020, the Company also granted, subject to stockholder approval, an aggregate of 614,824 restricted stock units to senior managers, employees, directors, consultants. Each of the awards are scheduled to vest on the first, second, and third anniversaries of August 15, 2020, so long as such award recipient remains in service of the Company on each such anniversary. Each restricted stock unit represents the right to receive one share of the Company’s common stock under the 2020 Stock Plan. On October 20, 2020, the Company held the 2020 Annual Meeting of Stockholders and approved the adoption of the 2020 Stock Plan and the reservation of an aggregate of 650,000 shares of the Company’s common stock. In connection with the approval, the Company issued 614,824 restricted stock units to employees, directors and consultants.

19

SUMMIT WIRELESS TECHNOLOGIES, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

For the Nine Months Ended September 30, 2021 and 2020

(unaudited)

6.    Convertible Preferred Stock and Stockholders’ Equity (Deficit), continued

A summary of activity related to restricted stock units under the Company’s 2020 Stock Plan for the nine months ended September 30, 2021 is presented below:

		Weighted-Average
Stock Units	Shares	Grant Date Fair  Value
Non-vested as of January 1, 2021	626,974	$	2.29
Granted	20,500	$	3.81
Vested	(201,343)	$	2.27
Forfeited	—	$	—
Non-vested as of September 30, 2021	446,131	$	2.36

As of September 30, 2021, the unamortized compensation costs related to the unvested restricted stock units was approximately $1,042,000 which is to be amortized on a straight-line basis over a weighted-average period of approximately 1.9 years.

For the three and nine months ended September 30, 2021, 201,343 shares of restricted stock units were released under the 2020 Stock Plan with an intrinsic value of approximately $646,000. For the three and nine months ended September 30, 2020, no shares of restricted stock units were released.

February 2020 Private Placement

On February 28, 2020, the Company completed a private placement (the “February 2020 Private Placement”) of 91,062 units (the “Units”), each unit consisting of (i) one (1) share of common stock and (ii) a warrant to purchase 0.50 of a share of common stock (the “February 2020 Warrants”), at a price per Unit of $9.17. The Units were issued pursuant to a Unit Purchase Agreement, dated February 4, 2020, and a subscription agreement, dated February 28, 2020 by and among the Company and the purchasers signatory thereto. In connection with the February 2020 Private Placement, we paid Alexander Capital, L.P. (“Alexander”) cash fees of $83,000 and issued to Alexander a warrant to purchase 4,553 shares of common stock (the “February 2020 Alexander Warrant”). Such warrant is exercisable at a per share price of $8.80 and is exercisable at any time during the five-year period commencing on the date of issuance. The February 2020 Private Placement, which was priced above market, resulted in gross proceeds of $835,000 before fees and other expenses associated with the transaction.

The February 2020 Warrants are exercisable to purchase up to an aggregate of 45,534 shares of common stock commencing on the date of issuance at an exercise price of $9.80 per share, subject to adjustment upon stock splits, reverse stock splits, and similar capital changes. The February 2020 Warrants are exercisable immediately and will expire on the close of business on February 28, 2025. The exercise of the February 2020 Warrants are subject to beneficial ownership limitations such that each holder of such February 2020 Warrant may exercise it to the extent that such exercise would result in such holder being the beneficial owner in excess of 4.99% (or, upon election of such holder, 9.99%), which beneficial ownership limitation may be increased or decreased up to 9.99% upon notice to the Company, provided that any increase in such limitation will not be effective until 61 days following notice to the Company.

The grant date fair value of February 2020 Warrants was $103,000, which was recorded within stockholders’ equity as a cost of issuance and an increase to additional paid-in capital on the accompanying condensed consolidated balance sheet. The fair value of such warrants was determined using the Black-Scholes Model based on the following weighted average assumptions: common stock price on date of grant of $6.00; expected dividend yield of 0.0%; expected volatility of 59.0%; risk-free interest rate of 0.89% and expected life of 5 years.

20

SUMMIT WIRELESS TECHNOLOGIES, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

For the Nine Months Ended September 30, 2021 and 2020

(unaudited)

6.    Convertible Preferred Stock and Stockholders’ Equity (Deficit), continued

The fair value of the February 2020 Alexander Warrant at issuance was $11,000. The fair value of such warrant was estimated using the Black-Scholes Model based on the following weighted average assumptions: common share price on date of grant $6.00, expected dividend yield 0%, expected volatility 59%, risk-free interest rate 0.89% and expected life of 5 years. The fair value was recorded within stockholders’ equity as a cost of issuance and an increase to additional paid-in capital on the accompanying condensed consolidated balance sheet.

April 2020 Public Offering

On April 23, 2020, the Company closed an underwritten public offering of 1,525,000 shares of its common stock, pre-funded common stock purchase warrants to purchase up to an aggregate of 475,000 shares of common stock, and common stock purchase warrants to purchase up to an aggregate of 2,000,000 shares of the Company’s common stock (the “April 2020 Public Offering”). Each share of common stock or pre-funded common stock purchase warrant was sold together with one common stock purchase warrant to purchase one share of common stock at a combined price to the public of $3.25 per share and common stock purchase warrant (or $3.24 per pre-funded common stock purchase warrant and common stock purchase warrant). Gross proceeds before deducting underwriting discounts, commissions and other offering expenses were approximately $6.5 million. In addition, the Company granted to Maxim a 45-day option to purchase up to an additional 300,000 shares of common stock and/or common stock purchase warrants to purchase up to an aggregate of 300,000 shares of common stock, at the public offering price, less discounts and commissions, of which Maxim partially exercised its option to purchase additional common stock purchase warrants to purchase up to an aggregate of 229,100 shares of common stock. Each common stock purchase warrant is immediately exercisable for one share of common stock at an exercise price of $3.25 per share and will expire five years from issuance. The Company also issued a warrant to Maxim to purchase up to 100,000 shares of common stock in connection with the April 2020 Public Offering (the “April 2020 Maxim Warrant”). Such warrant has an exercise price of $3.90 per share and is fully vested.

May 2020 Shelf Registration

On May 18, 2020, we registered for resale, pursuant to a prospectus supplement to our shelf registration statement, an aggregate of 60,250 shares of common stock, 50,000 of which shares were the Alexander Settlement Shares, and the remaining 10,250 of such shares which were issued to one of the Company’s vendors pursuant to the Settlement Letter, dated May 12, 2020, by and between us and such vendor.

Purchase Agreements

On June 4, 2020, we entered into a securities purchase agreement (the “June 4, 2020 Purchase Agreement”) with several accredited investors providing for the issuance of (i) 2,275,000 shares of the Company’s common stock and (ii) warrants, with a term of 5.5 years, to purchase an aggregate of up to 2,275,000 shares of common stock at an exercise price of $2.55 per share, subject to customary adjustments thereunder, which warrants were immediately exercisable upon issuance and on a cashless basis if such warrants have not been registered on or before six months after the date of issuance. Pursuant to the June 4, 2020 Purchase Agreement, the investors purchased all of the securities sold thereby for an aggregate purchase price of $5,801,000. Pursuant to the June 4, 2020 Purchase Agreement, an aggregate of 2,275,000 shares of common stock were issued to the investors in a registered direct offering pursuant to a prospectus supplement to the Company’s currently effective registration statement on Form S-3, which was declared effective on September 6, 2019. The Company filed the prospectus supplement on June 5, 2020. Maxim acted as the placement agent. The warrants were issued to the investors in a concurrent private placement transaction pursuant to an exemption from the registration requirements of the Securities Act provided in Section 4(a)(2) of the Securities Act and/or Regulation D promulgated thereunder. The Company paid Maxim a fee of approximately $464,000, which was equal to 8% of the aggregate purchase price paid by investors placed by Maxim and certain expenses. The June 4, 2020 Purchase Agreement contains customary representations, warranties and agreements of the Company and the investors and customary indemnification rights and obligations of the parties thereto. The offering of the securities pursuant to the June 4, 2020 Purchase Agreement was closed on June 8, 2020.

21

SUMMIT WIRELESS TECHNOLOGIES, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

For the Nine Months Ended September 30, 2021 and 2020

(unaudited)

6.    Convertible Preferred Stock and Stockholders’ Equity (Deficit), continued

On June 9, 2020, we entered into a securities purchase agreement (the “June 9, 2020 Purchase Agreement”) with several accredited investors providing for the issuance of (i) 2,040,000 shares of the Company’s common stock and (ii) warrants, with a term of 5.5 years, to purchase an aggregate of up to 2,040,000 shares of common stock at an exercise price of $2.61 per share, subject to customary adjustments thereunder, which warrants were immediately exercisable upon issuance and on a cashless basis if the Warrants have not been registered on or before six months after the date of issuance. Pursuant to the June 9, 2020 Purchase Agreement, the investors purchased all of the securities sold thereby for an aggregate purchase price of $5,324,000. Pursuant to the June 9, 2020 Purchase Agreement, an aggregate of 2,040,000 shares of common stock were issued to the investors in a registered direct offering, pursuant to a prospectus supplement to the Company’s currently effective registration statement on Form S-3, which was declared effective on September 6, 2019. The Company filed the prospectus supplement on June 10, 2020. Maxim acted as the placement agent. The warrants were issued to the investors in a concurrent private placement transaction pursuant to an exemption from the registration requirements of the Securities Act provided in Section 4(a)(2) of the Securities Act and/or Regulation D promulgated thereunder. The Company paid Maxim a fee of approximately $426,000, which was equal to 8% of the aggregate purchase price paid by investors placed by Maxim and certain expenses. The June 9, 2020 Purchase Agreement contains customary representations, warranties and agreements of the Company and the investors and customary indemnification rights and obligations of the parties thereto. The offering of the securities pursuant to the June 9, 2020 Purchase Agreement was closed on June 11, 2020.

On July 22, 2021, the Company entered into a securities purchase agreement (the “July 22nd Purchase Agreement”) with several accredited investors providing for the issuance of 2,500,000 shares of the Company’s common stock. Pursuant to the July 22nd Purchase Agreement, the investors purchased all of the securities sold thereby for an aggregate purchase price of $10,000,000. Pursuant to the July 22nd Purchase Agreement, an aggregate of 2,500,000 shares of common stock were issued to the investors in a registered direct offering pursuant to a prospectus supplement to the Company’s currently effective registration statement on Form S-3, which was declared effective on September 6, 2019. The offering of the securities pursuant to the July 22nd Purchase Agreement was closed on July 27, 2021. The Company filed the prospectus supplement on July 26, 2021. Maxim acted as the placement agent. The Company paid Maxim a fee of approximately $800,000, which was equal to 8% of the aggregate purchase price paid by investors placed by Maxim and certain expenses. The July 22nd Purchase Agreement contains customary representations, warranties and agreements of the Company and the investors and customary indemnification rights and obligations of the parties thereto.

Settlement Agreements

On May 14, 2020, we entered into a settlement agreement with Alexander (the “Alexander Settlement Agreement”), pursuant to which, in consideration for Alexander releasing us from all claims against us arising out of that certain engagement agreement, dated February 6, 2020, that we entered into with Alexander (the “Alexander Engagement Agreement”), other than indemnification for certain third-party claims, we agreed to (i) pay Alexander a one-time cash payment of $125,000 and (ii) issue to Alexander 50,000 shares of our common stock (the “Alexander Settlement Shares”) which had a value of approximately $111,000. We also released Alexander from the same type of claims against Alexander, other than indemnification for certain third-party claims. In connection with the Alexander Settlement Agreement, on May 14, 2020, we also entered into a leak-out agreement with Alexander (the “Alexander Leak-Out Agreement”), pursuant to which Alexander agreed not to dispose of more than 5,000 shares of common stock in any trading day, commencing on the date of such agreement and ending on the date on which Alexander no longer holds any Alexander Settlement Shares. The Company recorded a settlement expense of $237,000 which is included in general and administrative expense for the nine months ended September 30, 2020.

22

SUMMIT WIRELESS TECHNOLOGIES, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

For the Nine Months Ended September 30, 2021 and 2020

(unaudited)

6.    Convertible Preferred Stock and Stockholders’ Equity (Deficit), continued

On November 9, 2020, in order to resolve a dispute between certain investors (the “February 2020 Holders”) and the Company regarding certain registration rights in connection with the February 2020 Private Placement, the Company entered into a settlement and release agreement with each of the February 2020 Holders (the “Settlement Agreement”), pursuant to which (i) the Company and the February 2020 Holders agreed to amend the original warrants issued in February 2020 (the “Original Warrants”) to provide for the purchase of one additional share of common stock for each share of common stock available under the Original Warrants, totaling 45,534 additional common stock purchase warrants, (ii) the Company and the February 2020 Holders agreed to amend the Original Warrants to reduce the exercise price to $2.55, and (iii) the Company agreed to issue an additional 236,375 shares of common stock and 236,369 common stock purchase warrants to purchase up to 236,369 shares of common stock. As consideration for the foregoing, the February 2020 Holders agreed to release any and all claims they may have against the Company, including, but not limited to, claims arising in connection with any securities held by the February 2020 Holders.

Warrants for Shares of Common Stock

The Company has issued warrants to purchase shares of common stock to employees and consultants as compensation for services rendered, as well as in conjunction with the purchase of shares of common stock in equity and debt transactions.

In connection with the March 2020 Note, the Company issued the March 2020 Note to the investor and the March 2020 Maxim Warrant to Maxim to purchase shares of common stock of 227,679 and 20,400, respectively (see Note 4 – Borrowings) at an exercise price of $6.40 per share. The grant date fair value of such warrants was $625,000, which was recorded as debt discount with the offset recorded to additional paid-in capital on the condensed consolidated balance sheets. The fair value of such warrants was determined using the Black-Scholes Model based on the following weighted average assumptions: common stock price on date of grant of $5.40; expected dividend yield of 0.0%; expected volatility of 61.0%; risk-free interest rate of 0.38% and expected life of 5 years.

Such warrant issued to the investor contained an adjustment provision such that if the Company issues or sells any shares of common stock or common stock equivalents (as defined in the March 2020 Note), subject to certain exceptions, at an effective price lower than the conversion price, then in effect, the conversion price shall be reduced to the price per share paid for such shares of common stock or common stock equivalents. The common stock and common stock equivalents issued by the Company in the April 2020 Public Offering were issued at price per share of $3.25, which was lower than the conversion price then in effect. Additionally, the Alexander Settlement Shares, issued to Alexander under the Alexander Settlement Agreement, on May 14, 2020, were issued at a price per share which was lower than the conversion price then in effect. The Company modified the exercise price of the March 2020 Warrant as a result of each of these transactions and calculated the incremental fair value related to these modifications. The resulting deemed dividend from these down round adjustments was $134,000, and this is included as an offset to additional paid-in capital in the accompanying condensed consolidated balance sheets.

Concurrent with the April 2020 Public Offering, the Company issued prefunded warrants for $475,000 at an exercise price of $0.01 per share. These warrants were exercised immediately upon the closing of the transactions for proceeds of $4,750 and the investors received 475,000 shares of common stock.

Additionally, as a result of the April 2020 Public Offering, the Company issued warrants to purchase shares of common stock to the common stock investors, prefunded warrants investors, and Maxim of 1,525,000, 475,000 and 291,000, respectively. The warrants have an exercise price of $3.25 per share and are fully vested. The grant date fair value of those warrants was $2,606,000, which was recorded within stockholders’ equity as a cost of issuance and an increase to additional paid-in capital on the accompanying condensed consolidated balance sheet. The fair value of the warrants was determined using the Black-Scholes Model based on the following weighted average assumptions: common stock price on date of grant of $2.50; expected dividend yield of 0.0%; expected volatility of 64.0%; risk-free interest rate of 0.37% and expected life of 5 years.

23

SUMMIT WIRELESS TECHNOLOGIES, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

For the Nine Months Ended September 30, 2021 and 2020

(unaudited)

6.    Convertible Preferred Stock and Stockholders’ Equity (Deficit), continued

The Company also issued the April 2020 Maxim Warrant to purchase up to 100,000 shares of common stock to Maxim in connection with the April 2020 Public Offering. Such warrant has an exercise price of $3.90 per share and is fully vested. The fair value of such warrant at issuance was $106,000. The fair value of the warrant was estimated using the Black-Scholes Model based on the following weighted average assumptions: common share price on date of grant $2.50, expected dividend yield 0%, expected volatility 64%, risk-free interest rate 0.37% and expected life of 5 years. The fair value was recorded within stockholders’ equity as a cost of issuance and an increase to additional paid-in capital on the accompanying condensed consolidated balance sheet.

In connection with the offering pursuant to the June 4, 2020 Purchase Agreement, the Company issued warrants to the investors to purchase up to an aggregate of 2,275,000 shares of common stock. Such warrants have an exercise price of $2.55 per share and are fully vested. The grant date fair value of those warrants was $3,153,000, which was recorded within stockholders’ equity as a cost of issuance and an increase to additional paid-in capital on the accompanying condensed consolidated balance sheet. The fair value of such warrants was determined using the Black-Scholes Model based on the following weighted average assumptions: common stock price on date of grant of $2.52; expected dividend yield of 0.0%; expected volatility of 64.0%; risk-free interest rate of 0.45% and expected life of 5.5 years.

In connection with the offering pursuant to the June 9, 2020 Purchase Agreement, the Company issued warrants to the investors to purchase up to an aggregate of 2,040,000 shares of common stock. Such warrants have an exercise price of $2.61 per share and are fully vested. The grant date fair value of those warrants was $2,375,000, which was recorded within stockholders’ equity as a cost of issuance and an increase to additional paid-in capital on the accompanying condensed consolidated balance sheet. The fair value of such warrants was determined using the Black-Scholes Model based on the following weighted average assumptions: common stock price on date of grant of $2.25; expected dividend yield of 0.0%; expected volatility of 64.0%; risk-free interest rate of 0.32% and expected life of 5.5 years.

In January 2021, pursuant to the Company’s solicitation of certain warrant holders, such warrant holders agreed to exercise warrants to purchase an aggregate of 1,221,675 shares of common stock for net proceeds of approximately $2.9 million. In consideration for their exercise of these warrants, for cash, the exercising holders were issued new warrants to purchase up to an aggregate of 305,419 shares of common stock, at an exercise price of $4.20 per share, which are exercisable for a period of five years. The grant date fair value of those warrants was $567,000, which was recorded as warrant inducement expense and an increase to additional paid-in capital on the accompanying condensed consolidated balance sheet. The fair value of such warrants was determined using the Black-Scholes Model based on the following weighted average assumptions: common stock price on date of grant of $3.85; expected dividend yield of 0.0%; expected volatility of 60.1%; risk-free interest rate of 0.45% and expected life of 5.0 years.

On April 18, 2019, the Company entered into a Securities Purchase Agreement with an existing shareholder, Lisa Walsh (the “Investor”), pursuant to which the Company issued 250,000 shares of our Series A 8% Convertible Preferred Stock (the “Original Securities”). On June 4, 2021, the Company and the Investor entered into that an exchange agreement pursuant to which the Company exchanged with the Investor the Original Securities held by the investor for: (i) 250,000 shares of common stock and (ii) warrants to purchase up to 187,500 shares of Common Stock. The warrants will be exercisable for a period of five (5) years and four (4) months. The exercise price with respect to the warrants is $3.00 per share. The exercise price and the number of shares of common stock issuable upon exercise of the warrants are subject to adjustment upon certain events, such as stock splits, combinations, dividends, distributions, reclassifications, mergers or other corporate change and dilutive issuances. The grant date fair value of those warrants was $570,000, which was recorded as loss on exchange of preferred stock and an increase to additional paid-in capital on the accompanying condensed consolidated balance sheet. The fair value of such warrants was determined using the Black-Scholes Model based on the following weighted average assumptions: common stock price on date of grant of $4.77; expected dividend yield of 0.0%; expected volatility of 60.7%; risk-free interest rate of 0.78% and expected life of 5.4 years.

24

SUMMIT WIRELESS TECHNOLOGIES, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

For the Nine Months Ended September 30, 2021 and 2020

(unaudited)

6.    Convertible Preferred Stock and Stockholders’ Equity (Deficit), continued

In June 2021, pursuant to the Company’s solicitation of certain warrant holders, such warrant holders agreed to exercise warrants to purchase an aggregate of 1,000,000 shares of common stock for net proceeds of approximately $2.3 million. In consideration for their exercise of these warrants, for cash, the exercising holders were issued new warrants to purchase up to an aggregate of 250,000 shares of common stock, at an exercise price of $4.46 per share, which are exercisable for a period of five years. The grant date fair value of those warrants was $579,000, which was recorded as warrant inducement expense and an increase to additional paid-in capital on the accompanying condensed consolidated balance sheet. The fair value of such warrants was determined using the Black-Scholes Model based on the following weighted average assumptions: common stock price on date of grant of $4.50; expected dividend yield of 0.0%; expected volatility of 60.7%; risk-free interest rate of 0.77% and expected life of 5.0 years.

During the three months ended September 30, 2021, warrant holders exercised 19,000 warrants to purchase common stock, for proceeds of approximately $62,000.

Information regarding warrants for common stock outstanding and exercisable as of September 30, 2021 is as follows:

	Warrants	Weighted Average	Warrants
Exercise	Outstanding as of	Remaining	Exercisable as of
Price	September 30, 2021	Life (years)	September 30, 2021
$2.32 - $4.46	4,053,384	3.86	4,038,384
$6.40 - $9.80	32,889	3.41	32,889
$15.80 - $17.50	93,562	1.01	93,562
$24.80 - $99.00	222,807	1.38	222,807
$108.00 - $125.00	72,782	0.87	72,782
$7.88*	4,475,424	3.66	4,460,424

* Weighted average

Warrants exercisable as of September 30, 2021 excludes warrants to purchase 15,000 shares of common stock issued to a marketing firm, which vest upon the achievement of certain milestones. Additionally, warrants to purchase 20,722 shares of common stock which are shown above with a price of $15.80 are pre-funded warrants under which the holder must only pay $0.20 per share to complete the exercise.

Information regarding warrants for common stock outstanding and exercisable as of December 31, 2020 is as follows:

	Warrants	Weighted Average	Warrants
Exercise	Outstanding as of	Remaining	Exercisable as of
Price	December 31, 2020	Life (years)	December 31, 2020
$2.32 - $3.90	6,884,216	4.55	6,869,216
$6.40 - $9.80	32,889	4.15	32,889
$15.80 - $17.50	93,562	1.76	93,562
$24.80 - $99.00	230,571	0.99	230,571
$108.00 - $207.00	72,864	1.60	72,864
$5.81*	7,314,102	4.54	7,299,102

* Weighted average

25

SUMMIT WIRELESS TECHNOLOGIES, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

For the Nine Months Ended September 30, 2021 and 2020

(unaudited)

6.    Convertible Preferred Stock and Stockholders’ Equity (Deficit), continued

Warrants exercisable as of December 31, 2020 exclude a warrant to purchase 15,000 shares of common stock issued to a marketing consulting firm. Such warrant will vest upon the achievement of certain milestones. Additionally, warrants to purchase 20,722 shares of common stock which are shown above with a price of $15.80 are pre-funded warrants under which the holder must only pay $0.20 per share to complete the exercise.

7.    Income Taxes

The Company recorded a provision for income taxes of $0 and $2,000 for the three and nine months ended September 30, 2021, respectively. The Company recorded a provision for income taxes of $0 and $3,000 for the three and nine months ended September 30, 2020, respectively.

The Company’s effective tax rate was (0.02%) and (0.03%) for the nine months ended September 30, 2021 and 2020, respectively. The difference between the effective tax rate and the federal statutory tax rate for the nine months ended September 30, 2021 and 2020 primarily relates to the valuation allowance on the Company’s deferred tax assets.

For interim periods, the Company estimates its annual effective income tax rate and applies the estimated rate to the year-to-date income or loss before income taxes. The Company also computes the tax provision or benefit related to items reported separately and recognizes the items net of their related tax effect in the interim periods in which they occur. The Company also recognizes the effect of changes in enacted tax laws or rates in the interim periods in which the changes occur.

As of September 30, 2021 and December 31, 2020, the Company retains a full valuation allowance on its deferred tax assets. The realization of the Company’s deferred tax assets depends primarily on its ability to generate taxable income in future periods. The amount of deferred tax assets considered realizable in future periods may change as management continues to reassess the underlying factors it uses in estimating future taxable income.

The provision for income taxes for the nine months ended September 30, 2021 and 2020 was calculated on a jurisdiction basis.

On March 27, 2020, the U.S. enacted the Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”). The CARES Act includes provisions relating to refundable payroll tax credits, net operating loss carryback periods, alternative minimum tax credit refunds, modifications to the net interest deduction limitations and technical corrections to the tax depreciation methods for qualified improvement property. On December 21, 2020, the U.S. Congress passed the Consolidation Appropriations Act, 2021 (the “CAA Act”). The tax provisions under the CARES Act and CAA Act, do not have a material impact on the condensed consolidated financial statements for the nine months ended September 30, 2021, given the existence of a full valuation allowance.

On June 29, 2020, California Assembly Bill 85 (“AB 85”) was signed into law, which suspends the use of California net operating losses and limits the use of California research tax credits for tax years beginning in 2020 and before 2023. The Company does not expect the suspension of net operating losses to have a significant impact on the condensed consolidated financial statements.

26

SUMMIT WIRELESS TECHNOLOGIES, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

For the Nine Months Ended September 30, 2021 and 2020

(unaudited)

8.    Commitments and Contingencies

Operating Leases

The Company rented its Beaverton, Oregon office under an operating lease, which expired on October 31, 2020. Under the terms of the lease, the Company was responsible for taxes, insurance and maintenance expense. The Company recognized rent expense on a straight-line basis over the lease period. On August 18, 2020, the Company signed a new operating lease that began on November 1, 2020, to rent office space in Beaverton, Oregon, to replace the lease that expired on October 31, 2020. The new lease expires on January 31, 2024. The following are the future minimum lease payments for the years ending December 31, 2021 through December 31, 2024: $41,000, $153,000, $173,000, and $15,000.

Rent expense for the three months ended September 30, 2021 and 2020 was $56,000 and $87,000, respectively. Rent expense for the nine months ended September 30, 2021 and 2020 was $168,000 and $288,000, respectively.

Capital Leases

During August 2020, the Company entered into a lease agreement for equipment under a capital lease with a term of 36 months. The equipment under the lease is collateral for the agreement and is included within property and equipment, net on the condensed consolidated balance sheets.

Future minimum lease commitments for the capital lease as of September 30, 2021 are as follows:

(in thousands)
Payments due in:
Year ending December 31, 2021 (remaining 3 months)	$	6
Year ending December 31, 2022		26
Year ending December 31, 2023		15
Total minimum lease payments		47
Less: Amounts representing interest		(2)
Present value of capital lease obligations		45
Less: Current portion of capital lease liabilities		24
Other liabilities	$	21

Obligations under the capital lease are included in accrued liabilities and other liabilities on the condensed consolidated balance sheets.

Contingencies

In the normal course of business, the Company may become involved in legal proceedings. The Company will accrue a liability for such matters when it is probable that a liability has been incurred and the amount can be reasonably estimated. When only a range of a possible loss can be established, the most probable amount in the range is accrued. If no amount within this range is a better estimate than any other amount within the range, the minimum amount in the range is accrued. The accrual for a litigation loss contingency might include, for example, estimates of potential damages, outside legal fees and other directly related costs expected to be incurred.

27

SUMMIT WIRELESS TECHNOLOGIES, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

For the Nine Months Ended September 30, 2021 and 2020

(unaudited)

8.    Commitments and Contingencies, continued

The Company’s management does not believe that any such matters, individually or in the aggregate, will have a materially adverse effect on the Company’s condensed consolidated financial statements.

Coronavirus – COVID-19

On March 11, 2020, the World Health Organization designated COVID-19 as a global pandemic. The COVID 19 pandemic represents a fluid situation that presents a wide range of potential impacts of varying durations for different global geographies, including locations where we have offices, employees, customers, vendors and other suppliers and business partners.  Like most US-based businesses, the COVID-19 pandemic and efforts to mitigate the same began to impact on our business in March 2020. By that time, much of our first fiscal quarter of 2020 was completed. During our second fiscal quarter of 2020, we observed decreased demand from certain of our customers due to the temporary closure by many retailers. Our third and fourth fiscal quarters of 2020 and our first three fiscal quarters of 2021 saw sustained improved customer demand as retailers slowly reopened and demand for an in-home immersive cinema experience increased, following the initial closure of many public cinemas due to COVID-19. However, another closure by retailers could impact customer demand in the future. The Company believes the extent of the COVID-19 pandemic’s impact on its operating results and financial condition has been and will continue to be driven by many factors, most of which are beyond the Company’s control and ability to forecast. Although the Company has experienced some positive trends during the first nine months of 2021, because of these uncertainties, the Company cannot estimate how long or to what extent the pandemic will impact its operations. 

9.    Related Parties

Jonathan Gazdak

Mr. Gazdak is Managing Director – Head of Investment Banking for Alexander Capital, L.P., an investment banking firm based in New York. Mr. Gazdak was a member of the board of directors from June 2015 to May 10, 2021, and is no longer considered a related party as of May 10, 2021. Alexander Capital, L.P. acted as the lead investment bank in a number of the Company’s private financings and as an underwriter for the Company’s IPO. As of September 30, 2021 and December 31, 2020, Mr. Gazdak owned less than 1%of the outstanding shares of the Company’s common stock.

On February 6, 2020, the Company entered into a placement agency agreement with Alexander Capital, L.P. in connection with an offering by the Company of up to an aggregate of $835,000 of the Company’s securities, pursuant to which Alexander Capital, L.P. was paid cash fees of $83,000 and pursuant to which the Company agreed to issue to Alexander Capital, L.P. a warrant to purchase 4,553 shares of common stock. Such warrant is exercisable at a per share price of $8.80 and is exercisable at any time during the five-year period commencing on the date of issuance.

The Company also entered into the Alexander Settlement Agreement with Alexander Capital, L.P. on May 14, 2020. (See Note 6 – Convertible Preferred Stock and Stockholders’ Equity (Deficit)).

Helge Kristensen

Mr. Kristensen has served as a member of the Company’s board of directors since 2010. Mr. Kristensen serves as vice president of Hansong Technology, an original device manufacturer of audio products based in China, president of Platin Gate Technology (Nanjing) Co. Ltd, a company with focus on service-branding in lifestyle products as well as pro line products based in China and co-founder and director of Inizio Capital, an investment company based in the Cayman Islands.

28

SUMMIT WIRELESS TECHNOLOGIES, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

For the Nine Months Ended September 30, 2021 and 2020

(unaudited)

9.    Related Parties, continued

For the three months ended September 30, 2021 and 2020, Hansong Technology purchased modules from the Company of approximately $263,000 and $137,000, respectively, and made payments to the Company of approximately $333,000 and $0, respectively. For the three months ended September 30, 2021 and 2020, Hansong Technology sold speaker products to the Company of approximately $96,000 and $8,000, respectively, and the Company made payments to Hansong Technology of approximately $309,000 and $38,000, respectively. For the nine months ended September 30, 2021 and 2020, Hansong Technology purchased modules from the Company of approximately $496,000 and $155,000, respectively, and made payments to the Company of approximately $380,000 and $1,000, respectively. For the nine months ended September 30, 2021 and 2020, Hansong Technology sold speaker products to the Company of approximately $854,000 and $8,000, respectively, and the Company made payments to Hansong Technology of approximately $962,000 and $67,000, respectively. As of September 30, 2021 and December 31, 2020, Mr. Kristensen owned less than 1.0% of the outstanding shares of the Company’s common stock.

10.  Segment Information

The Company operates in one business segment, wireless audio products. Our chief decision-maker, the President and Chief Executive Officer, evaluates our performance based on company-wide consolidated results.

Net revenue from customers is designated based on the geographic region to which the product is delivered. Net revenue from customers is designated based on the geographic region to which the product is delivered. Net revenue by geographic region for the three and nine months ended September 30, 2021 and 2020 was as follows:

(in thousands)	For the three months ended				For the nine months ended
	September 30,				September 30,
	2021		2020		2021		2020
United States	$	166	$	75	$	710	$	167
Europe		162		100		403		169
Asia Pacific		1,479		432		3,427		1,030
Other		—		—		1		—
Total	$	1,807	$	607	$	4,541	$	1,366

Substantially all of our long-lived assets are located in the United States.

29

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

Cautionary Notice Regarding Forward Looking Statements

The information contained in Item 2 contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Actual results may materially differ from those projected in the forward-looking statements as a result of certain risks and uncertainties set forth in this Quarterly Report on Form 10-Q for the quarter ended September 30, 2021 (this “Report”). Although management believes that the assumptions made and expectations reflected in the forward-looking statements are reasonable, there is no assurance that the underlying assumptions will, in fact, prove to be correct or that actual results will not be different from expectations expressed in this Report.

This filing contains a number of forward-looking statements which reflect management’s current views and expectations with respect to our business, strategies, products, future results and events, and financial performance. All statements made in this filing other than statements of historical fact, including statements addressing operating performance, events, or developments which management expects or anticipates will or may occur in the future, and also including statements related to distributor channels, volume growth, revenues, profitability, new products, adequacy of funds from operations, statements expressing general optimism about future operating results, and non-historical information, are forward looking statements. In particular, the words “believe,” “expect,” “intend,” “anticipate,” “estimate,” “may,” variations of such words, and similar expressions identify forward-looking statements, but are not the exclusive means of identifying such statements, and their absence does not mean that the statement is not forward-looking. These forward-looking statements are subject to certain risks and uncertainties, including those discussed below. Our actual results, performance or achievements could differ materially from historical results as well as those expressed in, anticipated, or implied by these forward-looking statements. We do not undertake any obligation to revise these forward-looking statements to reflect any future events or circumstances.

Examples of forward-looking statements include, but are not limited to, statements we make regarding

• our expectations regarding future trends, expectations, and performance of our business;

• our expectations regarding supply chain disruptions and its impact on our business;

• our expectations about the impact of our strategic plans; and

• the amount and timing of our capital expenditures.

Readers should not place undue reliance on these forward-looking statements, which are based on management’s current expectations and projections about future events, are not guarantees of future performance, are subject to risks, uncertainties and assumptions (including those described below), and apply only as of the date of this filing. Our actual results, performance or achievements could differ materially from the results expressed in, or implied by, these forward-looking statements.

Overview

We were formed as Summit Semiconductor, LLC, a Delaware limited liability company, on July 23, 2010. We converted to a Delaware corporation, effective December 31, 2017. Effective as of September 11, 2018, we changed our name to Summit Wireless Technologies, Inc. We run our operations through Summit Wireless Technologies, Inc., as well as through our wholly-owned subsidiary WiSA, LLC, a Delaware limited liability company. The address of our corporate headquarters is 6840 Via Del Oro, Ste. 280, San Jose, CA 95119. Our website address is www.summitwireless.com. The information contained in or accessible through our website is not part of this Report and is intended for informational purposes only.

We are an early stage technology company and our primary business focus is to enable mainstream consumers and audio enthusiasts to experience high quality wireless audio. We intend to continue selling our proprietary wireless modules to consumer electronics companies while also expanding our focus to implement a lower cost solution by porting our software onto commercially available internet of things (“IoT”) modules with integrated Wi-Fi technology.

30

Our technology addresses some of the main issues that we perceive are hindering the growth of the home theater: complexity of installation and cost. We believe that consumers want to experience theater quality surround sound from the comfort of their homes. However, wired home theater systems often require expensive audio-visual (“AV”) receivers to decode the audio stream, leaving the consumer with the burden of concealing the wires. Hiring a professional to hide the wires into the walls or floor is invasive, complicated, costly and time consuming. Further, people who rent as opposed to own may not be able to install these systems as the installation construction needed may not be permitted under a lease agreement. Our first-generation wireless technology addresses these problems by transmitting wireless audio to each speaker at Blu-ray quality (uncompressed 24-bit audio up to 96 kHz sample rates) and emphasizing ease of setup. To our knowledge, our custom chips and modules technology is one of the few technologies available today that can stream up to eight (8) separate wireless audio channels with low latency, removing lip-sync issues between the audio and video sources. In addition, every speaker within a system that utilizes our technology can be synchronized to less than one microsecond, thus eliminating phase distortion between speakers. Our first-generation technology shows that wireless home theater systems are viable home audio solutions for the average consumer and audio enthusiast alike.

Current research and development investments focus on developing Wi-Fi compatible software for transmitting multichannel wireless audio for which patent applications have been submitted. A software solution enables smart devices that have Wi-Fi and video media to deliver surround sound audio and allows us to port our wireless audio technology to popular Wi-Fi based modules and systems on a chip (“SOC”) already shipping in volume. The Summit Wireless “Discovery” module announced in January 2021 is the first IoT module solution with our embedded wireless audio software that supports up to four separate wireless audio channels and, we believe, reduces the cost per wireless channel by over 50% for soundbars and entry level home theater applications up to a 3.1 configuration. Our goal is to continue to commercialize and improve performance of a software based-solution, which other brands can integrate into their devices, that will (i) reduce integration costs for mass market use, (ii) utilize Wi-Fi for wireless connectivity, making it easy to integrate into today’s high volume, low cost SOC and modules, (iii) provide a low power consumption option to allow for use in battery powered devices, and (iv) provide compatibility with popular consumer electronic operating systems.

To date, our operations have been funded through sales of our common and preferred equity, proceeds from the exercise of warrants to purchase common stock, sale of debt instruments, and revenue from the sale of our products. Our condensed consolidated financial statements contemplate the continuation of our business as a going concern. However, we are subject to the risks and uncertainties associated with an emerging business, as noted above we have no established source of capital, and we have incurred recurring losses from operations since inception.

In January 2021, pursuant to the Company’s solicitation of certain warrant holders, such warrant holders agreed to exercise warrants to purchase an aggregate of 1,221,675 shares of common stock for net proceeds of approximately $2.9 million. In consideration for their exercise of these warrants, for cash, the exercising holders are being issued new warrants to purchase up to an aggregate of 305,419 shares of common stock, at an exercise price of $4.20 per share, which are exercisable for a period of five years.

On June 4, 2021, the Company entered into an exchange agreement, pursuant to which the Company exchanged with an investor 250,000 Series A 8% Senior Convertible Preferred Stock, par value $0.0001 per share (the “Series A Preferred Stock”) held by such investor for: (i) 250,000 shares of common stock and (ii) warrants to purchase up to 187,500 shares of common stock. The warrants were exercisable for a period of five (5) years and four (4) months. The exercise price with respect to the warrants was $3.00 per share. The exercise price and the number of shares of common stock issuable upon exercise of the warrants were subject to adjustment upon certain events, such as stock splits, combinations, dividends, distributions, reclassifications, mergers or other corporate change and dilutive issuances. In June 2021, the investor subsequently fully exercised such warrant on a cashless basis for 79,244 shares of common stock.

On June 7, 2021, pursuant to the Company’s solicitation of certain warrant holders, such warrant holders agreed to exercise warrants to purchase an aggregate of 1,000,000 shares of common stock for net proceeds of approximately $2.3 million. In consideration for their exercise of such warrants for cash, such holders were issued new warrants to purchase up to an aggregate of 250,000 shares of common stock at an exercise price of $4.46 per share, which are exercisable for a period of five years.

On July 22, 2021, the Company entered into a securities purchase agreement (the “July 22nd Purchase Agreement”) with several accredited investors providing for the issuance of 2,500,000 shares of the Company’s common stock. Pursuant to the July 22nd Purchase Agreement, the investors purchased all of the securities sold thereby for an aggregate purchase price of $10,000,000. Pursuant to the July 22nd Purchase Agreement, an aggregate of 2,500,000 shares of common stock were issued to the investors in a registered direct offering pursuant to a prospectus supplement to the Company’s currently effective registration statement on Form S-3, which was declared effective on September 6, 2019. The offering of the securities pursuant to the July 22nd Purchase Agreement was closed on July 27, 2021, with the Company receiving net proceeds of $9,026,000.

31

Potential Impacts of the Novel Coronavirus (“COVID-19”) on Our Business and Operations

The COVID-19 pandemic represents a fluid situation that presents a wide range of potential impacts of varying durations for different global geographies, including locations where we have offices, employees, customers, vendors and other suppliers and business partners.

Like most US-based businesses, the COVID-19 pandemic and efforts to mitigate the same began to impact on our business in March 2020. By that time, much of our first fiscal quarter of 2020 was completed. During our second fiscal quarter of 2020, we observed decreased demand from certain of our customers due to the temporary closure by many retailers. Our third and fourth fiscal quarters of 2020 and our first three fiscal quarters of 2021 saw sustained improved customer demand as retailers slowly reopened and demand for an in-home immersive cinema experience increased, following the initial closure of many public cinemas due to COVID-19. However, another closure by retailers could impact customer demand in the future.

Given the fact that our products are sold through a variety of distribution channels, we have experienced and we continue to expect that our sales will experience some volatility as a result of the changing and less predictable operational needs of many customers as a result of the COVID-19 pandemic. We are aware that many companies, including many of our suppliers and customers, are reporting or predicting negative impacts from COVID-19 on future operating results. To date, we have experienced shipment delays from our suppliers due to COVID-19, however we do not believe such delays will have a material adverse impact on our operating results and we have not experienced a material supply interruption. There can be no assurance that we will not experience material supply delays or interruptions in the future due to COVID-19.

To date, travel restrictions and border closures have not materially impacted our ability to obtain inventory or manufacture or deliver products or services to customers. However, if such restrictions become more severe, they could negatively impact those activities in a way that would harm our business over the long term. Travel restrictions impacting people can restrain our ability to assist our customers and distributors as well as impact our ability to develop new distribution channels, but at present we do not expect these restrictions on personal travel to be material to our business operations or financial results.

Comparison of the Three and Nine Months Ended September 30, 2021 and 2020

Revenue

Revenue for the three months ended September 30, 2021 was $1,807,000, an increase of $1,200,000, or 198%, compared to the revenue for three months ended September 30, 2020 of $607,000. The increase was primarily due to increased sales volumes of both modules and speaker bundles.

Revenue for the nine months ended September 30, 2021 was $4,541,000, an increase of $3,175,000, or 232%, compared to the revenue for the nine months ended September 30, 2020 of $1,366,000. The increase was primarily due to increased sales volumes of both modules and speaker bundles.

Cost of Revenue and Operating Expenses

Cost of Revenue

Cost of revenue for the three months ended September 30, 2021 was $1,301,000, an increase of $798,000, or 159%, compared to the cost of revenue for the three months ended September 30, 2020 of $503,000. The increase was primarily attributable to the direct material costs associated with higher sales volume.

Cost of revenue for the nine months ended September 30, 2021 was $3,281,000, an increase of $2,094,000, or 176%, compared to the cost of revenue for the nine months ended September 30, 2020 of $1,187,000. The increase was primarily attributable to the direct material costs associated with higher sales volume.

Research and Development

Research and development expenses for the three months ended September 30, 2021 were $1,322,000, an increase of $82,000, compared to the research and development expenses for the three months ended September 30, 2020 of $1,240,000. The increase in research and

32

development expenses is primarily related to increased salary and benefit expense of $153,000 and consultant expenses of $36,000, partially offset by decreased stock-based compensation expenses of $51,000 and reduced facility allocation expense of $50,000.

Research and development expenses for the nine months ended September 30, 2021 were $3,800,000, an increase of $522,000 compared to the research and development expenses for the nine months ended September 30, 2020 of $3,278,000. The increase in research and development expenses is primarily related to increased salary and benefit expense of $556,000 and increased stock-based compensation and consulting expense of $74,000 and $81,000, respectively, partially offset by reduced facility allocation expense of $177,000.

Sales and Marketing

Sales and marketing expenses for the three months ended September 30, 2021 were $1,021,000, an increase of $186,000, compared to the sales and marketing expenses for the three months ended September 30, 2020 of $835,000. The increase in sales and marketing expenses is primarily related increased salary and benefit expenses of $73,000, website development of $89,000 and advertising expenses of $87,000, partially offset by decreased stock-based compensation of $110,000.

Sales and marketing expenses for the nine months ended September 30, 2021 were $2,870,000, an increase of $827,000, compared to the sales and marketing expenses for the nine months ended September 30, 2020 of $2,043,000. The increase in sales and marketing expenses is primarily related increased salary, incentive compensation and benefit expenses of $233,000, website development and advertising expenses of $272,000 and $370,000, respectively.

General and Administrative

General and administrative expenses for the three months ended September 30, 2021 were $1,081,000, an increase of $67,000, compared to the general and administrative expenses for the three months ended September 30, 2020 of $1,014,000. The increase in general and administrative expenses is primarily related to increased salary and benefit expenses, board fees and investor relations expenses of $22,000, $33,000 and $34,000, respectively, offset partially by increased stock-based compensation of $153,000.

General and administrative expenses for the nine months ended September 30, 2021 were $3,037,000, an increase of $525,000, compared to the general and administrative expenses for the nine months ended September 30, 2020 of $2,512,000. The increase in general and administrative expenses is primarily related to increased salary, incentive compensation and benefit expenses of $178,000, increased stock-based compensation, board fees and investor relations expenses of $87,000, $33,000 and $141,000, respectively, partially offset by a $237,000 expense recorded in 2020 pursuant to the Alexander Settlement Agreement discussed in Note 6 – Convertible Preferred Stock and Stockholders’ Equity (Deficit) recorded in the prior year.

Interest Expense

Interest expense for the three months ended September 30, 2021 was $3,000, a decrease of $2,000 compared to the interest expense for the three months ended September 30, 2020 of $5,000. Minimal interest expense for both periods was primarily related to interest accrued on the PPP loan.

Interest expense for the nine months ended September 30, 2021 was $9,000, a decrease of $1,385,000, compared to the interest expense for the nine months ended September 30, 2020 of $1,394,000. Minimal interest expense recorded in the nine months ended September 30, 2021, was primarily related to interest accrued on the PPP loan. Interest expense for the nine months ended September 30, 2020 was primarily due to the full amortization of debt discounts associated with the convertible debt that the Company incurred in March 2020, as such convertible debt was fully repaid in April 2020.

Change in Fair Value of Warrant Liability

There was no change in the fair value of the warrant liability for the three months ended September 30, 2021 and 2020.  

There was no change in the fair value of the warrant liability for the nine months ended September 30, 2021, compared to a gain of $24,000 due to the change in fair value of the warrant liability for the nine months ended September 30, 2020. The gain for the nine months ended September 30, 2020 was due to the decrease in our common stock price during the period.

33

Gain on Forgiveness of Paycheck Protection Loan

The Company recorded a gain of $859,000 due to the forgiveness of the Paycheck Protection Loan for the three and nine months ended September 30, 2021. No such forgiveness occurred during the three and nine months ended September 30, 2020.

Deemed Dividend on Exchange of Convertible Preferred Stock for Common Stock

During the three and nine months ended September 30, 2021, the Company recorded a deemed dividend of $0 and $1,192,000 in connection with the exchange of all 250,000 shares of preferred stock for 250,000 shares of common stock and warrants to purchase up to 187,500 shares of common stock, which warrants were subsequently fully exercised on a cashless basis for 79,244 shares of common stock. No such deemed dividend occurred during the three and nine months ended September 30, 2020.

Warrant Inducement Expense

During the three and nine months ended September 30, 2021, the Company recorded a charge of $0 and $1,146,000, respectively, in connection with the fair value of warrants issued to warrant holders in connection with a solicitation of such warrant holders to exercise their outstanding warrants during this period. See Note 6 – Convertible Preferred Stock and Stockholders’ Equity (Deficit). No such inducement occurred during the three and nine months ended September 30, 2020.

Liquidity and Capital Resources

Cash and cash equivalents as of September 30, 2021 were $16,067,000, compared to $7,415,000 as of December 31, 2020.

We incurred a net loss of $8,751,000 for the nine months ended September 30, 2021 and used net cash in operating activities of $8,574,000. We incurred a net loss of $9,068,000 for the nine months ended September 30, 2020 and used net cash in operating activities of $7,499,000. Excluding non-cash adjustments, the primary reasons for the increase in the use of net cash from operating activities during the nine months ended September 30, 2021, was related to the increase in accounts receivable, inventories, prepaid expenses and other assets, partially offset by an increase in accounts payable and accrued liabilities.

We have financed our operations to date primarily through the issuance of equity securities, proceeds from the exercise of warrants to purchase common stock and sale of debt instruments (approximately $17,028,000 raised from various financings in fiscal 2020). In addition, during the nine months ended September 30, 2021, we raised approximately $8,303,000 from exercises of warrants which were acquired by investors in conjunction with such financings during fiscal 2020. Warrants exercisable for approximately 4,053,384 shares of common stock with exercise prices ranging from $2.32 to $4.46 per share, remain outstanding. Additionally, in July 2021, we raised approximately $9,026,000 in net proceeds in a registered direct offering from the issuance and sale of 2,500,000 shares of common stock at a price of $4.00 per share. We believe that our current level of liquid assets will be sufficient to fund our operations through the balance of fiscal 2022.

Off-Balance Sheet Arrangements

We have no off-balance sheet arrangements.

Item 3. Quantitative and Qualitative Disclosures About Market Risk.

As a smaller reporting company, as defined in Rule 12b-2 of the Exchange Act, we are not required to provide the information required by this Item.

34

Item 4. Controls and Procedures.

Evaluation of Disclosure Controls and Procedures

We maintain disclosure controls and procedures that are designed to ensure that material information required to be disclosed in our periodic reports filed under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms and to ensure that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer as appropriate, to allow timely decisions regarding required disclosure. Under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, we conducted an evaluation of our disclosure controls and procedures. Based on the foregoing evaluation, our management concluded that, as of September 30, 2021, our disclosure controls and procedures were not effective to provide reasonable assurance that the information required to be disclosed by us in reports that we file or submit under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms, and is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure. Our management, including our Chief Executive Officer (Principal Executive Officer) and Chief Financial Officer (Principal Financial Officer), does not expect that our disclosure controls and procedures will prevent all errors and all fraud. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within our Company have been detected. These inherent limitations include, but are not limited to, the realities that judgments in decision-making can be faulty and that breakdowns can occur because of simple error or mistake. Additionally, controls can be circumvented by the individual acts of some persons, by collusion of two or more people, or by management override of the control. The design of any system of controls also is based in part upon certain assumptions about the likelihood of future events and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions.

Changes in Internal Controls

There were no changes in the Company’s internal control over financial reporting that occurred during the three months ended September 30, 2021 that have materially affected or are reasonably likely to materially affect our internal control over financial reporting.

35

PART II. OTHER INFORMATION

Item 1. Legal Proceedings

From time to time we may be involved in various claims and legal actions arising in the ordinary course of our business. There is no action, suit, proceeding, inquiry or investigation before or by any court, public board, government agency, self-regulatory organization or body pending or, to the knowledge of the executive officers of our company or any of our subsidiaries, threatened against or affecting our company, or any of our subsidiaries in which an adverse decision could have a material adverse effect upon our business, operating results, or financial condition.

Item 1A. Risk Factors

As a smaller reporting company, we are not required to provide the information required by this Item.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

In connection with the appointment of Eric Almgren as Chief Strategist of the Company, an inducement grant of 310,000 shares (the “inducement shares”), representing 2% of the outstanding shares of the Company on that date, was made to Mr. Almgren on September 13, 2021 outside of the Company’s existing incentive plans. The inducement shares were issued pursuant to Section 4(a)(2) of the Securities Act because, among other things, Mr. Almgren had sufficient sophistication and knowledge of the Company, and the issuance did not involve any form of general solicitation or general advertising. The inducement shares issued are restricted.

Item 3. Defaults Upon Senior Securities

None.

Item 4. Mine Safety Disclosures

Not applicable.

Item 5. Other Information

None.

36

Item 6. Exhibits

Exhibit Number	Description
31.1	Certification of Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
31.2	Certification of Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32.1	Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
32.2	Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101	Interactive Data Files (embedded within the Inline XBRL document)
104	Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

In accordance with SEC Release 33-8238, Exhibits 32.1 and 32.2 are being furnished and not filed.

37

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	Summit Wireless Technologies, Inc.
Date: November 9, 2021	By:	/s/ Brett Moyer
		Brett Moyer
		Chief Executive Officer
		(Duly Authorized Officer and Principal Executive Officer)
Date: November 9, 2021	By:	/s/ George Oliva
		George Oliva
		Principal Financial Officer
		(Duly Authorized Officer and Principal Financial Officer)

38

EX-31.1

Exhibit 31.1

CERTIFICATION

PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 302 OF

THE SARBANES-OXLEY ACT OF 2002

I, Brett Moyer, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of Summit Wireless Technologies, Inc. (the “registrant”):

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13-a13a-15(f) and 15d-15(f)) for the registrant and have:

a)     Designed such disclosure controls and procedures or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b)    Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c)    Evaluated the effectiveness of the registrant’s disclosure controls and procedures; and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures as of the end of the period covered by this report based on such evaluation; and

d)     Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a)     All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b)     Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: November 9, 2021	/s/ Brett Moyer
	Name:	Brett Moyer
	Title:	Chief Executive Officer
	(Principal Executive Officer)

EX-31.2

Exhibit 31.2

CERTIFICATION

PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 302 OF

THE SARBANES-OXLEY ACT OF 2002

I, George Oliva, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of Summit Wireless Technologies, Inc. (the “registrant”):

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13-a13a-15(f) and 15d-15(f)) for the registrant and have:

a)     Designed such disclosure controls and procedures or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b)    Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c)    Evaluated the effectiveness of the registrant’s disclosure controls and procedures; and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures as of the end of the period covered by this report based on such evaluation; and

d)     Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a)     All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b)     Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: November 9, 2021	/s/ George Oliva
	Name:	George Oliva
	Title:	Chief Financial Officer
	(Principal Financial Officer)

EX-32.1

Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report on Form 10-Q of Summit Wireless Technologies, Inc. (the “Company”) for the period ended September 30, 2021 (the “Report”), I, Brett Moyer, Chief Executive Officer of the Company, hereby certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to section 906 of the Sarbanes-Oxley Act of 2002, that:

1.   The Report fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934; and

2.   The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: November 9, 2021	/s/ Brett Moyer
	Name:	Brett Moyer
	Title:	Chief Executive Officer
		(Principal Executive Officer)

A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

EX-32.2

Exhibit 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report on Form 10-Q of Summit Wireless Technologies, Inc. (the “Company”) for the period ended September 30, 2021 (the “Report”), I, George Oliva, Chief Financial Officer of the Company, hereby certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to section 906 of the Sarbanes-Oxley Act of 2002, that:

1.     The Report fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934; and

2.   The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: November 9, 2021	/s/ George Oliva
	Name:	George Oliva
	Title:	Chief Financial Officer
		(Principal Financial Officer)

A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

XML

Document and Entity Information - shares	9 Months Ended
	Sep. 30, 2021	Nov. 09, 2021
Document and Entity Information
Document Type	10-Q
Document Quarterly Report	true
Document Transition Report	false
Document Period End Date	Sep. 30, 2021
Entity File Number	001-38608
Entity Registrant Name	Summit Wireless Technologies, Inc.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	30-1135279
Entity Address, Address Line One	6840 Via Del Oro, Ste. 280
Entity Address, City or Town	San Jose
Entity Address, Country	CA
Entity Address, Postal Zip Code	95119
City Area Code	408
Local Phone Number	627-4716
Title of 12(b) Security	Common Stock, par value $0.0001 per share
Trading Symbol	WISA
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		15,803,940
Entity Central Index Key	0001682149
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2021
Document Fiscal Period Focus	Q3
Amendment Flag	false

XML

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020	[1]
Current Assets:
Cash and cash equivalents	$ 16,067	$ 7,415
Accounts receivable	205	85
Inventories	3,954	2,708
Prepaid expenses and other current assets	1,480	908
Total current assets	21,706	11,116
Property and equipment, net	169	142
Other assets	41	41
Total assets	21,916	11,299
Current Liabilities:
Accounts payable	825	672
Accrued liabilities	2,040	1,433
Borrowings, current position	0	179
Total current liabilities	2,865	2,284
Other liabilities	47	39
Borrowings, net of current position	0	668
Derivative liability	0	387
Warrant liability	8	8
Total liabilities	2,920	3,386
Commitments and contingencies (Note 8)
Series A 8% Senior Convertible Preferred stock, par value $0.0001; 1,250,000 shares authorized; 0 and 250,000 shares issued and outstanding as of September 30, 2021 and December 31, 2020, (liquidation preference of $0 and $1,136,000)	0	597
Stockholders' Equity:
Common stock, par value $0.0001; 200,000,000 shares authorized; 15,803,940 and 8,402,250 shares issued and outstanding as of September 30, 2021 and December 31, 2020, respectively	2	1
Additional paid-in capital	228,128	207,698
Accumulated deficit	(209,134)	(200,383)
Total stockholders' equity	18,996	7,316
Total liabilities, convertible preferred stock and stockholders' equity	$ 21,916	$ 11,299

[1] The condensed consolidated balance sheet as of December 31, 2020 was derived from the audited consolidated balance sheet as of that date.

XML

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)	9 Months Ended	12 Months Ended
	Sep. 30, 2021 USD ($) $ / shares shares	Dec. 31, 2020 USD ($) $ / shares shares
CONDENSED CONSOLIDATED BALANCE SHEETS
Temporary equity, dividend rate, percentage	8.00%	8.00%
Temporary equity, par or stated value per share | $ / shares	$ 0.0001	$ 0.0001
Temporary equity, shares authorized	1,250,000	1,250,000
Temporary equity, shares issued	0	250,000
Temporary equity, shares outstanding	0	250,000
Temporary equity, liquidation preference | $	$ 0	$ 1,136,000
Common stock, par or stated value per share | $ / shares	$ 0.0001	$ 0.0001
Common stock, shares authorized	200,000,000	200,000,000
Common stock, shares issued	15,803,940	8,402,250
Common stock, shares outstanding	15,803,940	8,402,250
Reverse stock split	0.50

XML

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
Revenue, net	$ 1,807,000	$ 607,000	$ 4,541,000	$ 1,366,000
Cost of revenue	1,301,000	503,000	3,281,000	1,187,000
Gross profit	506,000	104,000	1,260,000	179,000
Operating Expenses:
Research and development	1,322,000	1,240,000	3,800,000	3,278,000
Sales and marketing	1,021,000	835,000	2,870,000	2,043,000
General and administrative	1,081,000	1,014,000	3,037,000	2,512,000
Total operating expenses	3,424,000	3,089,000	9,707,000	7,833,000
Loss from operations	(2,918,000)	(2,985,000)	(8,447,000)	(7,654,000)
Interest expense	(3,000)	(5,000)	(9,000)	(1,394,000)
Change in fair value of warrant liability	0	0	0	24,000
Gain on forgiveness of Paycheck Protection Program loan	859,000	0	859,000	0
Other expense	1,000	0	(6,000)	(41,000)
Warrant inducement expense	0	0	(1,146,000)	0
Loss before provision for income taxes	(2,061,000)	(2,990,000)	(8,749,000)	(9,065,000)
Provision for income taxes	0	0	2,000	3,000
Net loss	(2,061,000)	(2,990,000)	(8,751,000)	(9,068,000)
Convertible preferred stock dividend	0	(20,000)	(34,000)	(60,000)
Deemed dividend on exchange of convertible preferred stock for common stock	0	0	(1,192,000)	0
Deemed dividend from warrant repricing	0	0	0	(134,000)
Net loss attributable to common stockholders	$ (2,061,000)	$ (3,010,000)	$ (9,977,000)	$ (9,262,000)
Net loss per common share - Basic	$ (0.15)	$ (0.39)	$ (0.86)	$ (2.15)
Net loss per common share - Diluted	$ (0.15)	$ (0.39)	$ (0.86)	$ (2.15)
Weighted average number of common shares used in computing net loss per common share - Basic	13,917,295	7,709,692	11,600,875	4,304,721
Weighted average number of common shares used in computing net loss per common share - Diluted	13,917,295	7,709,692	11,600,875	4,304,721

XML

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Parenthetical)		9 Months Ended
	Apr. 09, 2020	Sep. 30, 2021
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
Reverse stock split	0.05	0.50

XML

CONDENSED CONSOLIDATED STATEMENTS OF CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT) - USD ($)	Preferred Stock Convertible Preferred Stock	Common Shares Shelf Offering	Common Shares	Additional Paid-in Capital Shelf Offering	Additional Paid-in Capital	Accumulated Other Comprehensive Loss	Accumulated Deficit	Shelf Offering	Total
Balance at Dec. 31, 2019	$ 517,000				$ 188,320,000	$ (48,000)	$ (187,678,000)		$ 594,000
Balance (in shares) at Dec. 31, 2019	250,000		1,245,238
Issuance of warrants in connection with convertible notes payable					630,000				630,000
Issuance of common stock and warrants, net of offering costs					725,000				725,000
Issuance of common stock and warrants, net of offering costs (in shares)			91,062
Issuance of common stock in connection with notes payable					4,000				4,000
Issuance of common stock in connection with notes payable (in shares)			500
Convertible preferred stock dividend	$ 20,000				(20,000)				(20,000)
Stock-based compensation					75,000				75,000
Stock-based compensation (in shares)			2,000
Restricted stock awards cancelled (in shares)			(550)
Release of vested restricted common stock (in shares)			353
Net loss							(2,680,000)		(2,680,000)
Balance at Mar. 31, 2020	$ 537,000		$ 0		189,734,000	(48,000)	(190,358,000)		(672,000)
Balance (in shares) at Mar. 31, 2020	250,000		1,338,603
Balance at Dec. 31, 2019	$ 517,000				188,320,000	(48,000)	(187,678,000)		594,000
Balance (in shares) at Dec. 31, 2019	250,000		1,245,238
Deemed dividend on exchange of convertible preferred stock for common stock									0
Warrant Repricing									134,000
Net loss									(9,068,000)
Balance at Sep. 30, 2020	$ 577,000		$ 1,000		206,030,000		(196,746,000)		9,285,000
Balance (in shares) at Sep. 30, 2020	250,000		7,822,375
Balance at Dec. 31, 2019	$ 517,000				188,320,000	(48,000)	(187,678,000)		594,000
Balance (in shares) at Dec. 31, 2019	250,000		1,245,238
Balance at Dec. 31, 2020	$ 597,000		$ 1,000		207,698,000		(200,383,000)		7,316,000	[1]
Balance (in shares) at Dec. 31, 2020	250,000		8,402,250
Balance at Mar. 31, 2020	$ 537,000		$ 0		189,734,000	(48,000)	(190,358,000)		(672,000)
Balance (in shares) at Mar. 31, 2020	250,000		1,338,603
Issuance of common stock, prefunded warrants and warrants, net of public offering costs					5,515,000				5,515,000
Issuance of common stock, prefunded warrants and warrants, net of public offering costs (in shares)			1,525,000
Proceeds from the exercise of prefunded warrants and common stock warrants					37,000				37,000
Proceeds from the exercise of prefunded warrants and common stock warrants (in shares)			485,000
Issuance of common stock and warrants, net of offering costs		$ 1,000		$ 9,957,000				$ 9,958,000
Issuance of common stock and warrants, net of offering costs (in shares)		4,315,000
Issuance of common stock in connection with settlements					135,000				135,000
Issuance of common stock in connection with settlements (in shares)			60,250
Convertible preferred stock dividend	$ 20,000				(20,000)				(20,000)
Deemed dividend from warrant down-round provision					(134,000)				(134,000)
Warrant Repricing					134,000				134,000
Stock-based compensation					72,000				72,000
Stock-based compensation (in shares)			2,000
Restricted stock awards cancelled (in shares)			(2,500)
Gain On Foreign Currency Translation On Subsidiary						$ 48,000			48,000
Net loss							(3,398,000)		(3,398,000)
Balance at Jun. 30, 2020	$ 557,000		$ 1,000		205,430,000		(193,756,000)		11,675,000
Balance (in shares) at Jun. 30, 2020	250,000		7,723,353
June 2020 shelf offering - issuance costs					(42,000)				(42,000)
Convertible preferred stock dividend	$ 20,000				(20,000)				(20,000)
Deemed dividend on exchange of convertible preferred stock for common stock									0
Stock-based compensation					662,000				662,000
Stock-based compensation (in shares)			98,669
Release of vested restricted common stock (in shares)			353
Net loss							(2,990,000)		(2,990,000)
Balance at Sep. 30, 2020	$ 577,000		$ 1,000		206,030,000		(196,746,000)		9,285,000
Balance (in shares) at Sep. 30, 2020	250,000		7,822,375
Balance at Dec. 31, 2020	$ 597,000		$ 1,000		207,698,000		(200,383,000)		7,316,000	[1]
Balance (in shares) at Dec. 31, 2020	250,000		8,402,250
Issuance of common stock upon warrant exercise, net of issuance costs					5,095,000				5,095,000
Issuance of common stock upon warrant exercise, net of issuance costs (in shares)	0		2,086,251
Issuance of warrants in connection with convertible notes payable	$ 0
Warrants issued in connection with warrant exercise					567,000				567,000
Convertible preferred stock dividend	$ 20,000				(20,000)				(20,000)
Stock-based compensation					254,000				254,000
Stock-based compensation (in shares)	0		643,700
Release of vested restricted common stock (in shares)			352
Net loss							(3,292,000)		(3,292,000)
Balance at Mar. 31, 2021	$ 617,000		$ 1,000		213,594,000		(203,675,000)		9,920,000
Balance (in shares) at Mar. 31, 2021	250,000		11,132,553
Balance at Dec. 31, 2020	$ 597,000		$ 1,000		207,698,000		(200,383,000)		7,316,000	[1]
Balance (in shares) at Dec. 31, 2020	250,000		8,402,250
Deemed dividend on exchange of convertible preferred stock for common stock									(1,192,000)
Warrant Repricing									0
Net loss									(8,751,000)
Balance at Sep. 30, 2021			$ 2,000		228,128,000		(209,134,000)		18,996,000
Balance (in shares) at Sep. 30, 2021			15,803,940
Balance at Mar. 31, 2021	$ 617,000		$ 1,000		213,594,000		(203,675,000)		9,920,000
Balance (in shares) at Mar. 31, 2021	250,000		11,132,553
Issuance of common stock upon warrant exercise, net of issuance costs					3,159,000				3,159,000
Issuance of common stock upon warrant exercise, net of issuance costs (in shares)			1,360,244
Issuance of common stock in connection with notes payable									1,640,000
Warrants issued in connection with warrant exercise					579,000				579,000
Convertible preferred stock dividend	$ 14,000				(14,000)				(14,000)
Exchange of convertible preferred stock for common stock	$ (631,000)				1,640,000
Exchange of convertible preferred stock for common stock (in shares)	(250,000)		250,000
Warrants issued upon exchange of preferred stock for common stock					570,000				570,000
Deemed dividend on exchange of convertible preferred stock for common stock					(1,192,000)				(1,192,000)
Stock-based compensation					335,000				335,000
Stock-based compensation (in shares)			10,000
Issuance of common stock to vendor					34,000				34,000
Issuance of common stock to vendor (in shares)			10,000
Net loss							(3,398,000)		(3,398,000)
Balance at Jun. 30, 2021			$ 1,000		218,705,000		(207,073,000)		11,633,000
Balance (in shares) at Jun. 30, 2021			12,762,797
Issuance of common stock upon warrant exercise, net of issuance costs					49,000				49,000
Issuance of common stock upon warrant exercise, net of issuance costs (in shares)			19,000
Registered direct offering, net of issuance costs			$ 1,000		9,025,000				9,026,000
Registered direct offering, net of issuance costs (in shares)			2,500,000
Deemed dividend on exchange of convertible preferred stock for common stock									0
Stock-based compensation					349,000				349,000
Stock-based compensation (in shares)			320,800
Release of vested restricted common stock (in shares)			201,343
Net loss							(2,061,000)		(2,061,000)
Balance at Sep. 30, 2021			$ 2,000		$ 228,128,000		$ (209,134,000)		$ 18,996,000
Balance (in shares) at Sep. 30, 2021			15,803,940

[1] The condensed consolidated balance sheet as of December 31, 2020 was derived from the audited consolidated balance sheet as of that date.

XML

CONDENSED CONSOLIDATED STATEMENTS OF CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT) (Parenthetical)		9 Months Ended
	Apr. 09, 2020	Sep. 30, 2021
CONSOLIDATED STATEMENTS OF CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY
Reverse stock split	0.05	0.50

XML

CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020
Cash flows from operating activities:
Net loss	$ (8,751,000)	$ (9,068,000)
Adjustments to reconcile net loss to net cash used in operating activities:
Warrant inducement expense	1,146,000	0
Gain on forgiveness of Paycheck Protection Program loan	(859,000)	0
Stock-based compensation	938,000	809,000
Depreciation and amortization	59,000	46,000
Expense for issuance of common stock for services	34,000	0
Amortization of intangible asset	0	25,000
Amortization of debt discounts	0	1,389,000
Expense related to common stock issued in settlements	0	135,000
Change in fair value of warrant liability	0	(24,000)
Gain on foreign currency translation from closure of subsidiary	0	(48,000)
Changes in operating assets and liabilities:
Accounts receivable	(120,000)	(138,000)
Inventories	(1,246,000)	90,000
Prepaid expenses and other assets	(572,000)	66,000
Accounts payable	153,000	(643,000)
Accrued liabilities	644,000	(234,000)
Net cash used in operating activities	(8,574,000)	(7,499,000)
Cash flows from investing activities:
Purchases of property and equipment	(86,000)	(15,000)
Net cash used in investing activities	(86,000)	(15,000)
Cash flows from financing activities:
Proceeds from issuance of common stock upon warrant exercises, net of issuance costs	8,303,000	0
Repayment of capital lease	(17,000)	0
Proceeds from issuance of common stock in registered direct offering, net of issuance costs	9,026,000	0
Proceeds from issuance of common stock, prefunded warrants and warrants, net of issuance costs	0	6,240,000
Proceeds from issuance of common stock, net of shelf offering costs	0	9,951,000
Proceeds from the exercise of prefunded warrants and common stock warrants	0	37,000
Proceeds from issuance of promissory notes	0	847,000
Proceeds from issuance of convertible notes payable, net of issuance costs	0	1,396,000
Repayment of convertible notes payable	0	(2,151,000)
Net cash provided by financing activities	17,312,000	16,320,000
Net increase in cash and cash equivalents	8,652,000	8,806,000
Cash and cash equivalents as of beginning of period	7,415,000	298,000
Cash and cash equivalents as of end of period	16,067,000	9,104,000
Supplemental disclosure of cash flow information:
Cash paid for interest	3,000	352,000
Cash paid for income taxes	2,000	3,000
Noncash Investing and Financing Activities:
Exchange of convertible preferred stock for common stock	1,640,000	0
Deemed dividend on exchange of convertible preferred stock for common stock	(1,192,000)	0
Issuance of warrants in connection with exchange of preferred stock	570,000	0
Convertible preferred stock dividend	34,000	60,000
Issuance of warrants in connection with convertible notes payable	0	630,000
Issuance of common stock in connection with convertible notes payable	0	4,000
Issuance of warrants in connection with common stock offerings	0	8,354,000
Deemed dividend from warrant repricing	0	(134,000)
Issuance costs for shelf offering of common stock in accounts payable	0	35,000
Warrant repricing	0	134,000
Property and equipment purchased through capital lease	$ 0	$ 72,000

XML

Business and Summary of Significant Accounting Policies

9 Months Ended

Sep. 30, 2020

Business and Summary of Significant Accounting Policies

Business and Summary of Significant Accounting Policies

1.    Business and Summary of Significant Accounting Policies

Summit Wireless Technologies, Inc. (together with its subsidiaries also referred to herein as “we”, “us”, “our”, or the “Company”) was originally formed as a limited liability company in Delaware on July 23, 2010. The Company develops wireless audio semiconductors and modules for consumer electronics companies to enable mainstream consumers and audio enthusiasts to experience high quality audio.

Basis of Presentation

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial information and pursuant to Article 10 of Regulation S-X of the Securities Act of 1933, as amended (“Securities Act”). Accordingly, they do not include all of the information and notes required by U.S. GAAP for complete financial statements. These unaudited condensed consolidated financial statements include all normal and recurring adjustments that the Company believes are necessary to fairly state the Company’s financial position and the results of operations and cash flows. Interim period results are not necessarily indicative of results of operations or cash flows for a full year or any subsequent interim period. The condensed consolidated balance sheet as of December 31, 2020 has been derived from audited consolidated financial statements at that date, but does not include all disclosures required by U.S. GAAP for complete financial statements.

Use of Estimates

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates.

Reclassification

Certain reclassifications have been made to prior periods’ consolidated financial statements to conform to the current period presentation. These reclassifications did not result in any change in previously reported net loss, total assets or stockholders’ equity.

Concentration of Credit Risk and Other Risks and Uncertainties

Financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash and cash equivalents and accounts receivable. Cash and cash equivalents are deposited in demand and money market accounts at one financial institution. At times, such deposits may be in excess of insured limits. The Company has not experienced any losses on its deposits of cash and cash equivalents.

The Company’s accounts receivable are derived from revenue earned from customers located throughout the world. The Company performs credit evaluations of its customers’ financial condition as necessary, and sometimes requires partial payment in advance of shipping. As of September 30, 2021 and December 31, 2020, there was no allowance for doubtful accounts. As of September 30, 2021, the Company had one customer accounting for 63% of accounts receivable. As of December 31, 2020, the Company had three customers accounting for 36%, 31% and 15% of accounts receivable. The Company had three customers accounting for 63%, 12% and 12% of its net revenue for the three months ended September 30, 2021. The Company had three customers accounting for 33%, 17%, and 10% of its net revenue for the nine months ended September 30, 2021. The Company had four customers accounting for 30%, 18%, 15% and 11% of its net revenue for the three months ended September 30, 2020. The Company had three customers accounting for 54%, 28% and 11% of its net revenue for the nine months ended September 30, 2020.

The Company’s future results of operations involve a number of risks and uncertainties. Factors that could affect the Company’s future operating results and cause actual results to vary materially from expectations include, but are not limited to, rapid technological change, continued acceptance of the Company’s products, competition from substitute products and larger companies, protection of proprietary technology, strategic relationships and dependence on key individuals.

1.    Summary of Significant Accounting Policies, continued

The Company relies on sole-source suppliers to manufacture some of the components used in its product. The Company’s manufacturers and suppliers may encounter problems during manufacturing due to a variety of reasons, any of which could delay or impede their ability to meet demand. The Company is heavily dependent on a single contractor in China for assembly and testing of its products, a single contractor in Japan for the production of its transmit semiconductor chip and a single contractor in China for the production of its receive semiconductor chip.

Convertible Financial Instruments

The Company bifurcates conversion options and warrants from their host instruments and accounts for them as freestanding derivative financial instruments if certain criteria are met. The criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re-measured at fair value under otherwise applicable generally accepted accounting principles with changes in fair value reported in earnings as they occur and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument. An exception to this rule is when the host instrument is deemed to be conventional, as that term is described under applicable U.S. GAAP.

When the Company has determined that the embedded conversion options and warrants should be bifurcated from their host instruments, discounts are recorded for the intrinsic value of conversion options embedded in the instruments based upon the differences between the fair value of the underlying common stock at the commitment date of the transaction and the effective conversion price embedded in the instrument.

Debt discounts under these arrangements are amortized to interest expense using the interest method over the earlier of the term of the related debt or their earliest date of redemption.

Warrants for Shares of Common Stock and Derivative Financial Instruments

Warrants for shares of common stock and other derivative financial instruments are classified as equity if the contracts (1) require physical settlement or net-share settlement or (2) give the Company a choice of net-cash settlement or settlement in its own shares (physical settlement or net-share settlement). Contracts which (1) require net-cash settlement (including a requirement to net cash settle the contract if an event occurs and if that event is outside the control of the Company), (2) give the counterparty a choice of net-cash settlement or settlement in shares (physical settlement or net-share settlement), or (3) that contain reset provisions that do not qualify for the scope exception are classified as liabilities. The Company assesses classification of its warrants for shares of common stock and other derivatives at each reporting date to determine whether a change in classification between equity and liabilities is required.

The issuance of the convertible notes payable generated a beneficial conversion feature (“BCF”), which arises when a debt or equity security is issued with an embedded conversion option that is beneficial to the investor or in the money at inception because the conversion option has an effective strike price that is less than the market price of the underlying stock at the commitment date. The Company recognized the BCF by allocating the intrinsic value of the conversion option, which is the number of shares of common stock available upon conversion multiplied by the difference between the effective conversion price per share and the fair value of common stock per share on the commitment date, to shares of common stock, resulting in a discount on the convertible debt.

1.    Summary of Significant Accounting Policies, continued

Revenue Recognition

Revenue consists primarily of the sale of the wireless modules. The Company applies the following five steps: (1) identify the contract with a customer, (2) identify the performance obligations in the contract, (3) determine the transaction price, (4) allocate the transaction price to the performance obligations in the contract, and (5) recognize revenue when a performance obligation is satisfied. The Company considers customer purchase orders to be the contracts with a customer. Revenues, net of expected discounts, are recognized when the performance obligations of the contract with the customer are satisfied and when control of the promised goods are transferred to the customer, typically when products, which have been determined to be the only distinct performance obligations, are shipped to the customer. Expected costs of assurance warranties and claims are recognized as expense.

Taxes assessed by a governmental authority that are both imposed on and concurrent with a specific revenue-producing transaction, that are collected by us from a customer and deposited with the relevant government authority, are excluded from revenue. Our revenue arrangements do not contain significant financing components.

Sales to certain distributors are made under arrangements which provide the distributors with price adjustments, price protection, stock rotation and other allowances under certain circumstances. The Company does not provide its customers with a contractual right of return. However, the Company accepts limited returns on a case-by-case basis. These returns, adjustments and other allowances are accounted for as variable consideration. We estimate these amounts based on the expected amount to be provided to customers and reduce revenue recognized. We believe that there will not be significant changes to our estimates of variable consideration.

If a customer pays consideration, or the Company has a right to an amount of consideration that is unconditional before we transfer a good or service to the customer, those amounts are classified as contract liabilities which are included in other current liabilities when the payment is made or it is due, whichever is earlier.

Contract Balances

We receive payments from customers based on a billing schedule as established in our contracts to partially offset prepayments required by our vendors on long lead time materials. Amounts collected prior to the fulfillment of the performance obligation are considered contract liabilities and classified as customer advances within accrued liabilities on the condensed consolidated balance sheets. Contract assets are recorded when we have a conditional right to consideration for our completed performance under the contracts. Accounts receivables are recorded when the right to this consideration becomes unconditional. We do not have any material contract assets as of September 30, 2021 and December 31, 2020.

(in thousands)

	September 30,		December 31,
	2021		2020
Contract Liabilities	$	715	$	373

During the nine months ended September 30, 2021, the Company recognized $373,000 of revenue that was included in the contract liabilities as of December 31, 2020.

Revenue by Geographic Area

In general, revenue disaggregated by geography (See Note 10) is aligned according to the nature and economic characteristics of our business and provides meaningful disaggregation of our results of operations. Since we operate in one segment, all financial segment and product line information can be found in the condensed consolidated financial statements.

1.    Summary of Significant Accounting Policies, continued

Advertising Costs

Advertising costs are charged to sales and marketing expenses as incurred. Advertising costs for the three and nine months ended September 30, 2021 were $152,000 and $451,000, respectively. Advertising costs for the three and nine months ended September 30, 2020 were $65,000 and $81,000, respectively.

Comprehensive Loss

Comprehensive loss represents the changes in equity of an enterprise, other than those resulting from stockholder transactions. Accordingly, comprehensive loss may include certain changes in equity that are excluded from net loss. For the three and nine months ended September 30, 2021 and 2020, the Company’s comprehensive loss is the same as its net loss.

Foreign Currency

The financial position and results of operations of the Company’s foreign operations are measured using currencies other than the U.S. dollar as their functional currencies. Accordingly, for these operations all assets and liabilities are translated into U.S. dollars at the current exchange rates as of the respective balance sheet date. Expense items are translated using the weighted average exchange rates prevailing during the period. Cumulative gains and losses from the translation of these operations’ financial statements are reported as a separate component of stockholders’ equity, while foreign currency transaction gains or losses, resulting from re-measuring local currency to the U.S. dollar are recorded in the condensed consolidated statement of operations in other income (expense), net and were not material for the three and nine months ended September 30, 2021 and 2020.

Net Loss per Common Share

Basic net loss per common share is calculated by dividing the net loss attributable to common stockholders by the weighted average number of shares of common stock outstanding during the period, without consideration for potentially dilutive securities. Diluted net loss per common share is computed by dividing the net loss attributable to common stockholders by the weighted average number of shares of common stock and potentially dilutive common share equivalents outstanding for the period determined using the treasury-stock and if-converted methods. For purposes of the diluted net loss per common share calculation, Series A Preferred Stock, warrants exercisable for common stock, restricted stock units and shares issuable upon the conversion of convertible notes payable are considered to be potentially dilutive securities.

For the three and nine months ended September 30, 2021, warrants to purchase 4,475,424 shares of common stock, 711,805 shares of restricted stock, 310,000 shares of restricted stock issued under an inducement grant and 456,931 shares underlying restricted stock units have been excluded from the calculation of net loss per common share because the inclusion would be antidilutive. For the three and nine months ended September 30, 2020, warrants to purchase 7,337,199 shares of common stock, 250,000 shares of Series A Preferred Stock and 98,669 shares of restricted stock have been excluded from the calculation of net loss per common share because the inclusion would be antidilutive.

1.     Summary of Significant Accounting Policies, continued

Recently Issued and Not Yet Adopted Accounting Pronouncements

In February 2016, the FASB issued ASU 2016-02, “Leases”. The objective of the update is to increase transparency and comparability among organizations by recognizing lease assets and liabilities on the balance sheet for leases with a lease term of more than 12 months. In addition, the update will require additional disclosures regarding key information about leasing arrangements. Under existing guidance, operating leases are not recorded as lease assets and lease liabilities on the balance sheet. In October 2019, the FASB decided to defer the mandatory effective date of ASU 2016-02 to fiscal years beginning after December 15, 2020 for certain entities, including private companies. In June 2020, in response to adverse effect caused by Coronavirus Disease pandemic on private businesses, the FASB issued ASU 2020-05 which deferred the effective date for ASU 2016-02 for private businesses to annual reporting periods beginning after December 15, 2021. As an emerging growth company, the Company is allowed to adopt accounting pronouncements at the same time as non-public business entities. As a result, we will adopt the update for our fiscal year beginning after December 15, 2021. The Company does not expect the adoption of this standard to significantly impact the condensed consolidated financial statements.

XML

Going Concern

9 Months Ended

Sep. 30, 2021

Going Concern

Going Concern

2.     Going Concern

The condensed consolidated financial statements of the Company have been prepared on a going concern basis, which contemplates the realization of assets and the discharge of liabilities in the normal course of business. The Company has incurred net operating losses each year since inception. As of September 30, 2021, the Company had cash and cash equivalents of $16.1 million and reported net cash used in operations of $8.6 million during the nine months ended September 30, 2021. The Company expects operating losses to continue in the foreseeable future because of additional costs and expenses related to research and development activities, plans to expand its product portfolio, and increase its market share. The Company’s ability to transition to attaining profitable operations is dependent upon achieving a level of revenues adequate to support its cost structure.

Based on current operating levels, the Company will need to raise additional funds by selling additional equity or incurring debt. To date, the Company has not generated significant revenues and has funded its operations primarily through sales of its common stock in public markets, sales of common and preferred units prior to its initial public offering (“IPO”), and proceeds from the exercise of warrants to purchase common stock and the sale of convertible notes. The Company also obtained a loan of $847,000, pursuant to the Paycheck Protection Program under Division A, Title I of the Coronavirus Aid, Relief, and Economic Security Act, but the use of funds from such loan, by its terms, has been limited to making payroll payments to our employees and other permitted purposes relating to the operation of our business. (See Note 4 – Borrowings – Payroll Protection Program Note Agreement.) Additionally, future capital requirements will depend on many factors, including the rate of revenue growth, the selling price of the Company’s products, the expansion of sales and marketing activities, the timing and extent of spending on research and development efforts and the continuing market acceptance of the Company’s products. These factors raise substantial doubt about the Company’s ability to continue as a going concern.

Management of the Company intends to raise additional funds through the issuance of equity securities or debt. There can be no assurance that, in the event the Company requires additional financing, such financing will be available at terms acceptable to the Company, if at all. Failure to generate sufficient cash flows from operations, raise additional capital and reduce discretionary spending could have a material adverse effect on the Company’s ability to achieve its intended business objectives. As a result, the substantial doubt about the Company’s ability to continue as a going concern has not been alleviated. The accompanying condensed consolidated financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.

XML

Balance Sheet Components

9 Months Ended

Sep. 30, 2021

Balance Sheet Components

Balance Sheet Components

3.    Balance Sheet Components

Inventories (in thousands):

	September 30,		December 31,
	2021		2020
Raw materials	$	1,693	$	1,872
Work in progress		539		283
Finished goods		1,722		553
Total inventories	$	3,954	$	2,708

Property and equipment, net (in thousands):

	September 30,		December 31,
	2021		2020
Machinery and equipment	$	952	$	866
Tooling		11		11
Computer software		89		89
Furniture and fixtures		15		15
Leasehold improvements		40		40
		1,107		1,021
Less: Accumulated depreciation and amortization		(938)		(879)
Property and equipment, net	$	169	$	142

Depreciation and amortization expense for the three months ended September 30, 2021 and 2020 was $20,000 and $17,000, respectively. Depreciation and amortization expense for the nine months ended September 30, 2021 and 2020 was $59,000 and $46,000, respectively.

The cost and accumulated depreciation of assets acquired under capital lease included in machinery and equipment in the above table as of September 30, 2021 were $72,000 and $26,000, respectively.

Accrued liabilities (in thousands):

	September 30,		December 31,
	2021		2020
Accrued vacation	$	344	$	328
Accrued compensation		321		84
Customer advances		715		373
Accrued professional fees		158		161
Accrued rebate		319		326
Accrued other		183		161
Total accrued liabilities	$	2,040	$	1,433

XML

Borrowings

9 Months Ended

Sep. 30, 2021

Borrowings

Borrowings

4.    Borrowings

Funding Agreement

On January 23, 2020, we entered into a funding agreement, as amended (the “Funding Agreement”), which provided for the issuance to an unaffiliated accredited investor of a convertible promissory note in the principal amount of $111,100, reflecting a 10% original issue discount, 500 shares of our common stock and a five-year warrant exercisable for 7,936 shares of our common stock at an exercise price of $9.80 per share in consideration for $100,000, which was funded on January 24, 2020. Repayment of the convertible promissory note was due 45 days from execution of the Funding Agreement, or March 9, 2020, and the investor was granted a most favored nation right. On March 31, 2020, the outstanding debt owed to such investor pursuant to the Funding Agreement was fully repaid. During the three and nine months ended September 30, 2020, the Company recognized $0 and $20,000, respectively, of interest expense from amortization of debt discounts related to the Funding Agreement.

Convertible Promissory Note

On March 30, 2020, the Company completed a private placement (the “March 2020 Private Placement”) of a senior secured convertible instrument (the “March 2020 Note”) and a warrant (the “March 2020 Warrant”) to purchase 227,679 shares of common stock at an exercise price of $6.40 per share, pursuant to which Maxim Group LLC (“Maxim”), acted as placement agent. The March 2020 Note and March 2020 Warrant were issued pursuant to a securities purchase agreement, entered into as of March 22, 2020 (the “March 2020 Purchase Agreement”) by and between the Company and an institutional investor. The March 2020 Private Placement resulted in gross proceeds of $1,700,000, before fees and other expenses associated with the transaction, including but not limited to, an $85,000 commitment fee payable to such investor. The net proceeds received by us in connection with the March 2020 Private Placement were used primarily for working capital, debt repayment and general corporate purposes. Additionally, the Company issue a warrant to Maxim to purchase up to an aggregate of 20,400 shares of common stock, subject to adjustment, as partial consideration for serving as placement agent in connection with the March 2020 Private Placement (the “March 2020 Maxim Warrant”).

The March 2020 Note ranked senior to the Company’s existing and future indebtedness and was secured to the extent and as provided in the security agreements entered into between the investor and each of the Company and its wholly-owned subsidiary, in connection with the March 2020 Private Placement. The March 2020 Note was convertible in whole or in part at the option of the investor into shares of common stock at a conversion price equal to the lesser of (a) 90% of the average of the five lowest daily VWAPs during the previous twenty trading days prior to delivery to the Company of such investor’s applicable notice of conversion and (b) $6.40, subject to certain adjustments, at any time following the earlier of (i) 60 days from execution of the March 2020 Purchase Agreement and (ii) the date on which a registration statement covering the shares of common stock underlying each of the March 2020 Note and the related warrant is declared effective by the SEC; however, if the Company entered into an underwriting agreement within 45 days of the date on which the March 2020 Note was issued in connection with an underwritten offering that closes within 45 days of the execution of the Purchase Agreement, such investor may not convert the March 2020 Note prior to the 61st day after the date on which such underwriting agreement was executed.

The March 2020 Note contained full ratchet anti-dilution protection, subject to certain price limitations required by the rules and regulations of Nasdaq and certain exceptions, upon any subsequent transaction at a price lower than the conversion price then in effect and standard adjustments in the event of stock dividends, stock splits, combinations or similar events. Additionally, upon three days’ written notice to the holder after receipt of a notice of conversion, in lieu of delivering shares of common stock upon a conversion, the Company had the right to pay the investor, in cash, an amount equal to 103% of the portion of the outstanding principal amount stated in such notice of conversion. Further, at the investor’s option, the March 2020 Note was convertible into shares of common stock or redeemable for 103% of the portion of the outstanding principal amount to be converted in the event that any transaction causes the conversion price to be lower than as required by Nasdaq rules and regulations. Subject to certain exceptions, commencing on the Conversion Trigger Date (as such term is defined in the March 2020 Note) and for a nine-month period after such date, the investor could convert only up to an aggregate of $102,000 in outstanding principal amount during any calendar month.

4.    Borrowings, continued

At any time after issuance of the March 2020 Note, the Company could repay all (but not less than all) of the outstanding principal amount of the March 2020 Note upon ten days’ written notice to the investor. If the Company exercised its right to prepay the March 2020 Note, the investor had the right, upon five days written notice to the Company after receipt of the notice of prepayment, to convert up to 33% of the principal amount of the March 2020 Note at the applicable conversion price. The investor also had the right to require the Company to repay 105% of the outstanding principal amount of the March 2020 Note in the event of a Change of Control (as defined in the March 2020 Purchase Agreement).

At any time after the closing date of the March 2020 Private Placement, in the event that the Company issued or sold any shares of common stock or common stock equivalents (as defined in the March 2020 Note), subject to certain exceptions, at an effective price lower than the conversion price then in effect or without consideration, then the conversion price would be reduced to the price per share paid for such shares of common stock or common stock equivalents.

In connection with the March 2020 Note, the Company issued the March 2020 Warrant to the investor and the March 2020 Maxim Warrant to Maxim, respectively (see Note 6 – Convertible Preferred Stock and Stockholders’ Equity for fair value computation). The sum of the fair value of the March 2020 Warrant and the March 2020 Maxim Warrant, and the original issue discount for interest and issuance costs for the March 2020 Note were recorded as debt discounts to be amortized to interest expense over the respective term using the effective interest method.

The March 2020 Note contained several embedded conversion features. The Company determined that there was no significant value to the embedded conversion features as the underlying events to trigger the conversion features were not likely to occur. The Company did not record any embedded conversion liability related to the March 2020 Note.

On April 29, 2020, the outstanding debt of $2,040,000, owed to the investor pursuant to the March 2020 Note, was fully repaid. During the three months ended September 30, 2021 and 2020, the Company recognized $0 and $0 of interest expense from the amortization of debt discounts. During the nine months ended September 30, 2021 and 2020, the Company recognized $0 and $1,389,000 of interest expense from the amortization of debt discounts.

Payroll Protection Program Note Agreement

On May 3, 2020, we received a loan (the “PPP Loan”) from Wells Fargo Bank, National Association in the aggregate amount of $847,000, pursuant to the Paycheck Protection Program (the “PPP”) under Division A, Title I of the Coronavirus Aid, Relief, and Economic Security Act, which was enacted on March 27, 2020. The PPP Loan was funded on May 7, 2020. The PPP Loan, which is in the form of a PPP promissory note and agreement, dated May 3, 2020 (the “PPP Note Agreement”), had a maturity date of May 3, 2022 and bore interest at a rate of 1.00% per annum. Pursuant to a change in guidance by the U.S. Small Business Administration, the initial monthly payment date of the PPP Note Agreement was deferred from November 1, 2020 to August 18, 2021. The PPP Loan may be prepaid by us at any time prior to maturity with no prepayment penalties. We have used the PPP Loan amount for payroll costs, costs used to continue group health care benefits, rent, and utilities. Under the terms of the PPP Note Agreement, certain amounts of the PPP Loan may be forgiven.

Under the terms of the CARES Act, PPP loan recipients can apply for and be granted forgiveness for all or a portion of the loan granted under the PPP. Such forgiveness will be determined, subject to limitations, based on the use of loan proceeds for qualifying expenses. During the third quarter of 2021, the Company received full loan forgiveness for obligations related to the PPP loan. The Company accounted for the PPP loan as debt, and the loan forgiveness was accounted for as a debt extinguishment. The amount of loan and interest forgiven totaling $859,000, was recognized as a gain upon debt extinguishment and was reported in the accompanying condensed consolidated statements of operations for the three months and nine months ended September 30, 2021.

XML

Convertible Preferred Stock and Stockholders' Equity (Deficit)

9 Months Ended

Sep. 30, 2021

Convertible Preferred Stock and Stockholders' Equity (Deficit)

Convertible Preferred Stock and Stockholders' Equity (Deficit)

6.    Convertible Preferred Stock and Stockholders’ Equity (Deficit)

Reverse Stock Split

On March 31, 2020, the Company held a special meeting of its stockholders, at which its stockholders approved an amendment to the Company’s certificate of incorporation, as amended, to effect a reverse stock split of all of the outstanding shares of common stock at a specific ratio within a range from one-for-four to one-for-twenty, and to grant authorization to the board of directors to determine, in its sole discretion, the specific ratio and timing of the reverse stock split. On April 9, 2020, a 1-for-20 reverse stock split was effected and the condensed consolidated financial statements have been retroactively adjusted. All common stock share numbers, warrants to purchase common stock, prices and exercise prices have been retroactively adjusted to reflect the reverse stock split. The par value of the common stock and the Series A 8% Senior Convertible Preferred Stock, par value $0.0001 per share (the “Series A Preferred Stock”) outstanding and its par value were not adjusted for the reverse stock split. The common stock began trading on a split-adjusted basis on that day under the new CUSIP number 86633R 203.

6.    Convertible Preferred Stock and Stockholders’ Equity (Deficit), continued

Series A 8% Senior Convertible Preferred Stock

On April 18, 2019, we entered into a Securities Purchase Agreement, dated as of April 18, 2019, with Lisa Walsh (the “Preferred SPA”), pursuant to which we issued 250,000 shares of our Series A 8% Senior Convertible Preferred Stock, par value $0.0001 per share (the “Series A Preferred Stock”), which shares did have a stated value of $4.00, grant holders the same voting rights as holders of our shares of common stock, and are convertible into shares of our common stock at price of $80.00 per share, subject to a floor price of $30.00 and to adjustment under our Certificate of Designations of the Preferences, Rights and Limitations of the Series A Preferred Stock, in consideration for $1,000,000 (the “Initial Tranche”). The Series A Preferred Stock may be issued in tranches of at least $500,000 and in an aggregate of up to $5 million. In connection with the Initial Tranche, the Company also issued to Ms. Walsh a warrant to purchase 12,756 shares of our common stock.

The Series A Preferred Stock contained an embedded conversion feature that the Company determined is a derivative requiring bifurcation. The fair value of the derivative liability at the issuance of the Series A Preferred Stock was $216,000, which was recorded as a derivative liability with the offset recorded as a discount to the Series A Preferred Stock. (See Note 5 – Fair Value Measurements for the fair value computation.)

As of September 30, 2021, the Company no longer has a derivative liability or any preferred stock outstanding, as all outstanding shares of Series A Preferred Stock were exchanged for 250,000 shares of common stock and warrants to purchase up to 187,500 shares of Common Stock during the three months ending June 30, 2021. On June 4, 2021, the Company and Lisa Walsh (the “Investor”) entered into an exchange agreement pursuant to which the Company effected such exchange of securities with the Investor.

As of September 30, 2021, there are 20,000,000 shares of preferred stock authorized, but there are no shares issued or outstanding.

Common Stock

Carve-Out Plan

For the three and nine months ended September 30, 2021, 0 and 352 shares of restricted stock issued under the Carve-Out Plan (the “Plan”), respectively, were released with an intrinsic value of approximately $0 and $2,000, respectively. For the three and nine months ended September 30, 2020, 353 and 706 shares of restricted stock were released with an intrinsic value of approximately $1,000 and $3,000, respectively.

2018 Long Term Stock Incentive Plan

On January 30, 2018, the Company’s board of directors approved the establishment of the Company’s 2018 Long-Term Stock Incentive Plan (the “LTIP”) and termination of the Plan. Under the LTIP, the aggregate maximum number of shares of common stock (including shares underlying options) that may be issued under the LTIP pursuant to awards of Restricted Shares or Options will be limited to 15% of the outstanding shares of common stock , which calculation shall be made on the first trading day of each new fiscal year; provided that, in any year no more than 8% of the common stock or derivative securitization with common stock underlying 8% of the common stock may be issued in any fiscal year. Thereafter, the 15% evergreen provision governs the LTIP. For fiscal year 2021, up to 672,180 shares of common stock are available for participants under the LTIP.

For the three and nine months ended September 30, 2021, 29,064 shares of restricted stock issued under the LTIP, were released with an intrinsic value of approximately $93,000. For the three and nine months ended September 30, 2020, 0 shares of restricted stock were released.

6.    Convertible Preferred Stock and Stockholders’ Equity (Deficit), continued

A summary of activity related to restricted stock awards (excluding the deferred shares and the inducement grant restricted stock award) for the nine months ended September 30, 2021 is presented below:

		Weighted-Average
Stock Awards	Shares	Grant Date Fair Value
Non-vested as of January 1, 2021	87,169	$	2.26
Granted	664,500	$	3.57
Vested	(29,064)	$	2.26
Forfeited	—	$	—
Non-vested as of September 30, 2021	722,605	$	3.46

As of September 30, 2021, the unamortized compensation costs related to the unvested restricted stock awards was approximately $2,028,000 which is to be amortized on a straight-line basis over a weighted-average period of approximately 2.4 years.

On September 13, 2021, the Company issued 310,000 shares of restricted common stock to Eric Almgren, the Company’s new Chief Strategist, as an inducement grant (“September 2021 Inducement Grant”). Such shares were issued outside the Company’s LTIP and 2020 Stock Plan. In accordance with the September 2021 Inducement Grant, 77,500 shares will vest monthly over a period of 36 months and the remaining 232,500 will vest in 77,500 increments, upon the achievement of certain company milestones related to the volume weighted average closing price per share of the Company’s common stock, as reported on NASDAQ, for the ten (10) consecutive days in which thresholds of the Company’s market capitalization of $75 million, $100 million and $150 million are achieved. The September 2021 Inducement Grant has been valued with an approximate value of $772,000 and will be amortized over 36 months. The Company recorded $10,000 of stock-based compensation for the three and nine months ended September 30, 2021.

2020 Stock Incentive Plan

On July 27, 2020, the board of directors adopted the Company’s 2020 Stock Incentive Plan (the “2020 Stock Plan”) and the reservation of an aggregate of 650,000 shares of the Company’s common stock authorized for issuance under the 2020 Stock Plan, subject to stockholder approval. The 2020 Stock Plan authorizes the grant of equity-based compensation to the Company’s senior managers, employees, directors, consultants, professionals and service providers in the form of stock options, restricted stock and restricted stock units. On July 27, 2020, the Company also granted, subject to stockholder approval, an aggregate of 614,824 restricted stock units to senior managers, employees, directors, consultants. Each of the awards are scheduled to vest on the first, second, and third anniversaries of August 15, 2020, so long as such award recipient remains in service of the Company on each such anniversary. Each restricted stock unit represents the right to receive one share of the Company’s common stock under the 2020 Stock Plan. On October 20, 2020, the Company held the 2020 Annual Meeting of Stockholders and approved the adoption of the 2020 Stock Plan and the reservation of an aggregate of 650,000 shares of the Company’s common stock. In connection with the approval, the Company issued 614,824 restricted stock units to employees, directors and consultants.

6.    Convertible Preferred Stock and Stockholders’ Equity (Deficit), continued

A summary of activity related to restricted stock units under the Company’s 2020 Stock Plan for the nine months ended September 30, 2021 is presented below:

		Weighted-Average
Stock Units	Shares	Grant Date Fair  Value
Non-vested as of January 1, 2021	626,974	$	2.29
Granted	20,500	$	3.81
Vested	(201,343)	$	2.27
Forfeited	—	$	—
Non-vested as of September 30, 2021	446,131	$	2.36

As of September 30, 2021, the unamortized compensation costs related to the unvested restricted stock units was approximately $1,042,000 which is to be amortized on a straight-line basis over a weighted-average period of approximately 1.9 years.

For the three and nine months ended September 30, 2021, 201,343 shares of restricted stock units were released under the 2020 Stock Plan with an intrinsic value of approximately $646,000. For the three and nine months ended September 30, 2020, no shares of restricted stock units were released.

February 2020 Private Placement

On February 28, 2020, the Company completed a private placement (the “February 2020 Private Placement”) of 91,062 units (the “Units”), each unit consisting of (i) one (1) share of common stock and (ii) a warrant to purchase 0.50 of a share of common stock (the “February 2020 Warrants”), at a price per Unit of $9.17. The Units were issued pursuant to a Unit Purchase Agreement, dated February 4, 2020, and a subscription agreement, dated February 28, 2020 by and among the Company and the purchasers signatory thereto. In connection with the February 2020 Private Placement, we paid Alexander Capital, L.P. (“Alexander”) cash fees of $83,000 and issued to Alexander a warrant to purchase 4,553 shares of common stock (the “February 2020 Alexander Warrant”). Such warrant is exercisable at a per share price of $8.80 and is exercisable at any time during the five-year period commencing on the date of issuance. The February 2020 Private Placement, which was priced above market, resulted in gross proceeds of $835,000 before fees and other expenses associated with the transaction.

The February 2020 Warrants are exercisable to purchase up to an aggregate of 45,534 shares of common stock commencing on the date of issuance at an exercise price of $9.80 per share, subject to adjustment upon stock splits, reverse stock splits, and similar capital changes. The February 2020 Warrants are exercisable immediately and will expire on the close of business on February 28, 2025. The exercise of the February 2020 Warrants are subject to beneficial ownership limitations such that each holder of such February 2020 Warrant may exercise it to the extent that such exercise would result in such holder being the beneficial owner in excess of 4.99% (or, upon election of such holder, 9.99%), which beneficial ownership limitation may be increased or decreased up to 9.99% upon notice to the Company, provided that any increase in such limitation will not be effective until 61 days following notice to the Company.

The grant date fair value of February 2020 Warrants was $103,000, which was recorded within stockholders’ equity as a cost of issuance and an increase to additional paid-in capital on the accompanying condensed consolidated balance sheet. The fair value of such warrants was determined using the Black-Scholes Model based on the following weighted average assumptions: common stock price on date of grant of $6.00; expected dividend yield of 0.0%; expected volatility of 59.0%; risk-free interest rate of 0.89% and expected life of 5 years.

6.    Convertible Preferred Stock and Stockholders’ Equity (Deficit), continued

The fair value of the February 2020 Alexander Warrant at issuance was $11,000. The fair value of such warrant was estimated using the Black-Scholes Model based on the following weighted average assumptions: common share price on date of grant $6.00, expected dividend yield 0%, expected volatility 59%, risk-free interest rate 0.89% and expected life of 5 years. The fair value was recorded within stockholders’ equity as a cost of issuance and an increase to additional paid-in capital on the accompanying condensed consolidated balance sheet.

April 2020 Public Offering

On April 23, 2020, the Company closed an underwritten public offering of 1,525,000 shares of its common stock, pre-funded common stock purchase warrants to purchase up to an aggregate of 475,000 shares of common stock, and common stock purchase warrants to purchase up to an aggregate of 2,000,000 shares of the Company’s common stock (the “April 2020 Public Offering”). Each share of common stock or pre-funded common stock purchase warrant was sold together with one common stock purchase warrant to purchase one share of common stock at a combined price to the public of $3.25 per share and common stock purchase warrant (or $3.24 per pre-funded common stock purchase warrant and common stock purchase warrant). Gross proceeds before deducting underwriting discounts, commissions and other offering expenses were approximately $6.5 million. In addition, the Company granted to Maxim a 45-day option to purchase up to an additional 300,000 shares of common stock and/or common stock purchase warrants to purchase up to an aggregate of 300,000 shares of common stock, at the public offering price, less discounts and commissions, of which Maxim partially exercised its option to purchase additional common stock purchase warrants to purchase up to an aggregate of 229,100 shares of common stock. Each common stock purchase warrant is immediately exercisable for one share of common stock at an exercise price of $3.25 per share and will expire five years from issuance. The Company also issued a warrant to Maxim to purchase up to 100,000 shares of common stock in connection with the April 2020 Public Offering (the “April 2020 Maxim Warrant”). Such warrant has an exercise price of $3.90 per share and is fully vested.

May 2020 Shelf Registration

On May 18, 2020, we registered for resale, pursuant to a prospectus supplement to our shelf registration statement, an aggregate of 60,250 shares of common stock, 50,000 of which shares were the Alexander Settlement Shares, and the remaining 10,250 of such shares which were issued to one of the Company’s vendors pursuant to the Settlement Letter, dated May 12, 2020, by and between us and such vendor.

Purchase Agreements

On June 4, 2020, we entered into a securities purchase agreement (the “June 4, 2020 Purchase Agreement”) with several accredited investors providing for the issuance of (i) 2,275,000 shares of the Company’s common stock and (ii) warrants, with a term of 5.5 years, to purchase an aggregate of up to 2,275,000 shares of common stock at an exercise price of $2.55 per share, subject to customary adjustments thereunder, which warrants were immediately exercisable upon issuance and on a cashless basis if such warrants have not been registered on or before six months after the date of issuance. Pursuant to the June 4, 2020 Purchase Agreement, the investors purchased all of the securities sold thereby for an aggregate purchase price of $5,801,000. Pursuant to the June 4, 2020 Purchase Agreement, an aggregate of 2,275,000 shares of common stock were issued to the investors in a registered direct offering pursuant to a prospectus supplement to the Company’s currently effective registration statement on Form S-3, which was declared effective on September 6, 2019. The Company filed the prospectus supplement on June 5, 2020. Maxim acted as the placement agent. The warrants were issued to the investors in a concurrent private placement transaction pursuant to an exemption from the registration requirements of the Securities Act provided in Section 4(a)(2) of the Securities Act and/or Regulation D promulgated thereunder. The Company paid Maxim a fee of approximately $464,000, which was equal to 8% of the aggregate purchase price paid by investors placed by Maxim and certain expenses. The June 4, 2020 Purchase Agreement contains customary representations, warranties and agreements of the Company and the investors and customary indemnification rights and obligations of the parties thereto. The offering of the securities pursuant to the June 4, 2020 Purchase Agreement was closed on June 8, 2020.

6.    Convertible Preferred Stock and Stockholders’ Equity (Deficit), continued

On June 9, 2020, we entered into a securities purchase agreement (the “June 9, 2020 Purchase Agreement”) with several accredited investors providing for the issuance of (i) 2,040,000 shares of the Company’s common stock and (ii) warrants, with a term of 5.5 years, to purchase an aggregate of up to 2,040,000 shares of common stock at an exercise price of $2.61 per share, subject to customary adjustments thereunder, which warrants were immediately exercisable upon issuance and on a cashless basis if the Warrants have not been registered on or before six months after the date of issuance. Pursuant to the June 9, 2020 Purchase Agreement, the investors purchased all of the securities sold thereby for an aggregate purchase price of $5,324,000. Pursuant to the June 9, 2020 Purchase Agreement, an aggregate of 2,040,000 shares of common stock were issued to the investors in a registered direct offering, pursuant to a prospectus supplement to the Company’s currently effective registration statement on Form S-3, which was declared effective on September 6, 2019. The Company filed the prospectus supplement on June 10, 2020. Maxim acted as the placement agent. The warrants were issued to the investors in a concurrent private placement transaction pursuant to an exemption from the registration requirements of the Securities Act provided in Section 4(a)(2) of the Securities Act and/or Regulation D promulgated thereunder. The Company paid Maxim a fee of approximately $426,000, which was equal to 8% of the aggregate purchase price paid by investors placed by Maxim and certain expenses. The June 9, 2020 Purchase Agreement contains customary representations, warranties and agreements of the Company and the investors and customary indemnification rights and obligations of the parties thereto. The offering of the securities pursuant to the June 9, 2020 Purchase Agreement was closed on June 11, 2020.

On July 22, 2021, the Company entered into a securities purchase agreement (the “July 22nd Purchase Agreement”) with several accredited investors providing for the issuance of 2,500,000 shares of the Company’s common stock. Pursuant to the July 22nd Purchase Agreement, the investors purchased all of the securities sold thereby for an aggregate purchase price of $10,000,000. Pursuant to the July 22nd Purchase Agreement, an aggregate of 2,500,000 shares of common stock were issued to the investors in a registered direct offering pursuant to a prospectus supplement to the Company’s currently effective registration statement on Form S-3, which was declared effective on September 6, 2019. The offering of the securities pursuant to the July 22nd Purchase Agreement was closed on July 27, 2021. The Company filed the prospectus supplement on July 26, 2021. Maxim acted as the placement agent. The Company paid Maxim a fee of approximately $800,000, which was equal to 8% of the aggregate purchase price paid by investors placed by Maxim and certain expenses. The July 22nd Purchase Agreement contains customary representations, warranties and agreements of the Company and the investors and customary indemnification rights and obligations of the parties thereto.

Settlement Agreements

On May 14, 2020, we entered into a settlement agreement with Alexander (the “Alexander Settlement Agreement”), pursuant to which, in consideration for Alexander releasing us from all claims against us arising out of that certain engagement agreement, dated February 6, 2020, that we entered into with Alexander (the “Alexander Engagement Agreement”), other than indemnification for certain third-party claims, we agreed to (i) pay Alexander a one-time cash payment of $125,000 and (ii) issue to Alexander 50,000 shares of our common stock (the “Alexander Settlement Shares”) which had a value of approximately $111,000. We also released Alexander from the same type of claims against Alexander, other than indemnification for certain third-party claims. In connection with the Alexander Settlement Agreement, on May 14, 2020, we also entered into a leak-out agreement with Alexander (the “Alexander Leak-Out Agreement”), pursuant to which Alexander agreed not to dispose of more than 5,000 shares of common stock in any trading day, commencing on the date of such agreement and ending on the date on which Alexander no longer holds any Alexander Settlement Shares. The Company recorded a settlement expense of $237,000 which is included in general and administrative expense for the nine months ended September 30, 2020.

6.    Convertible Preferred Stock and Stockholders’ Equity (Deficit), continued

On November 9, 2020, in order to resolve a dispute between certain investors (the “February 2020 Holders”) and the Company regarding certain registration rights in connection with the February 2020 Private Placement, the Company entered into a settlement and release agreement with each of the February 2020 Holders (the “Settlement Agreement”), pursuant to which (i) the Company and the February 2020 Holders agreed to amend the original warrants issued in February 2020 (the “Original Warrants”) to provide for the purchase of one additional share of common stock for each share of common stock available under the Original Warrants, totaling 45,534 additional common stock purchase warrants, (ii) the Company and the February 2020 Holders agreed to amend the Original Warrants to reduce the exercise price to $2.55, and (iii) the Company agreed to issue an additional 236,375 shares of common stock and 236,369 common stock purchase warrants to purchase up to 236,369 shares of common stock. As consideration for the foregoing, the February 2020 Holders agreed to release any and all claims they may have against the Company, including, but not limited to, claims arising in connection with any securities held by the February 2020 Holders.

Warrants for Shares of Common Stock

The Company has issued warrants to purchase shares of common stock to employees and consultants as compensation for services rendered, as well as in conjunction with the purchase of shares of common stock in equity and debt transactions.

In connection with the March 2020 Note, the Company issued the March 2020 Note to the investor and the March 2020 Maxim Warrant to Maxim to purchase shares of common stock of 227,679 and 20,400, respectively (see Note 4 – Borrowings) at an exercise price of $6.40 per share. The grant date fair value of such warrants was $625,000, which was recorded as debt discount with the offset recorded to additional paid-in capital on the condensed consolidated balance sheets. The fair value of such warrants was determined using the Black-Scholes Model based on the following weighted average assumptions: common stock price on date of grant of $5.40; expected dividend yield of 0.0%; expected volatility of 61.0%; risk-free interest rate of 0.38% and expected life of 5 years.

Such warrant issued to the investor contained an adjustment provision such that if the Company issues or sells any shares of common stock or common stock equivalents (as defined in the March 2020 Note), subject to certain exceptions, at an effective price lower than the conversion price, then in effect, the conversion price shall be reduced to the price per share paid for such shares of common stock or common stock equivalents. The common stock and common stock equivalents issued by the Company in the April 2020 Public Offering were issued at price per share of $3.25, which was lower than the conversion price then in effect. Additionally, the Alexander Settlement Shares, issued to Alexander under the Alexander Settlement Agreement, on May 14, 2020, were issued at a price per share which was lower than the conversion price then in effect. The Company modified the exercise price of the March 2020 Warrant as a result of each of these transactions and calculated the incremental fair value related to these modifications. The resulting deemed dividend from these down round adjustments was $134,000, and this is included as an offset to additional paid-in capital in the accompanying condensed consolidated balance sheets.

Concurrent with the April 2020 Public Offering, the Company issued prefunded warrants for $475,000 at an exercise price of $0.01 per share. These warrants were exercised immediately upon the closing of the transactions for proceeds of $4,750 and the investors received 475,000 shares of common stock.

Additionally, as a result of the April 2020 Public Offering, the Company issued warrants to purchase shares of common stock to the common stock investors, prefunded warrants investors, and Maxim of 1,525,000, 475,000 and 291,000, respectively. The warrants have an exercise price of $3.25 per share and are fully vested. The grant date fair value of those warrants was $2,606,000, which was recorded within stockholders’ equity as a cost of issuance and an increase to additional paid-in capital on the accompanying condensed consolidated balance sheet. The fair value of the warrants was determined using the Black-Scholes Model based on the following weighted average assumptions: common stock price on date of grant of $2.50; expected dividend yield of 0.0%; expected volatility of 64.0%; risk-free interest rate of 0.37% and expected life of 5 years.

6.    Convertible Preferred Stock and Stockholders’ Equity (Deficit), continued

The Company also issued the April 2020 Maxim Warrant to purchase up to 100,000 shares of common stock to Maxim in connection with the April 2020 Public Offering. Such warrant has an exercise price of $3.90 per share and is fully vested. The fair value of such warrant at issuance was $106,000. The fair value of the warrant was estimated using the Black-Scholes Model based on the following weighted average assumptions: common share price on date of grant $2.50, expected dividend yield 0%, expected volatility 64%, risk-free interest rate 0.37% and expected life of 5 years. The fair value was recorded within stockholders’ equity as a cost of issuance and an increase to additional paid-in capital on the accompanying condensed consolidated balance sheet.

In connection with the offering pursuant to the June 4, 2020 Purchase Agreement, the Company issued warrants to the investors to purchase up to an aggregate of 2,275,000 shares of common stock. Such warrants have an exercise price of $2.55 per share and are fully vested. The grant date fair value of those warrants was $3,153,000, which was recorded within stockholders’ equity as a cost of issuance and an increase to additional paid-in capital on the accompanying condensed consolidated balance sheet. The fair value of such warrants was determined using the Black-Scholes Model based on the following weighted average assumptions: common stock price on date of grant of $2.52; expected dividend yield of 0.0%; expected volatility of 64.0%; risk-free interest rate of 0.45% and expected life of 5.5 years.

In connection with the offering pursuant to the June 9, 2020 Purchase Agreement, the Company issued warrants to the investors to purchase up to an aggregate of 2,040,000 shares of common stock. Such warrants have an exercise price of $2.61 per share and are fully vested. The grant date fair value of those warrants was $2,375,000, which was recorded within stockholders’ equity as a cost of issuance and an increase to additional paid-in capital on the accompanying condensed consolidated balance sheet. The fair value of such warrants was determined using the Black-Scholes Model based on the following weighted average assumptions: common stock price on date of grant of $2.25; expected dividend yield of 0.0%; expected volatility of 64.0%; risk-free interest rate of 0.32% and expected life of 5.5 years.

In January 2021, pursuant to the Company’s solicitation of certain warrant holders, such warrant holders agreed to exercise warrants to purchase an aggregate of 1,221,675 shares of common stock for net proceeds of approximately $2.9 million. In consideration for their exercise of these warrants, for cash, the exercising holders were issued new warrants to purchase up to an aggregate of 305,419 shares of common stock, at an exercise price of $4.20 per share, which are exercisable for a period of five years. The grant date fair value of those warrants was $567,000, which was recorded as warrant inducement expense and an increase to additional paid-in capital on the accompanying condensed consolidated balance sheet. The fair value of such warrants was determined using the Black-Scholes Model based on the following weighted average assumptions: common stock price on date of grant of $3.85; expected dividend yield of 0.0%; expected volatility of 60.1%; risk-free interest rate of 0.45% and expected life of 5.0 years.

On April 18, 2019, the Company entered into a Securities Purchase Agreement with an existing shareholder, Lisa Walsh (the “Investor”), pursuant to which the Company issued 250,000 shares of our Series A 8% Convertible Preferred Stock (the “Original Securities”). On June 4, 2021, the Company and the Investor entered into that an exchange agreement pursuant to which the Company exchanged with the Investor the Original Securities held by the investor for: (i) 250,000 shares of common stock and (ii) warrants to purchase up to 187,500 shares of Common Stock. The warrants will be exercisable for a period of five (5) years and four (4) months. The exercise price with respect to the warrants is $3.00 per share. The exercise price and the number of shares of common stock issuable upon exercise of the warrants are subject to adjustment upon certain events, such as stock splits, combinations, dividends, distributions, reclassifications, mergers or other corporate change and dilutive issuances. The grant date fair value of those warrants was $570,000, which was recorded as loss on exchange of preferred stock and an increase to additional paid-in capital on the accompanying condensed consolidated balance sheet. The fair value of such warrants was determined using the Black-Scholes Model based on the following weighted average assumptions: common stock price on date of grant of $4.77; expected dividend yield of 0.0%; expected volatility of 60.7%; risk-free interest rate of 0.78% and expected life of 5.4 years.

6.    Convertible Preferred Stock and Stockholders’ Equity (Deficit), continued

In June 2021, pursuant to the Company’s solicitation of certain warrant holders, such warrant holders agreed to exercise warrants to purchase an aggregate of 1,000,000 shares of common stock for net proceeds of approximately $2.3 million. In consideration for their exercise of these warrants, for cash, the exercising holders were issued new warrants to purchase up to an aggregate of 250,000 shares of common stock, at an exercise price of $4.46 per share, which are exercisable for a period of five years. The grant date fair value of those warrants was $579,000, which was recorded as warrant inducement expense and an increase to additional paid-in capital on the accompanying condensed consolidated balance sheet. The fair value of such warrants was determined using the Black-Scholes Model based on the following weighted average assumptions: common stock price on date of grant of $4.50; expected dividend yield of 0.0%; expected volatility of 60.7%; risk-free interest rate of 0.77% and expected life of 5.0 years.

During the three months ended September 30, 2021, warrant holders exercised 19,000 warrants to purchase common stock, for proceeds of approximately $62,000.

Information regarding warrants for common stock outstanding and exercisable as of September 30, 2021 is as follows:

	Warrants	Weighted Average	Warrants
Exercise	Outstanding as of	Remaining	Exercisable as of
Price	September 30, 2021	Life (years)	September 30, 2021
$2.32 - $4.46	4,053,384	3.86	4,038,384
$6.40 - $9.80	32,889	3.41	32,889
$15.80 - $17.50	93,562	1.01	93,562
$24.80 - $99.00	222,807	1.38	222,807
$108.00 - $125.00	72,782	0.87	72,782
$7.88*	4,475,424	3.66	4,460,424

* Weighted average

Warrants exercisable as of September 30, 2021 excludes warrants to purchase 15,000 shares of common stock issued to a marketing firm, which vest upon the achievement of certain milestones. Additionally, warrants to purchase 20,722 shares of common stock which are shown above with a price of $15.80 are pre-funded warrants under which the holder must only pay $0.20 per share to complete the exercise.

Information regarding warrants for common stock outstanding and exercisable as of December 31, 2020 is as follows:

	Warrants	Weighted Average	Warrants
Exercise	Outstanding as of	Remaining	Exercisable as of
Price	December 31, 2020	Life (years)	December 31, 2020
$2.32 - $3.90	6,884,216	4.55	6,869,216
$6.40 - $9.80	32,889	4.15	32,889
$15.80 - $17.50	93,562	1.76	93,562
$24.80 - $99.00	230,571	0.99	230,571
$108.00 - $207.00	72,864	1.60	72,864
$5.81*	7,314,102	4.54	7,299,102

* Weighted average

6.    Convertible Preferred Stock and Stockholders’ Equity (Deficit), continued

Warrants exercisable as of December 31, 2020 exclude a warrant to purchase 15,000 shares of common stock issued to a marketing consulting firm. Such warrant will vest upon the achievement of certain milestones. Additionally, warrants to purchase 20,722 shares of common stock which are shown above with a price of $15.80 are pre-funded warrants under which the holder must only pay $0.20 per share to complete the exercise.

XML

Income Taxes

9 Months Ended

Sep. 30, 2021

Income Taxes

Income Taxes

7.    Income Taxes

The Company recorded a provision for income taxes of $0 and $2,000 for the three and nine months ended September 30, 2021, respectively. The Company recorded a provision for income taxes of $0 and $3,000 for the three and nine months ended September 30, 2020, respectively.

The Company’s effective tax rate was (0.02%) and (0.03%) for the nine months ended September 30, 2021 and 2020, respectively. The difference between the effective tax rate and the federal statutory tax rate for the nine months ended September 30, 2021 and 2020 primarily relates to the valuation allowance on the Company’s deferred tax assets.

For interim periods, the Company estimates its annual effective income tax rate and applies the estimated rate to the year-to-date income or loss before income taxes. The Company also computes the tax provision or benefit related to items reported separately and recognizes the items net of their related tax effect in the interim periods in which they occur. The Company also recognizes the effect of changes in enacted tax laws or rates in the interim periods in which the changes occur.

As of September 30, 2021 and December 31, 2020, the Company retains a full valuation allowance on its deferred tax assets. The realization of the Company’s deferred tax assets depends primarily on its ability to generate taxable income in future periods. The amount of deferred tax assets considered realizable in future periods may change as management continues to reassess the underlying factors it uses in estimating future taxable income.

The provision for income taxes for the nine months ended September 30, 2021 and 2020 was calculated on a jurisdiction basis.

On March 27, 2020, the U.S. enacted the Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”). The CARES Act includes provisions relating to refundable payroll tax credits, net operating loss carryback periods, alternative minimum tax credit refunds, modifications to the net interest deduction limitations and technical corrections to the tax depreciation methods for qualified improvement property. On December 21, 2020, the U.S. Congress passed the Consolidation Appropriations Act, 2021 (the “CAA Act”). The tax provisions under the CARES Act and CAA Act, do not have a material impact on the condensed consolidated financial statements for the nine months ended September 30, 2021, given the existence of a full valuation allowance.

On June 29, 2020, California Assembly Bill 85 (“AB 85”) was signed into law, which suspends the use of California net operating losses and limits the use of California research tax credits for tax years beginning in 2020 and before 2023. The Company does not expect the suspension of net operating losses to have a significant impact on the condensed consolidated financial statements.

XML

Commitments and Contingencies

9 Months Ended

Sep. 30, 2021

Commitments and Contingencies

Commitments and Contingencies

8.    Commitments and Contingencies

Operating Leases

The Company rented its Beaverton, Oregon office under an operating lease, which expired on October 31, 2020. Under the terms of the lease, the Company was responsible for taxes, insurance and maintenance expense. The Company recognized rent expense on a straight-line basis over the lease period. On August 18, 2020, the Company signed a new operating lease that began on November 1, 2020, to rent office space in Beaverton, Oregon, to replace the lease that expired on October 31, 2020. The new lease expires on January 31, 2024. The following are the future minimum lease payments for the years ending December 31, 2021 through December 31, 2024: $41,000, $153,000, $173,000, and $15,000.

Rent expense for the three months ended September 30, 2021 and 2020 was $56,000 and $87,000, respectively. Rent expense for the nine months ended September 30, 2021 and 2020 was $168,000 and $288,000, respectively.

Capital Leases

During August 2020, the Company entered into a lease agreement for equipment under a capital lease with a term of 36 months. The equipment under the lease is collateral for the agreement and is included within property and equipment, net on the condensed consolidated balance sheets.

Future minimum lease commitments for the capital lease as of September 30, 2021 are as follows:

(in thousands)
Payments due in:
Year ending December 31, 2021 (remaining 3 months)	$	6
Year ending December 31, 2022		26
Year ending December 31, 2023		15
Total minimum lease payments		47
Less: Amounts representing interest		(2)
Present value of capital lease obligations		45
Less: Current portion of capital lease liabilities		24
Other liabilities	$	21

Obligations under the capital lease are included in accrued liabilities and other liabilities on the condensed consolidated balance sheets.

Contingencies

In the normal course of business, the Company may become involved in legal proceedings. The Company will accrue a liability for such matters when it is probable that a liability has been incurred and the amount can be reasonably estimated. When only a range of a possible loss can be established, the most probable amount in the range is accrued. If no amount within this range is a better estimate than any other amount within the range, the minimum amount in the range is accrued. The accrual for a litigation loss contingency might include, for example, estimates of potential damages, outside legal fees and other directly related costs expected to be incurred.

8.    Commitments and Contingencies, continued

The Company’s management does not believe that any such matters, individually or in the aggregate, will have a materially adverse effect on the Company’s condensed consolidated financial statements.

Coronavirus – COVID-19

On March 11, 2020, the World Health Organization designated COVID-19 as a global pandemic. The COVID 19 pandemic represents a fluid situation that presents a wide range of potential impacts of varying durations for different global geographies, including locations where we have offices, employees, customers, vendors and other suppliers and business partners.  Like most US-based businesses, the COVID-19 pandemic and efforts to mitigate the same began to impact on our business in March 2020. By that time, much of our first fiscal quarter of 2020 was completed. During our second fiscal quarter of 2020, we observed decreased demand from certain of our customers due to the temporary closure by many retailers. Our third and fourth fiscal quarters of 2020 and our first three fiscal quarters of 2021 saw sustained improved customer demand as retailers slowly reopened and demand for an in-home immersive cinema experience increased, following the initial closure of many public cinemas due to COVID-19. However, another closure by retailers could impact customer demand in the future. The Company believes the extent of the COVID-19 pandemic’s impact on its operating results and financial condition has been and will continue to be driven by many factors, most of which are beyond the Company’s control and ability to forecast. Although the Company has experienced some positive trends during the first nine months of 2021, because of these uncertainties, the Company cannot estimate how long or to what extent the pandemic will impact its operations. 

XML

Related Parties

9 Months Ended

Sep. 30, 2021

Related Parties

Related Parties

9.    Related Parties

Jonathan Gazdak

Mr. Gazdak is Managing Director – Head of Investment Banking for Alexander Capital, L.P., an investment banking firm based in New York. Mr. Gazdak was a member of the board of directors from June 2015 to May 10, 2021, and is no longer considered a related party as of May 10, 2021. Alexander Capital, L.P. acted as the lead investment bank in a number of the Company’s private financings and as an underwriter for the Company’s IPO. As of September 30, 2021 and December 31, 2020, Mr. Gazdak owned less than 1%of the outstanding shares of the Company’s common stock.

On February 6, 2020, the Company entered into a placement agency agreement with Alexander Capital, L.P. in connection with an offering by the Company of up to an aggregate of $835,000 of the Company’s securities, pursuant to which Alexander Capital, L.P. was paid cash fees of $83,000 and pursuant to which the Company agreed to issue to Alexander Capital, L.P. a warrant to purchase 4,553 shares of common stock. Such warrant is exercisable at a per share price of $8.80 and is exercisable at any time during the five-year period commencing on the date of issuance.

The Company also entered into the Alexander Settlement Agreement with Alexander Capital, L.P. on May 14, 2020. (See Note 6 – Convertible Preferred Stock and Stockholders’ Equity (Deficit)).

Helge Kristensen

Mr. Kristensen has served as a member of the Company’s board of directors since 2010. Mr. Kristensen serves as vice president of Hansong Technology, an original device manufacturer of audio products based in China, president of Platin Gate Technology (Nanjing) Co. Ltd, a company with focus on service-branding in lifestyle products as well as pro line products based in China and co-founder and director of Inizio Capital, an investment company based in the Cayman Islands.

9.    Related Parties, continued

For the three months ended September 30, 2021 and 2020, Hansong Technology purchased modules from the Company of approximately $263,000 and $137,000, respectively, and made payments to the Company of approximately $333,000 and $0, respectively. For the three months ended September 30, 2021 and 2020, Hansong Technology sold speaker products to the Company of approximately $96,000 and $8,000, respectively, and the Company made payments to Hansong Technology of approximately $309,000 and $38,000, respectively. For the nine months ended September 30, 2021 and 2020, Hansong Technology purchased modules from the Company of approximately $496,000 and $155,000, respectively, and made payments to the Company of approximately $380,000 and $1,000, respectively. For the nine months ended September 30, 2021 and 2020, Hansong Technology sold speaker products to the Company of approximately $854,000 and $8,000, respectively, and the Company made payments to Hansong Technology of approximately $962,000 and $67,000, respectively. As of September 30, 2021 and December 31, 2020, Mr. Kristensen owned less than 1.0% of the outstanding shares of the Company’s common stock.

XML

Segment Information

9 Months Ended

Sep. 30, 2021

Segment Information

Segment Information

10.  Segment Information

The Company operates in one business segment, wireless audio products. Our chief decision-maker, the President and Chief Executive Officer, evaluates our performance based on company-wide consolidated results.

Net revenue from customers is designated based on the geographic region to which the product is delivered. Net revenue from customers is designated based on the geographic region to which the product is delivered. Net revenue by geographic region for the three and nine months ended September 30, 2021 and 2020 was as follows:

(in thousands)	For the three months ended				For the nine months ended
	September 30,				September 30,
	2021		2020		2021		2020
United States	$	166	$	75	$	710	$	167
Europe		162		100		403		169
Asia Pacific		1,479		432		3,427		1,030
Other		—		—		1		—
Total	$	1,807	$	607	$	4,541	$	1,366

Substantially all of our long-lived assets are located in the United States.

XML

Business and Summary of Significant Accounting Policies (Policies)

9 Months Ended

Sep. 30, 2021

Business and Summary of Significant Accounting Policies

Basis of Presentation

Basis of Presentation

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial information and pursuant to Article 10 of Regulation S-X of the Securities Act of 1933, as amended (“Securities Act”). Accordingly, they do not include all of the information and notes required by U.S. GAAP for complete financial statements. These unaudited condensed consolidated financial statements include all normal and recurring adjustments that the Company believes are necessary to fairly state the Company’s financial position and the results of operations and cash flows. Interim period results are not necessarily indicative of results of operations or cash flows for a full year or any subsequent interim period. The condensed consolidated balance sheet as of December 31, 2020 has been derived from audited consolidated financial statements at that date, but does not include all disclosures required by U.S. GAAP for complete financial statements.

Use of Estimates

Use of Estimates

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates.

Reclassification

Reclassification

Certain reclassifications have been made to prior periods’ consolidated financial statements to conform to the current period presentation. These reclassifications did not result in any change in previously reported net loss, total assets or stockholders’ equity.

Concentration of Credit Risk and Other Risks and Uncertainties

Concentration of Credit Risk and Other Risks and Uncertainties

Financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash and cash equivalents and accounts receivable. Cash and cash equivalents are deposited in demand and money market accounts at one financial institution. At times, such deposits may be in excess of insured limits. The Company has not experienced any losses on its deposits of cash and cash equivalents.

The Company’s accounts receivable are derived from revenue earned from customers located throughout the world. The Company performs credit evaluations of its customers’ financial condition as necessary, and sometimes requires partial payment in advance of shipping. As of September 30, 2021 and December 31, 2020, there was no allowance for doubtful accounts. As of September 30, 2021, the Company had one customer accounting for 63% of accounts receivable. As of December 31, 2020, the Company had three customers accounting for 36%, 31% and 15% of accounts receivable. The Company had three customers accounting for 63%, 12% and 12% of its net revenue for the three months ended September 30, 2021. The Company had three customers accounting for 33%, 17%, and 10% of its net revenue for the nine months ended September 30, 2021. The Company had four customers accounting for 30%, 18%, 15% and 11% of its net revenue for the three months ended September 30, 2020. The Company had three customers accounting for 54%, 28% and 11% of its net revenue for the nine months ended September 30, 2020.

The Company’s future results of operations involve a number of risks and uncertainties. Factors that could affect the Company’s future operating results and cause actual results to vary materially from expectations include, but are not limited to, rapid technological change, continued acceptance of the Company’s products, competition from substitute products and larger companies, protection of proprietary technology, strategic relationships and dependence on key individuals.

1.    Summary of Significant Accounting Policies, continued

The Company relies on sole-source suppliers to manufacture some of the components used in its product. The Company’s manufacturers and suppliers may encounter problems during manufacturing due to a variety of reasons, any of which could delay or impede their ability to meet demand. The Company is heavily dependent on a single contractor in China for assembly and testing of its products, a single contractor in Japan for the production of its transmit semiconductor chip and a single contractor in China for the production of its receive semiconductor chip.

Convertible Financial Instruments

Convertible Financial Instruments

The Company bifurcates conversion options and warrants from their host instruments and accounts for them as freestanding derivative financial instruments if certain criteria are met. The criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re-measured at fair value under otherwise applicable generally accepted accounting principles with changes in fair value reported in earnings as they occur and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument. An exception to this rule is when the host instrument is deemed to be conventional, as that term is described under applicable U.S. GAAP.

When the Company has determined that the embedded conversion options and warrants should be bifurcated from their host instruments, discounts are recorded for the intrinsic value of conversion options embedded in the instruments based upon the differences between the fair value of the underlying common stock at the commitment date of the transaction and the effective conversion price embedded in the instrument.

Debt discounts under these arrangements are amortized to interest expense using the interest method over the earlier of the term of the related debt or their earliest date of redemption.

Warrants for Shares of Common Stock and Derivative Financial Instruments

Warrants for Shares of Common Stock and Derivative Financial Instruments

Warrants for shares of common stock and other derivative financial instruments are classified as equity if the contracts (1) require physical settlement or net-share settlement or (2) give the Company a choice of net-cash settlement or settlement in its own shares (physical settlement or net-share settlement). Contracts which (1) require net-cash settlement (including a requirement to net cash settle the contract if an event occurs and if that event is outside the control of the Company), (2) give the counterparty a choice of net-cash settlement or settlement in shares (physical settlement or net-share settlement), or (3) that contain reset provisions that do not qualify for the scope exception are classified as liabilities. The Company assesses classification of its warrants for shares of common stock and other derivatives at each reporting date to determine whether a change in classification between equity and liabilities is required.

The issuance of the convertible notes payable generated a beneficial conversion feature (“BCF”), which arises when a debt or equity security is issued with an embedded conversion option that is beneficial to the investor or in the money at inception because the conversion option has an effective strike price that is less than the market price of the underlying stock at the commitment date. The Company recognized the BCF by allocating the intrinsic value of the conversion option, which is the number of shares of common stock available upon conversion multiplied by the difference between the effective conversion price per share and the fair value of common stock per share on the commitment date, to shares of common stock, resulting in a discount on the convertible debt.

Revenue Recognition

1.    Summary of Significant Accounting Policies, continued

Revenue Recognition

Revenue consists primarily of the sale of the wireless modules. The Company applies the following five steps: (1) identify the contract with a customer, (2) identify the performance obligations in the contract, (3) determine the transaction price, (4) allocate the transaction price to the performance obligations in the contract, and (5) recognize revenue when a performance obligation is satisfied. The Company considers customer purchase orders to be the contracts with a customer. Revenues, net of expected discounts, are recognized when the performance obligations of the contract with the customer are satisfied and when control of the promised goods are transferred to the customer, typically when products, which have been determined to be the only distinct performance obligations, are shipped to the customer. Expected costs of assurance warranties and claims are recognized as expense.

Taxes assessed by a governmental authority that are both imposed on and concurrent with a specific revenue-producing transaction, that are collected by us from a customer and deposited with the relevant government authority, are excluded from revenue. Our revenue arrangements do not contain significant financing components.

Sales to certain distributors are made under arrangements which provide the distributors with price adjustments, price protection, stock rotation and other allowances under certain circumstances. The Company does not provide its customers with a contractual right of return. However, the Company accepts limited returns on a case-by-case basis. These returns, adjustments and other allowances are accounted for as variable consideration. We estimate these amounts based on the expected amount to be provided to customers and reduce revenue recognized. We believe that there will not be significant changes to our estimates of variable consideration.

If a customer pays consideration, or the Company has a right to an amount of consideration that is unconditional before we transfer a good or service to the customer, those amounts are classified as contract liabilities which are included in other current liabilities when the payment is made or it is due, whichever is earlier.

Contract Balances

We receive payments from customers based on a billing schedule as established in our contracts to partially offset prepayments required by our vendors on long lead time materials. Amounts collected prior to the fulfillment of the performance obligation are considered contract liabilities and classified as customer advances within accrued liabilities on the condensed consolidated balance sheets. Contract assets are recorded when we have a conditional right to consideration for our completed performance under the contracts. Accounts receivables are recorded when the right to this consideration becomes unconditional. We do not have any material contract assets as of September 30, 2021 and December 31, 2020.

(in thousands)

	September 30,		December 31,
	2021		2020
Contract Liabilities	$	715	$	373

During the nine months ended September 30, 2021, the Company recognized $373,000 of revenue that was included in the contract liabilities as of December 31, 2020.

Revenue by Geographic Area

In general, revenue disaggregated by geography (See Note 10) is aligned according to the nature and economic characteristics of our business and provides meaningful disaggregation of our results of operations. Since we operate in one segment, all financial segment and product line information can be found in the condensed consolidated financial statements.

Advertising Costs

1.    Summary of Significant Accounting Policies, continued

Advertising Costs

Advertising costs are charged to sales and marketing expenses as incurred. Advertising costs for the three and nine months ended September 30, 2021 were $152,000 and $451,000, respectively. Advertising costs for the three and nine months ended September 30, 2020 were $65,000 and $81,000, respectively.

Comprehensive Loss

Comprehensive Loss

Comprehensive loss represents the changes in equity of an enterprise, other than those resulting from stockholder transactions. Accordingly, comprehensive loss may include certain changes in equity that are excluded from net loss. For the three and nine months ended September 30, 2021 and 2020, the Company’s comprehensive loss is the same as its net loss.

Foreign Currency

Foreign Currency

The financial position and results of operations of the Company’s foreign operations are measured using currencies other than the U.S. dollar as their functional currencies. Accordingly, for these operations all assets and liabilities are translated into U.S. dollars at the current exchange rates as of the respective balance sheet date. Expense items are translated using the weighted average exchange rates prevailing during the period. Cumulative gains and losses from the translation of these operations’ financial statements are reported as a separate component of stockholders’ equity, while foreign currency transaction gains or losses, resulting from re-measuring local currency to the U.S. dollar are recorded in the condensed consolidated statement of operations in other income (expense), net and were not material for the three and nine months ended September 30, 2021 and 2020.

Net Loss per Common Share

Net Loss per Common Share

Basic net loss per common share is calculated by dividing the net loss attributable to common stockholders by the weighted average number of shares of common stock outstanding during the period, without consideration for potentially dilutive securities. Diluted net loss per common share is computed by dividing the net loss attributable to common stockholders by the weighted average number of shares of common stock and potentially dilutive common share equivalents outstanding for the period determined using the treasury-stock and if-converted methods. For purposes of the diluted net loss per common share calculation, Series A Preferred Stock, warrants exercisable for common stock, restricted stock units and shares issuable upon the conversion of convertible notes payable are considered to be potentially dilutive securities.

For the three and nine months ended September 30, 2021, warrants to purchase 4,475,424 shares of common stock, 711,805 shares of restricted stock, 310,000 shares of restricted stock issued under an inducement grant and 456,931 shares underlying restricted stock units have been excluded from the calculation of net loss per common share because the inclusion would be antidilutive. For the three and nine months ended September 30, 2020, warrants to purchase 7,337,199 shares of common stock, 250,000 shares of Series A Preferred Stock and 98,669 shares of restricted stock have been excluded from the calculation of net loss per common share because the inclusion would be antidilutive.

Recently Issued and Not Yet Adopted Accounting Pronouncements

1.     Summary of Significant Accounting Policies, continued

Recently Issued and Not Yet Adopted Accounting Pronouncements

In February 2016, the FASB issued ASU 2016-02, “Leases”. The objective of the update is to increase transparency and comparability among organizations by recognizing lease assets and liabilities on the balance sheet for leases with a lease term of more than 12 months. In addition, the update will require additional disclosures regarding key information about leasing arrangements. Under existing guidance, operating leases are not recorded as lease assets and lease liabilities on the balance sheet. In October 2019, the FASB decided to defer the mandatory effective date of ASU 2016-02 to fiscal years beginning after December 15, 2020 for certain entities, including private companies. In June 2020, in response to adverse effect caused by Coronavirus Disease pandemic on private businesses, the FASB issued ASU 2020-05 which deferred the effective date for ASU 2016-02 for private businesses to annual reporting periods beginning after December 15, 2021. As an emerging growth company, the Company is allowed to adopt accounting pronouncements at the same time as non-public business entities. As a result, we will adopt the update for our fiscal year beginning after December 15, 2021. The Company does not expect the adoption of this standard to significantly impact the condensed consolidated financial statements.

XML

Business and Summary of Significant Accounting Policies (Tables)

9 Months Ended

Sep. 30, 2021

Business and Summary of Significant Accounting Policies

Summary of contract liabilities

	September 30,		December 31,
	2021		2020
Contract Liabilities	$	715	$	373

XML

Balance Sheet Components (Tables)

9 Months Ended

Sep. 30, 2021

Balance Sheet Components

Schedule of Inventories

Inventories (in thousands):

	September 30,		December 31,
	2021		2020
Raw materials	$	1,693	$	1,872
Work in progress		539		283
Finished goods		1,722		553
Total inventories	$	3,954	$	2,708

Schedule of Property, Plant and Equipment

Property and equipment, net (in thousands):

	September 30,		December 31,
	2021		2020
Machinery and equipment	$	952	$	866
Tooling		11		11
Computer software		89		89
Furniture and fixtures		15		15
Leasehold improvements		40		40
		1,107		1,021
Less: Accumulated depreciation and amortization		(938)		(879)
Property and equipment, net	$	169	$	142

Schedule of Accrued Liabilities

Accrued liabilities (in thousands):

	September 30,		December 31,
	2021		2020
Accrued vacation	$	344	$	328
Accrued compensation		321		84
Customer advances		715		373
Accrued professional fees		158		161
Accrued rebate		319		326
Accrued other		183		161
Total accrued liabilities	$	2,040	$	1,433

XML

Fair Value Measurements (Tables)

9 Months Ended

Sep. 30, 2021

Schedule of Company's financial assets and liabilities that are measured at fair value on a recurring basis

The Company’s financial assets and liabilities that are measured at fair value on a recurring basis as of September 30, 2021 and December 31, 2020 by level within the fair value hierarchy, are as follows:

(in thousands)	September 30, 2021
			Significant
	Quoted prices		other		Significant
	in active		observable		unobservable
	markets		inputs		inputs
	(Level 1)		(Level 2)		(Level 3)
Liabilities:
Warrant liability	$	—	$	—	$	8

(in thousands)	December 31, 2020
			Significant
	Quoted prices		other		Significant
	in active		observable		unobservable
	markets		inputs		inputs
	(Level 1)		(Level 2)		(Level 3)
Liabilities:
Derivative liability	$	—	$	—	$	387
Warrant liability	$	—	$	—	$	8

Warrant

Schedule of changes in fair value of the Company's warrant liability and derivative liability measured at fair value using significant unobservable inputs (Level 3)

The following table includes a summary of changes in fair value of the Company’s warrant liability measured at fair value using significant unobservable inputs (Level 3) for the three and nine months ended September 30, 2021 and 2020:

	For the three months ended				For the nine months ended
(in thousands)	September 30, 2021		September 30, 2020		September 30, 2021		September 30, 2020
Beginning balance	$	8	$	—	$	8	$	24
Additions		—		—		—		—
Change in fair value		—		—		—		(24)
Ending balance	$	8	$	—	$	8	$	—

XML

Convertible Preferred Stock and Stockholders' Equity (Deficit) (Tables)

9 Months Ended

Sep. 30, 2021

Summary of activity related to restricted stock awards/units

A summary of activity related to restricted stock awards (excluding the deferred shares and the inducement grant restricted stock award) for the nine months ended September 30, 2021 is presented below:

		Weighted-Average
Stock Awards	Shares	Grant Date Fair Value
Non-vested as of January 1, 2021	87,169	$	2.26
Granted	664,500	$	3.57
Vested	(29,064)	$	2.26
Forfeited	—	$	—
Non-vested as of September 30, 2021	722,605	$	3.46

Schedule of Information regarding warrants for common stock outstanding and exercisable

Information regarding warrants for common stock outstanding and exercisable as of September 30, 2021 is as follows:

	Warrants	Weighted Average	Warrants
Exercise	Outstanding as of	Remaining	Exercisable as of
Price	September 30, 2021	Life (years)	September 30, 2021
$2.32 - $4.46	4,053,384	3.86	4,038,384
$6.40 - $9.80	32,889	3.41	32,889
$15.80 - $17.50	93,562	1.01	93,562
$24.80 - $99.00	222,807	1.38	222,807
$108.00 - $125.00	72,782	0.87	72,782
$7.88*	4,475,424	3.66	4,460,424

* Weighted average

Information regarding warrants for common stock outstanding and exercisable as of December 31, 2020 is as follows:

	Warrants	Weighted Average	Warrants
Exercise	Outstanding as of	Remaining	Exercisable as of
Price	December 31, 2020	Life (years)	December 31, 2020
$2.32 - $3.90	6,884,216	4.55	6,869,216
$6.40 - $9.80	32,889	4.15	32,889
$15.80 - $17.50	93,562	1.76	93,562
$24.80 - $99.00	230,571	0.99	230,571
$108.00 - $207.00	72,864	1.60	72,864
$5.81*	7,314,102	4.54	7,299,102

* Weighted average

2020 Stock Incentive Plan

Summary of activity related to restricted stock awards/units

A summary of activity related to restricted stock units under the Company’s 2020 Stock Plan for the nine months ended September 30, 2021 is presented below:

		Weighted-Average
Stock Units	Shares	Grant Date Fair  Value
Non-vested as of January 1, 2021	626,974	$	2.29
Granted	20,500	$	3.81
Vested	(201,343)	$	2.27
Forfeited	—	$	—
Non-vested as of September 30, 2021	446,131	$	2.36

XML

Commitments and Contingencies (Tables)

9 Months Ended

Sep. 30, 2021

Commitments and Contingencies

Summary of future minimum lease commitments for capital lease

(in thousands)
Payments due in:
Year ending December 31, 2021 (remaining 3 months)	$	6
Year ending December 31, 2022		26
Year ending December 31, 2023		15
Total minimum lease payments		47
Less: Amounts representing interest		(2)
Present value of capital lease obligations		45
Less: Current portion of capital lease liabilities		24
Other liabilities	$	21

XML

Segment Information (Tables)

9 Months Ended

Sep. 30, 2021

Segment Information

Schedule of net revenue by geographic region

(in thousands)	For the three months ended				For the nine months ended
	September 30,				September 30,
	2021		2020		2021		2020
United States	$	166	$	75	$	710	$	167
Europe		162		100		403		169
Asia Pacific		1,479		432		3,427		1,030
Other		—		—		1		—
Total	$	1,807	$	607	$	4,541	$	1,366

XML

Business and Summary of Significant Accounting Policies - Contract Balances (Details) - USD ($)	9 Months Ended
	Sep. 30, 2021	Dec. 31, 2020
Business and Summary of Significant Accounting Policies
Contract liabilities	$ 715,000	$ 373,000
Revenue included in contract liabilities	$ 373,000

XML

Business and Summary of Significant Accounting Policies - Additional Information (Details) - USD ($)	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020	Dec. 31, 2020
Allowance for doubtful accounts	$ 0		$ 0		$ 0
Advertising Expense	$ 152,000	$ 65,000	$ 451,000	$ 81,000
Warrant
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	4,475,424	7,337,199	4,475,424	7,337,199
Restricted Stock
Number of restricted shares granted	310,000		310,000
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	711,805	98,669	711,805	98,669
Restricted stock units
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	456,931		456,931
Series A Preferred Stock
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount		250,000		250,000
Accounts Receivable | Customer Concentration Risk One
Concentration Risk, Percentage			63.00%		36.00%
Accounts Receivable | Customer Concentration Risk Two
Concentration Risk, Percentage					31.00%
Accounts Receivable | Customer Concentration Risk Three
Concentration Risk, Percentage					15.00%
Sales Revenue, Net | Customer Concentration Risk One
Concentration Risk, Percentage		30.00%	33.00%	54.00%
Sales Revenue, Net | Customer Concentration Risk Two
Concentration Risk, Percentage	12.00%	18.00%	17.00%	28.00%
Sales Revenue, Net | Customer Concentration Risk Three
Concentration Risk, Percentage	12.00%	15.00%	10.00%	11.00%
Sales Revenue, Net | Customer Concentration Risk Four
Concentration Risk, Percentage		11.00%

XML

Going Concern (Details) - USD ($)	9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Dec. 31, 2020	[1]
Going Concern
Cash and cash equivalents	$ 16,067,000		$ 7,415,000
Net cash used in operations	(8,574,000)	$ (7,499,000)
Proceeds from Paycheck Protection Program	$ 847,000

[1] The condensed consolidated balance sheet as of December 31, 2020 was derived from the audited consolidated balance sheet as of that date.

XML

Balance Sheet Components - Inventories (Details) - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020
Balance Sheet Components
Raw materials	$ 1,693	$ 1,872
Work in progress	539	283
Finished goods	1,722	553
Total inventories	$ 3,954	$ 2,708	[1]

[1] The condensed consolidated balance sheet as of December 31, 2020 was derived from the audited consolidated balance sheet as of that date.

XML

Balance Sheet Components - Property and equipment (Details) - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020
Property and equipment, gross	$ 1,107	$ 1,021
Less: Accumulated depreciation and amortization	(938)	(879)
Property and equipment, net	169	142	[1]
Machinery and equipment
Property and equipment, gross	952	866
Tooling
Property and equipment, gross	11	11
Computer software
Property and equipment, gross	89	89
Furniture and fixtures
Property and equipment, gross	15	15
Leasehold improvements
Property and equipment, gross	$ 40	$ 40

[1] The condensed consolidated balance sheet as of December 31, 2020 was derived from the audited consolidated balance sheet as of that date.

XML

Balance Sheet Components - Accrued liabilities (Details) - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020
Balance Sheet Components
Accrued vacation	$ 344	$ 328
Accrued compensation	321	84
Customer advances	715	373
Accrued professional fees	158	161
Accrued rebate	319	326
Accrued other	183	161
Total accrued liabilities	$ 2,040	$ 1,433	[1]

[1] The condensed consolidated balance sheet as of December 31, 2020 was derived from the audited consolidated balance sheet as of that date.

XML

Balance Sheet Components - Additional Information (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020	Dec. 31, 2020
Depreciation and amortization expense	$ 20,000	$ 17,000	$ 59,000	$ 46,000
Property and equipment, gross	1,107,000		1,107,000		$ 1,021,000
Accumulated Depreciation	938,000		938,000		$ 879,000
Capital lease
Property and equipment, gross	72,000		72,000
Accumulated Depreciation	$ 26,000		$ 26,000

XML

Borrowings (Details) - USD ($)					3 Months Ended	9 Months Ended
	Nov. 09, 2020	May 18, 2020	Mar. 09, 2020	Jan. 23, 2020	Sep. 30, 2020	Sep. 30, 2020
Issuance of common stock	236,375	60,250
Funding Agreement | Convertible debt
Principal amount of debt				$ 111,100
Original issue discount				10.00%
Issuance of common stock				500
Term of warrant exercisable				5 years
Warrant exercisable for shares of common stock				7,936
Exercise price of warrants				$ 9.80
Consideration				$ 100,000
Period of execution of funding agreement			45 days
Interest expense from amortization of debt discounts					$ 0	$ 20,000

XML

Borrowings - Convertible Promissory Note (Details)	3 Months Ended		9 Months Ended
	Sep. 30, 2021 USD ($) $ / shares shares	Sep. 30, 2020 USD ($)	Sep. 30, 2021 USD ($) D $ / shares shares	Sep. 30, 2020 USD ($)	Dec. 31, 2020 USD ($)	[1]	May 03, 2020 USD ($)	Apr. 29, 2020 USD ($)	Mar. 30, 2020 $ / shares shares
Deemed dividend from warrant repricing	$ 0	$ 0	$ 0	$ 134,000
Debt outstanding	$ 0		0		$ 668,000
Payroll Protection Program Note Agreement
Principal amount of debt							$ 847,000
Debt Instrument, Interest Rate, Stated Percentage							1.00%
Gain on extinguishment of debt			$ 859,000
Convertible debt | March 2020 Private Placement
Period of execution of funding agreement			60 days
Period to enter into an underwriting agreement			45 days
Threshold period for conversion of notes			45 days
Percentage of average of lowest daily VWAPs			90.00%
Number of lowest daily VWAPs | $ / shares			$ 5
Number of trading days for lowest daily VWAPs | D			20
Base conversion price | $ / shares	$ 6.40		$ 6.40
Threshold notice period for payment to investors in cash			3 days
Right to pay the investors as a percentage of portion of outstanding principal amount			103.00%
Redeemable portion of outstanding principal amount			103.00%
Threshold period for conversion of debt			9 months
Outstanding principal amount of debt converted			$ 102,000
Threshold prepayment notice to investor			10 days
Threshold prepayment notice to company			5 days
Percentage of conversion of principal amount			33.00%
Percentage repayments of outstanding principal amount in the event of change of control			105.00%
Convertible debt | Maxim Group LLC | March 2020 Private Placement
Warrants to purchase shares of Common Stock | shares									227,679
Price per Unit | $ / shares									$ 6.40
Net proceeds			$ 1,700,000
Commitment Fee Payable To Investor	$ 85,000		$ 85,000
Convertible debt | Maxim Group LLC | Maximum | March 2020 Private Placement
Warrants to purchase shares of Common Stock | shares	20,400		20,400
Notes March 2020
Interest expense from amortization of debt discounts	$ 0	$ 0	$ 0	$ 1,389,000
Debt outstanding								$ 2,040,000

[1] The condensed consolidated balance sheet as of December 31, 2020 was derived from the audited consolidated balance sheet as of that date.

XML

Fair Value Measurements (Details) - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020
Quoted prices in active markets (Level 1)
Liabilities:
Derivative liability		$ 0
Quoted prices in active markets (Level 1) | Warrant
Liabilities:
Warrant liability	$ 0	0
Significant other observable inputs (Level 2)
Liabilities:
Derivative liability		0
Significant other observable inputs (Level 2) | Warrant
Liabilities:
Warrant liability	0	0
Significant unobservable inputs (Level 3)
Liabilities:
Derivative liability		387
Significant unobservable inputs (Level 3) | Warrant
Liabilities:
Warrant liability	$ 8	$ 8

XML

Fair Value Measurements - Summary of changes in fair value of the Company's warrant liability measured at fair value using significant unobservable inputs (Leve3) (Details) - Warrant - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Beginning balance	$ 8,000	$ 0	$ 8,000	$ 24,000
Additions	0	0	0	0
Change in fair value	0	0	0	(24,000)
Ending balance	$ 8,000	$ 0	$ 8,000	$ 0

XML

Fair Value Measurements - Additional Information (Details)	9 Months Ended
	Sep. 30, 2021 USD ($) D $ / shares	Dec. 31, 2020 USD ($)
Fair value of the derivative liability | $	$ 0	$ 387,000
Series A Preferred Stock
Debt Instrument, Interest Rate, Stated Percentage	95.00%
Trading days to calculate volume weighted average price | D	10
Debt Instrument, Convertible, Conversion Price | $ / shares	$ 30.00

XML

Convertible Preferred Stock and Stockholders' Equity (Deficit) - Activity related to restricted stock award (Details) - $ / shares	3 Months Ended	9 Months Ended
	Sep. 30, 2021	Sep. 30, 2021
2020 Stock Incentive Plan
Shares
Non-vested as of January 1, 2021		626,974
Granted		20,500
Vested		(201,343)
Forfeited		0
Non-vested as of September 30, 2021	446,131	446,131
Weighted-Average Grant Date Fair Value
Non-vested as of January 1, 2021		$ 2.29
Granted		3.81
Vested		2.27
Forfeited		0
Non-vested as of September 30, 2021	$ 2.36	$ 2.36
Restricted Stock
Shares
Non-vested as of January 1, 2021		87,169
Granted		664,500
Vested		(29,064)
Forfeited		0
Non-vested as of September 30, 2021	722,605	722,605
Weighted-Average Grant Date Fair Value
Non-vested as of January 1, 2021		$ 2.26
Granted		3.57
Vested		2.26
Forfeited		0
Non-vested as of September 30, 2021	$ 3.46	$ 3.46
Restricted Stock | 2020 Stock Incentive Plan
Shares
Vested	(201,343)	(201,343)

XML

Convertible Preferred Stock and Stockholders' Equity (Deficit) - Warrants for common stock outstanding and exercisable (Details) - Warrant - $ / shares	9 Months Ended	12 Months Ended
	Sep. 30, 2021	Dec. 31, 2020
Exercise Price Range One
Class of Stock [Line Items]
Warrants Outstanding	4,053,384	6,884,216
Weighted Average Remaining Life (years)	3 years 10 months 9 days	4 years 6 months 18 days
Warrants Exercisable	4,038,384	6,869,216
Exercise Price Range One | Minimum
Class of Stock [Line Items]
Exercise Price	$ 2.32	$ 2.32
Exercise Price Range One | Maximum
Class of Stock [Line Items]
Exercise Price	$ 4.46	$ 3.90
Exercise Price Range Two
Class of Stock [Line Items]
Warrants Outstanding	32,889	32,889
Weighted Average Remaining Life (years)	3 years 4 months 28 days	4 years 1 month 24 days
Warrants Exercisable	32,889	32,889
Exercise Price Range Two | Minimum
Class of Stock [Line Items]
Exercise Price	$ 6.40	$ 6.40
Exercise Price Range Two | Maximum
Class of Stock [Line Items]
Exercise Price	$ 9.80	$ 9.80
Exercise Price Range Three
Class of Stock [Line Items]
Warrants Outstanding	93,562	93,562
Weighted Average Remaining Life (years)	1 year 3 days	1 year 9 months 3 days
Warrants Exercisable	93,562	93,562
Exercise Price Range Three | Minimum
Class of Stock [Line Items]
Exercise Price	$ 15.80	$ 15.80
Exercise Price Range Three | Maximum
Class of Stock [Line Items]
Exercise Price	$ 17.50	$ 17.50
Exercise Price Range Four
Class of Stock [Line Items]
Warrants Outstanding	222,807	230,571
Weighted Average Remaining Life (years)	1 year 4 months 17 days	11 months 26 days
Warrants Exercisable	222,807	230,571
Exercise Price Range Four | Minimum
Class of Stock [Line Items]
Exercise Price	$ 24.80	$ 24.80
Exercise Price Range Four | Maximum
Class of Stock [Line Items]
Exercise Price	$ 99.00	$ 99.00
Exercise Price Range Five
Class of Stock [Line Items]
Warrants Outstanding	72,782	72,864
Weighted Average Remaining Life (years)	10 months 13 days	1 year 7 months 6 days
Warrants Exercisable	72,782	72,864
Exercise Price Range Five | Minimum
Class of Stock [Line Items]
Exercise Price	$ 108.00	$ 108.00
Exercise Price Range Five | Maximum
Class of Stock [Line Items]
Exercise Price	125.00	207.00
Exercise Price Range Six
Class of Stock [Line Items]
Exercise Price	$ 7.88	$ 5.81
Warrants Outstanding	4,475,424	7,314,102
Weighted Average Remaining Life (years)	3 years 7 months 28 days	4 years 6 months 14 days
Warrants Exercisable	4,460,424	7,299,102

XML

Convertible Preferred Stock and Stockholders' Equity (Deficit) - Equity Transactions (Details) - USD ($) $ / shares in Units, $ in Millions					1 Months Ended	9 Months Ended	12 Months Ended
	Apr. 23, 2021	Nov. 09, 2020	May 18, 2020	Apr. 23, 2020	Apr. 30, 2020	Sep. 30, 2021	Dec. 31, 2020
Class of Stock [Line Items]
Issuance of common stock		236,375	60,250
April 2020 Maxim Warrant
Class of Stock [Line Items]
Warrants to purchase shares of Common Stock					100,000	15,000	15,000
Exercise price of warrants					$ 3.90
Combined shares price						$ 0.20	$ 0.20
Warrant
Class of Stock [Line Items]
Warrants to purchase shares of Common Stock						19,000
April 2020 public offering
Class of Stock [Line Items]
Issuance of common stock				1,525,000
Exercise price of warrants				$ 3.25	0.01
Combined shares price				$ 3.24	$ 3.25
Consideration				$ 6.5
Option to purchase additional shares or warrants, days	45 days
Option to purchase additional shares or warrants, shares				300,000
Warrant term	5 years
April 2020 public offering | Prefunded common stock purchase warrants
Class of Stock [Line Items]
Warrants to purchase shares of Common Stock					475,000
April 2020 public offering | Common stock purchase warrants
Class of Stock [Line Items]
Warrants to purchase shares of Common Stock				475,000	1,525,000
Warrants to purchase shares (per share)				2,000,000
Exercise price of warrants					$ 3.25
Option to purchase additional shares or warrants, shares				229,100
April 2020 public offering | April 2020 Maxim Warrant
Class of Stock [Line Items]
Warrants to purchase shares of Common Stock				100,000	291,000
Exercise price of warrants					$ 3.90

XML

Convertible Preferred Stock and Stockholders' Equity (Deficit) - Alexander settlement agreement (Details) - USD ($)				3 Months Ended	9 Months Ended
	Nov. 09, 2020	May 18, 2020	May 14, 2020	Mar. 31, 2020	Sep. 30, 2020
Class of Stock [Line Items]
Issuance of common stock	236,375	60,250
Aggregate purchase price				$ 725,000
Vendors
Class of Stock [Line Items]
Issuance of common stock		10,250
Alexander Settlement Agreement
Class of Stock [Line Items]
Cash fees paid			$ 125,000
Issuance of common stock		50,000	50,000
Aggregate purchase price			$ 111,000
Shares disposal allowed per day			5,000
Settlement expense					$ 237,000

XML

Convertible Preferred Stock and Stockholders' Equity (Deficit) - Securities purchase agreement (Details) - USD ($)	Jul. 22, 2021	Nov. 09, 2020	Jun. 09, 2020	Jun. 04, 2020	May 18, 2020	Sep. 30, 2021
Class of Stock [Line Items]
Issuance of common stock		236,375			60,250
June 4th Purchase Agreement
Class of Stock [Line Items]
Warrants to purchase shares of Common Stock						2,275,000
Exercise price of warrants						$ 2.55
June 4th Purchase Agreement | Securities Purchase Agreement
Class of Stock [Line Items]
Issuance of common stock				2,275,000
Warrant term				5 years 6 months
Warrants to purchase shares of Common Stock				2,275,000
Exercise price of warrants				$ 2.55
Aggregate purchase price				$ 5,801,000
Cash fees paid				$ 464,000
Cash fees paid percentage				8.00%
June 9th Purchase Agreement | Securities Purchase Agreement
Class of Stock [Line Items]
Issuance of common stock			2,040,000
Warrant term			5 years 6 months
Warrants to purchase shares of Common Stock			2,040,000
Exercise price of warrants			$ 2.61
Aggregate purchase price			$ 5,324,000
Cash fees paid			$ 426,000
Cash fees paid percentage			8.00%
July 22nd Purchase Agreement | Securities Purchase Agreement
Class of Stock [Line Items]
Issuance of common stock	2,500,000
Aggregate purchase price	$ 10,000,000
Cash fees paid percentage	8.00%

XML

Convertible Preferred Stock and Stockholders' Equity (Deficit) - Warrants for shares of common stock (Details)			1 Months Ended				3 Months Ended					9 Months Ended		12 Months Ended
	Jun. 04, 2021 USD ($) $ / shares shares	Apr. 23, 2020 $ / shares shares	Jun. 30, 2021 USD ($) $ / shares shares	Jan. 31, 2021 USD ($) $ / shares shares	Apr. 30, 2020 USD ($) $ / shares shares	Feb. 29, 2020 USD ($)	Sep. 30, 2021 USD ($) $ / shares shares	Jun. 30, 2021 USD ($) $ / shares shares	Mar. 31, 2021 shares	Sep. 30, 2020 USD ($)	Mar. 31, 2020 USD ($) $ / shares shares	Sep. 30, 2021 USD ($) $ / shares shares	Sep. 30, 2020 USD ($)	Dec. 31, 2020 $ / shares shares	Apr. 23, 2021	Nov. 09, 2020 shares	Apr. 18, 2019 shares
Class of Stock [Line Items]
Deemed dividend from warrant repricing							$ 0			$ 0		$ 0	$ 134,000
Proceeds from Warrant Exercises												$ 0	$ 37,000
Lisa Walsh
Class of Stock [Line Items]
Warrants to purchase shares of Common Stock | shares	187,500																12,756
Warrant term	5 years 4 months
Alexander Capital, LP.
Class of Stock [Line Items]
Proceeds from Warrant Exercises						$ 11,000
Common Shares
Class of Stock [Line Items]
Warrants to purchase shares of Common Stock | shares																236,369
Warrants to purchase shares of common stock for cash | shares			250,000
Issuance of common stock upon warrant exchanged | shares							19,000	1,360,244	2,086,251
June 4th Purchase Agreement
Class of Stock [Line Items]
Warrants to purchase shares of Common Stock | shares							2,275,000					2,275,000
Exercise price of warrants | $ / shares							$ 2.55					$ 2.55
Fair value of warrant							$ 3,153,000					$ 3,153,000
Common Stock Price | $ / shares							$ 2.52					$ 2.52
June 8th Purchase Agreement
Class of Stock [Line Items]
Warrants to purchase shares of Common Stock | shares							2,040,000					2,040,000
Exercise price of warrants | $ / shares							$ 2.61					$ 2.61
Fair value of warrant							$ 2,375,000					$ 2,375,000
Common Stock Price | $ / shares							$ 2.25					$ 2.25
April 2020 public offering
Class of Stock [Line Items]
Exercise price of warrants | $ / shares		$ 3.25			$ 0.01
Fair value of warrant					$ 475,000
Common Stock Price | $ / shares					$ 2.50
Combined shares price | $ / shares		$ 3.24			$ 3.25
Deemed dividend from warrant repricing					$ 2,606,000							$ 134,000
Proceeds from Issuance of Warrants					$ 4,750
Issuance of common stock upon warrant exchanged | shares					475,000
Warrant term															5 years
Warrant
Class of Stock [Line Items]
Warrants to purchase shares of Common Stock | shares							19,000					19,000
Proceeds from Issuance of Warrants							$ 62,000
Warrant | Lisa Walsh
Class of Stock [Line Items]
Exercise price of warrants | $ / shares	$ 3.00
Fair value of warrant	$ 570,000
Common Stock Price | $ / shares	$ 4.77
Warrant | Common Shares
Class of Stock [Line Items]
Warrants to purchase shares of Common Stock | shares			1,000,000					1,000,000
Exercise price of warrants | $ / shares			$ 4.46					$ 4.46
Fair value of warrant			$ 579,000					$ 579,000
Common Stock Price | $ / shares			$ 4.50					$ 4.50
Net proceeds			$ 2,300,000
Warrant term			5 years					5 years
Warrant | January 2021
Class of Stock [Line Items]
Warrants to purchase shares of Common Stock | shares				1,221,675
Warrants to purchase shares of common stock for cash | shares				305,419
Exercise price of warrants | $ / shares				$ 4.20
Fair value of warrant				$ 567,000
Common Stock Price | $ / shares				$ 3.85
Proceeds from Warrant Exercises				$ 2,900,000
Warrant term				5 years
March 2020 Warrant
Class of Stock [Line Items]
Warrants to purchase shares of Common Stock | shares											227,679
Exercise price of warrants | $ / shares											$ 6.40
Fair value of warrant											$ 625,000
Common Stock Price | $ / shares											$ 5.40
March 2020 Maxim Warrant
Class of Stock [Line Items]
Warrants to purchase shares of Common Stock | shares											20,400
Prefunded common stock purchase warrants | April 2020 public offering
Class of Stock [Line Items]
Warrants to purchase shares of Common Stock | shares					475,000
Common stock purchase warrants | April 2020 public offering
Class of Stock [Line Items]
Warrants to purchase shares of Common Stock | shares		475,000			1,525,000
Exercise price of warrants | $ / shares					$ 3.25
April 2020 Maxim Warrant
Class of Stock [Line Items]
Warrants to purchase shares of Common Stock | shares					100,000		15,000					15,000		15,000
Exercise price of warrants | $ / shares					$ 3.90
Fair value of warrant					$ 106,000
Common Stock Price | $ / shares					$ 2.50		$ 15.80					$ 15.80		$ 15.80
Combined shares price | $ / shares												$ 0.20		$ 0.20
Issuance of common stock upon warrant exchanged | shares												20,722		20,722
April 2020 Maxim Warrant | April 2020 public offering
Class of Stock [Line Items]
Warrants to purchase shares of Common Stock | shares		100,000			291,000
Exercise price of warrants | $ / shares					$ 3.90
Dividend Yield | June 4th Purchase Agreement
Class of Stock [Line Items]
Measurement input							0.0					0.0
Dividend Yield | June 8th Purchase Agreement
Class of Stock [Line Items]
Measurement input							0.0					0.0
Dividend Yield | April 2020 public offering
Class of Stock [Line Items]
Measurement input					0.0
Dividend Yield | Warrant | Lisa Walsh
Class of Stock [Line Items]
Measurement input	0.0
Dividend Yield | Warrant | Common Shares
Class of Stock [Line Items]
Measurement input			0.0					0.0
Dividend Yield | Warrant | January 2021
Class of Stock [Line Items]
Measurement input				0.0
Dividend Yield | March 2020 Warrant
Class of Stock [Line Items]
Measurement input											0.0
Dividend Yield | April 2020 Maxim Warrant
Class of Stock [Line Items]
Measurement input					0
Volatility | June 4th Purchase Agreement
Class of Stock [Line Items]
Measurement input							64.0					64.0
Volatility | June 8th Purchase Agreement
Class of Stock [Line Items]
Measurement input							64.0					64.0
Volatility | April 2020 public offering
Class of Stock [Line Items]
Measurement input					64.0
Volatility | Warrant | Lisa Walsh
Class of Stock [Line Items]
Measurement input	60.7
Volatility | Warrant | Common Shares
Class of Stock [Line Items]
Measurement input			60.7					60.7
Volatility | Warrant | January 2021
Class of Stock [Line Items]
Measurement input				60.1
Volatility | March 2020 Warrant
Class of Stock [Line Items]
Measurement input											61.0
Volatility | April 2020 Maxim Warrant
Class of Stock [Line Items]
Measurement input					64
Risk-free rate of interest | June 4th Purchase Agreement
Class of Stock [Line Items]
Measurement input							0.45					0.45
Risk-free rate of interest | June 8th Purchase Agreement
Class of Stock [Line Items]
Measurement input							0.32					0.32
Risk-free rate of interest | April 2020 public offering
Class of Stock [Line Items]
Measurement input					0.37
Risk-free rate of interest | Warrant | Lisa Walsh
Class of Stock [Line Items]
Measurement input	0.78
Risk-free rate of interest | Warrant | Common Shares
Class of Stock [Line Items]
Measurement input			0.77					0.77
Risk-free rate of interest | Warrant | January 2021
Class of Stock [Line Items]
Measurement input				0.45
Risk-free rate of interest | March 2020 Warrant
Class of Stock [Line Items]
Measurement input											0.38
Risk-free rate of interest | April 2020 Maxim Warrant
Class of Stock [Line Items]
Measurement input					0.37
Term (Years) | June 4th Purchase Agreement
Class of Stock [Line Items]
Fair Value Expected Term												5 years 6 months
Term (Years) | June 8th Purchase Agreement
Class of Stock [Line Items]
Fair Value Expected Term												5 years 6 months
Term (Years) | April 2020 public offering
Class of Stock [Line Items]
Fair Value Expected Term					5 years
Term (Years) | Warrant | Lisa Walsh
Class of Stock [Line Items]
Fair Value Expected Term	5 years 4 months 24 days
Term (Years) | Warrant | Common Shares
Class of Stock [Line Items]
Fair Value Expected Term			5 years
Term (Years) | Warrant | January 2021
Class of Stock [Line Items]
Fair Value Expected Term									5 years
Term (Years) | March 2020 Warrant
Class of Stock [Line Items]
Fair Value Expected Term											5 years
Term (Years) | April 2020 Maxim Warrant
Class of Stock [Line Items]
Fair Value Expected Term					5 years
Series A Preferred Stock | Lisa Walsh
Class of Stock [Line Items]
Issuance of common stock upon warrant exchanged | shares							187,500

XML

Convertible Preferred Stock and Stockholders' Equity (Deficit) - Additional Information (Details)												1 Months Ended	3 Months Ended					9 Months Ended		12 Months Ended
	Sep. 13, 2021 USD ($) shares	Jul. 22, 2021 USD ($) shares	Jun. 04, 2021 $ / shares shares	Nov. 09, 2020 $ / shares shares	Oct. 20, 2020 shares	Jul. 27, 2020 shares	May 18, 2020 shares	Apr. 09, 2020	Mar. 30, 2020	Feb. 28, 2020 USD ($) $ / shares shares	Apr. 18, 2019 USD ($) $ / shares shares	Feb. 29, 2020 USD ($) $ / shares shares	Sep. 30, 2021 USD ($) $ / shares shares	Jun. 30, 2021 $ / shares shares	Mar. 31, 2021 shares	Sep. 30, 2020 USD ($) shares	Mar. 31, 2020 shares	Sep. 30, 2021 USD ($) $ / shares shares	Sep. 30, 2020 USD ($) shares	Dec. 31, 2020 $ / shares shares
Class of Stock [Line Items]
Reverse stock split								0.05										0.50
Temporary equity, par or stated value per share | $ / shares													$ 0.0001					$ 0.0001		$ 0.0001
Shares issued													0					0		250,000
Dividend rate																		8.00%		8.00%
Number of Shares Authorized													1,250,000					1,250,000		1,250,000
Number of shares outstanding													0					0		250,000
Stock-based compensation | $													$ 10,000					$ 10,000
Proceeds from Warrant Exercises | $																		$ 0	$ 37,000
Issuance of common stock				236,375			60,250
Warrant
Class of Stock [Line Items]
Warrants to purchase shares of Common Stock													19,000					19,000
Common Shares
Class of Stock [Line Items]
Warrants to purchase shares of Common Stock				236,369
Exchange of convertible preferred stock for common stock (in shares)																	500
Issuance of common stock upon warrant exchanged													19,000	1,360,244	2,086,251
Issuance of common stock																	91,062
Common Shares | Warrant
Class of Stock [Line Items]
Warrants to purchase shares of Common Stock														1,000,000
Share Price | $ / shares														$ 4.50
Exercise price of warrants | $ / shares														$ 4.46
Warrant term														5 years
February 2020 Private Placement
Class of Stock [Line Items]
Warrants to purchase shares of Common Stock				45,534						4,553		45,534
Number of units issued										91,062
Number of shares per unit										1
Warrant to purchase share of common stock per unit										0.50
Share Price | $ / shares										$ 9.17
Cash fees paid | $										$ 83,000
Exercise price of warrants | $ / shares				$ 2.55						$ 8.80		$ 9.80
Warrant term										5 years
Gross proceeds | $										$ 835,000
Beneficial ownership interest												4.99%
Convertible Preferred Stock, Convertible, Issue of Shares, Threshold Percentage												9.99%
Proceeds from Warrant Exercises | $												$ 103,000
Exercise price | $ / shares												$ 6.00
Dividend rate												0.00%
Volatility rate												59.00%
Risk free interest rate												0.89%
Expected term												5 years
July 22nd Purchase Agreement | Securities Purchase Agreement
Class of Stock [Line Items]
Aggregate purchase price | $		$ 10,000,000
Cash fees paid percentage		8.00%
Cash fees paid | $		$ 800,000
Issuance of common stock		2,500,000
Threshold market capitalization of $75 million
Class of Stock [Line Items]
Market capitalization | $	$ 75,000,000
Threshold market capitalization of $100 million
Class of Stock [Line Items]
Market capitalization | $	100,000,000
Threshold market capitalization of $150 million
Class of Stock [Line Items]
Market capitalization | $	$ 150,000,000
Restricted Stock
Class of Stock [Line Items]
Number of stock released																		29,064
Number of restricted shares granted																		664,500
Unamortized compensation costs | $													$ 2,028,000					$ 2,028,000
Weighted-average period																		2 years 4 months 24 days
Carve-Out Plan | Restricted Stock
Class of Stock [Line Items]
Number of stock released													0			353		352	706
Aggregate intrinsic value | $													$ 0			$ 1,000		$ 2,000	$ 3,000
LTSI
Class of Stock [Line Items]
Maximum shares authorized to issue, percentage													15.00%					15.00%
Number of shares available for grant													672,180					672,180
Number of restricted shares granted													29,064			0		29,064	0
Aggregate intrinsic value | $													$ 93,000					$ 93,000
September 2021 Inducement Grant
Class of Stock [Line Items]
Number of stock released	232,500
September 2021 Inducement Grant | Vest monthly over a period of 36 months
Class of Stock [Line Items]
Number of stock released	77,500
Vesting term	36 months
Value of grant | $	$ 772,000
September 2021 Inducement Grant | Vest upon the achievement of certain company milestones
Class of Stock [Line Items]
Number of stock released	77,500
September 2021 Inducement Grant | Restricted Stock
Class of Stock [Line Items]
Number of restricted shares granted	310,000
2020 Stock Incentive Plan
Class of Stock [Line Items]
Number of stock released																		201,343
Number of restricted shares granted																		20,500
2020 Stock Incentive Plan | Restricted Stock
Class of Stock [Line Items]
Number of stock released													201,343					201,343
Aggregate intrinsic value | $													$ 646,000					$ 646,000
Unamortized compensation costs | $													$ 1,042,000					$ 1,042,000
Weighted-average period																		1 year 10 months 24 days
Shares authorized for issuance					650,000	650,000
Shares issued to to employees, directors and consultants					614,824	614,824
Minimum
Class of Stock [Line Items]
Reverse stock split									0.25
Maximum
Class of Stock [Line Items]
Reverse stock split									0.05
Lisa Walsh
Class of Stock [Line Items]
Warrants to purchase shares of Common Stock			187,500								12,756
Exchange of convertible preferred stock for common stock (in shares)			250,000
Warrant term			5 years 4 months
Lisa Walsh | Warrant
Class of Stock [Line Items]
Share Price | $ / shares			$ 4.77
Exercise price of warrants | $ / shares			$ 3.00
Alexander Capital, LP.
Class of Stock [Line Items]
Proceeds from Warrant Exercises | $												$ 11,000
Exercise price | $ / shares												$ 6.00
Dividend rate												0.00%
Volatility rate												59.00%
Risk free interest rate												0.89%
Expected term												5 years
Series A Preferred Stock
Class of Stock [Line Items]
Temporary equity, par or stated value per share | $ / shares													$ 0.0001					$ 0.0001
Shares issued													0					0
Dividend rate																		8.00%
Number of Shares Authorized													20,000,000					20,000,000
Number of shares outstanding													0					0
Series A Preferred Stock | Minimum
Class of Stock [Line Items]
Proceeds from Issuance of Convertible Preferred Stock | $											$ 500,000
Series A Preferred Stock | Maximum
Class of Stock [Line Items]
Proceeds from Issuance of Convertible Preferred Stock | $											$ 5,000,000
Series A Preferred Stock | Lisa Walsh
Class of Stock [Line Items]
Shares issued											250,000
Dividend rate											8.00%
Par value | $ / shares											$ 0.0001
Stated value | $ / shares											4.00
Conversion price per share | $ / shares											80.00
Floor price per share | $ / shares											$ 30.00
Proceeds from Issuance of Convertible Preferred Stock | $											$ 1,000,000
Fair value of embedded derivative liability | $											$ 216,000
Exchange of convertible preferred stock for common stock (in shares)													250,000
Issuance of common stock upon warrant exchanged													187,500

XML

Income Taxes - Effective Income Tax Rate Reconciliation (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Income Taxes
Provision for income taxes	$ 0	$ 0	$ 2,000	$ 3,000
Effective tax rate			0.02%	0.03%

XML

Commitments and Contingencies - Operating Leases (Details) - USD ($)	1 Months Ended	3 Months Ended		9 Months Ended
	Jul. 31, 2018	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Commitments and Contingencies
Lease Expiration Date	Oct. 31, 2020
Operating Leases, Rent Expense		$ 56,000	$ 87,000	$ 168,000	$ 288,000
Annual minimum lease payments for operating lease
Year ending December 31, 2021		41,000		41,000
Year ending December 31, 2022		153,000		153,000
Year ending December 31, 2023		173,000		173,000
Year ending December 31, 2024		$ 15,000		$ 15,000

XML

Commitments and Contingencies - Capital Leases (Details) - USD ($) $ in Thousands	1 Months Ended
	Aug. 31, 2020	Sep. 30, 2021
Commitments and Contingencies
Term of capital lease	36 months
Payments due in:
Year ending December 31, 2021 (remaining 3 months)		$ 6
Year ending December 31, 2022		26
Year ending December 31, 2023		15
Total minimum lease payments		47
Less: Amounts representing interest		(2)
Present value of capital lease obligations		45
Less: Current portion of capital lease liabilities		24
Other liabilities		$ 21

XML

Related Parties (Details) - USD ($)				3 Months Ended				9 Months Ended
	Nov. 09, 2020	May 18, 2020	Feb. 06, 2020	Sep. 30, 2021	Sep. 30, 2020	Jun. 30, 2020	Mar. 31, 2020	Sep. 30, 2021	Sep. 30, 2020	Dec. 31, 2020
Issuance of common stock in connection with settlements						$ 135,000
Aggregate purchase price							$ 725,000
Issuance of common stock	236,375	60,250
Alexander Capital, LP.
Other Expenses			$ 83,000
Aggregate purchase price			$ 835,000
Alexander Capital, LP.
Warrants exercise price			$ 8.80
Warrant term			5 years
Warrant exercisable for shares of common stock			4,553
Warrant
Warrant exercisable for shares of common stock				19,000				19,000
Jonathan Gazdak | Warrant
Ownership percentage				1.00%				1.00%		1.00%
Helge Kristensen | Warrant
Ownership percentage				1.00%				1.00%		1.00%
Hansong Technology
Purchase of wireless audio speaker systems from related party				$ 96,000	$ 8,000			$ 854,000	$ 8,000
Payments for purchases				309,000	38,000			962,000	67,000
Hansong Technology | Sales To Related Party
Revenue from Related Parties				263,000	137,000			496,000	155,000
Payments for purchases				$ 333,000	$ 0			$ 380,000	$ 1,000

XML

Segment Information (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Revenues	$ 1,807	$ 607	$ 4,541	$ 1,366
United States
Revenues	166	75	710	167
Europe
Revenues	162	100	403	169
Asia Pacific
Revenues	1,479	$ 432	3,427	$ 1,030
Other
Revenues	$ 0		$ 1